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It is well-established that the genotoxin, cytolethal distending toxin (CDT) which is 
produced by nearly two dozens of clinically-important bacterial pathogens causes 
DNA damage in a wide range of eukaryotic cells in vitro. More recently, it has 
become clear that irrespective of the origin of CDT,  genotoxic damage results in a 
robust DNA damage response (DDR) in which the serine/threonine protein kinase 
ataxia telangiectasia mutated (ATM) plays a central role. The CDT-induced DDR 
closely resembles the response to DNA double strand breaks (DSBs) elicited by 
ionizing radiation (IR) which can lead to irreversible cell cycle arrest and apoptosis of 
mammalian cells. It is currently believed that CDT-induces ATM-dependent arrest at 
the G1/S and G2/M transitions of the cell cycle by activation of p53/Chk2 and p21(for 
G1/S) and Chk2 and CDC25C (for G2/M) respectively. By contrast, the mechanism of 
CDT-induced apoptosis remains incompletely understood; however, there is some 
evidence that it results from activation of the intrinsic apoptotic pathway through up-
regulation of Bax together with down-regulation of Bcl-2 and the release of 
mitochondrial cytochrome c causing down-stream activation of caspase-9. Moreover, 
on the basis of a higher sensitivity of hematopoietic cells to the cytotoxic effects of 
CDT, it has been suggested that CDT modulates the host immune response in vivo.  
 
To provide a well-characterized in vitro model system that complements in vivo 
studies in a mouse model of defective DNA damage, we first generated several cells 
lines from spontaneous thymic lymphomas of Atm
-/-
 and p53
-/-
 mice. Then by 
comparing the responses of primary thymic lymphocytes with that of thymic 
lymphoma cell lines originated from Atm
-/-
 and p53
-/-
 mice, we clearly showed that 
treatment with H. hepaticus CDT causes a transient reduction in DNA synthesis which 
  
is characteristic of activation of the ATM-dependent intra-S checkpoint.   By 
demonstrating an ATM-dependent reduction in phosphorylated histone H3, we further 
confirmed CDT-mediated G2/M cell cycle arrest. These are the first conclusive 
evidences that CDT is capable of inducing cell cycle arrest in all phases of lymphoid 
cell cycle. Finally, we used our Atm
-/-
 and p53
-/-
 mouse thymic lymphoma cells lines to 
show that CDT-induced apoptosis is also p53-dependent.   
 
Next, we examined the in vitro DDR of several human leukemia and lymphoma cell 
lines to genotoxic damage induced by CDT obtained from the human intestinal 
pathogen Campylobacter jejuni. While all human leukemia and lymphoma cell lines 
irrespective of their p53 status display comparable levels of activation of the ATM 
effector γ-H2AX in response to CDT treatment, two leukemic cell lines, MOLT-3 and 
MOLT-4 with wild-type p53 showed time- and dose-dependent increased 
susceptibility to C. jejuni CDT-induced apoptosis when compared to Jurkat, CEM and 
CA46 (also Bax deficient) cell lines with mutated p53. Demonstration of CDT-
induced Chk1 activation in human leukemic cell lines suggests for the first time the 
involvement of ATR in the DDR to CDT-induced genotoxic damage. Taken together, 
we again conclude that p53 mutational status is a major determinant of the variable 
susceptibility of human lymphoma and leukemia cell lines to CDT. Activation of 
intra-S checkpoint by CDT may contribute to bacterial virulence by modulating 
rapidly dividing host lymphocytes, and thus, host adaptive immune response following 
bacterial infection.  
 
To address this question directly, we assessed the adaptive humoral immune response 
following H. hepaticus infection of laboratory mice with a defective DDR due to a 
mutation in Atm. While infected wild type and heterozygous mice had high levels of 
IgG1 antibodies to H. hepaticus whole cell lysate (WCL), Atm null mice had 
approximately 60% reduction in serum antibody responses to both WCL and CdtB.  
The data suggest that DDR mechanisms are essential for bacterial and CDT-specific 
host adaptive immune responses.       
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CHAPTER 1 
Cytolethal Distending Toxin: A Conserved Bacterial Genotoxin that Blocks Cell Cycle 
Progression Leading to Apoptosis of a Broad Range of Mammalian Cell Lineages
1
 
Abstract 
Cytolethal distending toxin (CDT) is a heterotrimeric AB type genotoxin produced by several 
clinically important Gram negative mucocutaneous bacterial pathogens.  Irrespective of the bacterial 
species of origin, CDT causes characteristic and irreversible cell cycle arrest and apoptosis in a broad 
range of cultured mammalian cell lineages. The active subunit CdtB has structural homology with 
phosphodiesterase family of enzymes including mammalian deoxyribonuclease I, and alone is 
necessary and sufficient to account for cellular toxicity. Indeed, mammalian cells treated with CDT 
initiate a DNA damage response similar to that elicited by ionizing radiation-induced DNA double 
strand breaks resulting in cell cycle arrest and apoptosis. The mechanism of CDT-induced apoptosis 
remains incompletely understood, but appears to involve both p53-dependent and -independent 
pathways. While epithelial, endothelial and fibroblast cell lines respond to CDT by undergoing arrest 
of cell cycle progression resulting in nuclear and cytoplasmic distension that precedes apoptotic cell 
death, cells of hematopoietic origin display rapid apoptosis following a brief period of cell cycle arrest. 
In this review, the ecology and molecular biology of bacterial CDT and the molecular mechanisms of 
CDT-induced cytoxicity are critically appraised. Understanding the contribution of a broadly-
conserved bacterial genotoxin that blocks progression of the cell cycle and causes cell death should 
assist with elucidating disease mechanisms for these important pathogens. 
This article has been published in Microbiology: 
1
Jinadasa, R. N., Bloom, S. E., Weiss, R. S. & Duhamel, G. E. (2011). Cytolethal distending toxin: a 
conserved bacterial genotoxin that blocks cell cycle progression, leading to apoptosis of a broad range of 
mammalian cell lineages. Microbiology 157, 1851-1875. 
Author contributions: R.N.J. performed the experiemnts. R.N.J, S.E.B, R.S.W and G.E.D wrote the paper. 
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Introduction  
Johnson and Lior’s seminal observations over two decades ago demonstrating a novel heat-
labile toxin in culture filtrates obtained from certain Escherichia coli, Shigella dysenteriae, and 
Campylobacter jejuni which caused distinctive and progressive cytoplasmic and nuclear 
enlargement of cultured mammalian cells, so called cytolethal distending toxin (CDT) uncovered 
a novel paradigm amongst bacterial toxins and virulence mechanisms (Johnson & Lior, 1987; 
Johnson & Lior, 1988a; Johnson & Lior, 1988b).  It was not until several years later that Scott 
and Kaper (1994) identified the genes encoding CDT in E. coli, which set the stage for 
fundamental investigations into the ecology, biochemistry, and molecular mechanisms of cellular 
toxicity associated with this novel bacterial toxin (Table 1.1). Few years later, Peres and 
coworkers (1997) noted for the first time that the cellular enlargement associated with CDT 
intoxication was attributable to cell cycle arrest (Peres et al., 1997).  Soon after that, Gelfanova 
and coworkers (1999) demonstrated that the underlying mechanism of CDT-induced cell death 
involved apoptosis (Gelfanova et al., 1999). 
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Table 1.1. Major milestones in CDT discovery time line. 
Discovery Bacteria Reference  
Biological activity 
  
Shigella dysenteriae Johnson & Lior, 1987 
Escherichia coli Johnson & Lior, 1988a 
Campylobacter jejuni Johnson & Lior, 1988b 
Gene sequence  Escherichia coli Scott & Kaper, 1994 
Cell cycle arrest Escherichia coli Peres et al., 1997  
Apoptosis   Haemophilus ducreyi   Gelfanova et al., 1999 
Nuclease activity 
     
Campylobacter jejuni  Lara-Tejero & Galan, 2000 
Escherichia coli Elwell & Dreyfus, 2000 
Crystal structure  Haemophilus ducreyi   Nesic et al., 2004 
Cell surface receptor  Escherichia coli  Carette et al., 2009 
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  The next milestone in CDT research discoveries came with the independent 
demonstration of structural conservation of amino acid residues and functional homology of 
CDTs from E. coli and C. jejuni to mammalian deoxyribonuclease-I (DNase-I) enzyme and 
correlation with DNA double strand breaks (DSBs) as the molecular basis of CDT-mediated 
mammalian cell cycle arrest (Elwell & Dreyfus, 2000; Lara-Tejero & Galan, 2000). With the 
understanding that CDT holotoxin consists of a heterotrimeric complex of three subunits and 
reconstitution of the CDT complex with individually expressed recombinant subunits, Lara-
Tejero and Galan (2001) later proposed an AB toxin molecular model for CDT-induced cellular 
toxicity [as described below;(Lara-Tejero & Galan, 2001)]. This model has since been validated 
on the basis of high resolution crystal structure analysis of CDT from Haemophilus ducreyi and 
Aggregatibacter (Actinobacillus) actinomycetemcomitans (Nesic et al., 2004; Yamada et al., 
2006). The identification of a protein receptor required for CDT binding to a myeloid leukemia 
cell line recently linked cell surface binding of the toxin to DNA damage, and further confirmed 
the AB toxin mechanistic model (Carette et al., 2009).  
Currently, CDT is the only member of the bacterial AB toxins that exhibits 
deoxyribonuclease activity, and irrespective of the bacterial species of origin, exerts genotoxic 
damage by causing DSB leading to irreversible cell cycle arrest and apoptosis in a broad range of 
mammalian cell lineages (Alouf, 2006; Dassanayake et al., 2005a; Frisan et al., 2003; Gelfanova 
et al., 1999; Hickey et al., 2005; Hontz et al., 2006a; Hontz et al., 2006b; Nesic et al., 2004; 
Scott & Kaper, 1994; Whitehouse et al., 1998; Yamada et al., 2006; Young et al., 2000b). The 
genes encoding CDT have now been found in more than two dozen bacteria belonging to the 
Gamma and Epsilon class of Proteobacteria. Many of these Gram negative bacteria are 
 5 
 
clinically-important mucocutaneous pathogens of humans and animals that are responsible for 
major food-borne and water-borne bacterial illnesses worldwide (Table 1.2).  
The biological activity of CDT is highly dependent on cellular targets; however, 
hematopoietic cells display several orders of magnitude higher susceptibility than all other cell 
types suggesting a potential immunomodulatory role of CDT in the pathogenesis of diseases 
caused by CDT-producing bacterial pathogens. In this review, we highlight the ecology and 
molecular biology of bacterial CDT, summarize current structural features and biological 
characteristics of CDT, and critically address the molecular mechanisms of cellular toxicity.  The 
respective roles of ATM and p53 in CDT-induced DNA damage response (DDR) leading to 
arrest of the cell cycle and ultimately cell death by apoptosis are reviewed in detail. 
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Table 1.2. Gram negative mucocutaneous bacteria harboring cytolethal distending toxin (CDT), their respective colonization niches, 
and associated clinical diseases in human and animal hosts. 
Bacteria 
  
CDT
a
  Host   Niche  Associated Disease Reference 
Class Gammaproteobacteria 
Family Pasteurellaceae   
 
Haemophilus species  
H. ducreyi  HducCDT Human  External genitalia Chancroid  Cortes-Bratti et al., 1999 
 H. parasuis  HparCDT Pig  Upper respiratory 
mucosa 
Septicemia  Yue et al., 2009 
Aggregatibacter (formerly Actinobacillus) species  
A. 
actinomycetemcomitans 
AactCDT Human  Oral mucosa  Periodontitis  Ohguchi et  al., 1998 
Family Enterobacteriaceae   
Escherichia coli
b
  
EPEC
c
/ExPEC
d
  
   
EcolCdtB-I
  
Human   
   
Intestinal mucosa  Enterocolitis/septicemia  Asakura et al., 2007a; Pickett & 
Whitehouse, 1999; Scott & Kaper, 
1994; Toth et al., 2003 
Urogenital mucosa UTI
f
  Toth et al., 2003 
APEC
e
  Chicken Intestinal mucosa Septicemia  Johnson et al., 2007 
EPEC   EcolCdtB-II Human  Intestinal mucosa  Enterocolitis  Pickett et al., 1994; Pickett & 
Whitehouse, 1999 
EPEC/ExPEC  EcolCdtB-III Human   Intestinal mucosa  Enterocolitis   Bielaszewska et al., 2004; Peres et al., 
1997; Toth et al., 2003  
NTEC
g
  EcolCdtB-III Cattle  Intestinal mucosa 
  
Enterocolitis/septicemia  Johnson et al., 2009; Peres et al., 
1997; Pickett & Whitehouse, 1999 
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EPEC/ExPEC 
  
EcolCdtB-IV Human   Intestinal mucosa  Enterocolitis/septicemia Toth et al., 2003; Toth et al., 2009 
NTEC  
  
   
EcolCdtB-IV Human  Urogenital mucosa UTI  Toth et al., 2003 
Pig  Intestinal mucosa  Enterocolitis/septicemia  Toth et al., 2003; Toth et al., 2009 
ExPEC  
  
Chicken  Unknown Septicemia  Toth et al., 2003; Toth et al., 2009 
EHEC
h
/STEC
i
  EcolCdtB-V Human  Intestinal mucosa Enterocolitis/HUS
j
  Bielaszewska et al., 2004 
Shigella species   
S. boydii serotype 13  
(E. albertii) 
SboyCDT Human   Intestinal mucosa  Dysentery  Hyma et al., 2005; Johnson & Lior, 
1987 
S. dysenteriae  SdysCDT Human  Intestinal mucosa Dysentery  Johnson & Lior, 1987; Okuda et al., 
1997 
Salmonella species
  
S.enterica  serotype 
Typhi  
StypCdtB Human   Intestinal mucosa  Typhoid fever  Haghjoo & Galan, 2004 
Class Epsilonproteobacteria 
Family Campylobacteraceae  
 
Campylobacter species  
C. jejuni 
  
  
  
CjejCDT
 
 
 
  
Human   Intestinal mucosa  Enterocolitis  Fouts et al., 2005; Johnson & Lior, 
1988b; Young et al., 2007 
NHP
k
  Intestinal mucosa Enterocolitis  Fouts et al., 2005; Johnson & Lior, 
1988b; Young et al., 2007 
Cattle, sheep, pig 
Sheep 
Intestinal mucosa  
Intestinal mucosa  
Enterocolitis  
Reproductive loss 
Bang et al., 2003; Inglis et al., 2005 
Sahin et al, 2008 
Dog, cat, ferret Intestinal mucosa  Enterocolitis  Fox et al., 1987; Young & Mansfield, 
2005 
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Chicken  Intestinal mucosa Commensal  Young et al., 2007 
C. coli  
   
  
  
  
  
CcolCDT Human   Intestinal mucosa  Enterocolitis  Fouts et al., 2005; Pickett et al., 1996 
NHP  Intestinal mucosa  Enterocolitis  Dassanayake et al., 2005b 
Cattle, pig Intestinal mucosa  Commensal  Bang et al., 2003 
Sheep, chicken Intestinal mucosa Commensal  Garrity, 2005 
C. upsaliensis  
  
  
CupsCDT
  
Human   Intestinal mucosa  Enterocolitis/bacteremia  Fouts et al., 2005; Mooney et al., 
2001; Pickett et al., 1996 
Pig,dog,cat,chicken Intestinal mucosa Commensal  Garrity, 2005 
C. hyointestinalis ChyoCDT 
 
  
Human  Intestinal mucosa  Enterocolitis  Edmonds et al., 1987 
Cattle  Intestinal mucosa  Commensal  Inglis et al., 2005 
Pig Intestinal mucosa Enterocolitis  Gebhart et al., 1983; Pickett et al., 
1996 
C. lari   
  
ClarCDT Human   Intestinal mucosa  Enterocolitis  Fouts et al., 2005; Pickett et al., 1996; 
Shigematsu et al., 2006 
C. fetus subsp. fetus
  
  
  
  
  
CfetCDT 
 
  
Human   Intestinal mucosa  Enterocolitis/bacteremia  Garrity, 2005; Johnson & Lior, 1988b; 
Pickett et al., 1996 
Cattle  Intestinal mucosa  Enterocolitis  Ohya et al., 1993 
Cattle, sheep Urogenital mucosa Reproductive loss  Garrity, 2005 
C. fetus subsp. venerealis
   
CvenCDT Human   Intestinal mucosa  Enterocolitis  Asakura et al., 2008; Moolhuijzen et 
al., 2009 
Cattle  Urogenital mucosa Reproductive loss  Garrity, 2005; Moolhuijzen et al., 
2009 
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Family Helicobacteraceae  
Enterohepatic Helicobacter species  
H. hepaticus 
  
HhepCDT Laboratory mice Intestinal mucosa  Enterocolitis/hepatitis  Young et al., 2000b 
H. bilis  
  
HbilCDT
  
Laboratory mice Intestinal/biliary 
mucosa 
Typhlocolitis/hepatitis  Fox et al., 2004b; Fox, 2007 
Dog  Intestinal mucosa  Commensal Hanninen et al., 2005; Kostia et al., 
2003 
H. mastomyrinus  HmasCDT
  
Laboratory mice Intestinal mucosa  Proctitis  Shen et al., 2005 
Mastomys Liver   Hepatitis  Shen et al., 2005 
H. cinaedi 
  
HcinCDT 
 
  
Human  Intestinal mucosa  Septicemia  Taylor et al., 2003 
NHP   Intestinal mucosa/liver Colitis/hepatitis Fernandez et al., 2002; Fox et al., 
2001 
Laboratory mice Intestinal mucosa  Typhlocolitis  Shen et al., 2009 
H. canis  
  
HcanCDT Human   Intestinal mucosa  Bacteremia  Leemann et al., 2006 
Dog  Intestinal mucosa/liver Enterocolitis/hepatitis  Fox et al., 1996 
H. pullorum 
  
HpulCDT Human   Intestinal mucosa  Enteritis  Ceelen et al., 2006; Young et al., 
2000a 
Chicken  
Laboratory mice 
Intestinal mucosa  
Intestinal mucosa 
Enteritis/hepatitis  
Commensal 
Ceelen et al., 2006; Young et al., 
2000a 
Boutin et al., 2010 
H. winghamensis 
  
HwinCDT Human   Intestinal mucosa  Enteritis   Melito et al., 2001 
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a
CDT designation according to a modification of the nomenclature proposed by Cortes-Bratti, 2001 (Cortes-Bratti et al., 2001a); only 
the genes encoding CDT have been described in H. parasuis and C. fetus subsp. Venerealis; the biological activity of CDT has not 
been determined in these bacteria. 
b
Variants of CdtB identified amongst pathotypes of E. coli are designated as EcolCdtB-I to -V 
c
EPEC, enteropathogenic E. coli; 
d
ExPEC, extraintestinal pathogenic E. coli; 
e
APEC, avian pathogenic E. coli; 
f
UTI, urinary tract 
infection;  
g
NTEC, necrotoxigenic E. coli; 
h
EHEC, enterohemorrhagic E. coli; 
i
STEC, Shiga toxin-producing E. coli; 
j
HUS, hemolytic uremic 
syndrome; 
k
NHP, non-human primates 
 
 CDT genes and encoded proteins 
Distribution of CDT genes amongst bacteria  
Currently, bacteria that harbor CDT gene and display biological activity are restricted to 
the Gamma and Epsilon classes in the Proteobacteria phylum (Table 1.2). Within the 
Gammaproteobacteria one subset belongs to the family Pasteurellaceae and includes H. 
ducreyi, the cause of a sexually transmitted disease known as chancroid (Abeck et al., 1997), 
H. parasuis, a commensal organism of the upper respiratory tract associated with septicemia 
in pigs (Yue et al., 2009), and A. actinomycetemcomitans, a common contributing agent to 
aggressive periodontitis (Henderson et al., 2002). A second subset of Gammaproteobacteria 
belongs to the Enterobacteriaceae family, and collectively, these organisms are responsible 
for intestinal and urinary tract infections that can lead to systemic spread. All members of the 
Epsilonproteobacteria belong to the order Campylobacterales and include several species of 
Campylobacter and enterohepatic Helicobacter species (EHS) which are primarily associated 
with enterocolitis; however, some species cause bacteremia/septicemia, hepatitis, and 
reproductive losses in humans and animals (Dassanayake et al., 2005a; Dassanayake et al., 
2005b; Ge et al., 2008; Johnson & Lior, 1987; Liyanage et al., 2010).  It is noteworthy that in 
addition to mammalian bacterial pathogens, a monophyletic group of bacteriophage-encoded 
CdtB orthologs has been found amongst facultative endosymbionts of sap-feeding insects 
(Degnan & Moran, 2008). Thus, the ecology of CDT-harboring bacteria is restricted to 
certain Gram negative bacteria that primarily occupy mucocutaneous niches where persistent 
colonization can occur as either a commensal or result in localized or disseminated infections 
and diseases in a broad range of mammalian hosts. 
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Nomenclature of CDT proteins 
To simplify the designation of CDT produced by various bacteria, Cortes-Bratti and co-
workers proposed a nomenclature system which has been widely adopted by the scientific 
community (Cortes-Bratti et al., 2001a). Since then, the list of bacteria that harbor CDT has 
expanded significantly (Table 1.2). Consequently, the original system consisting of the 
capitalized first letter of the genus followed by a single lower case species letter initial is no 
longer adequate, and some bacterial species now have overlapping designations; for example, 
Hp for Haemophilus parasuis and Helicobacter pullorum or Hc for Helicobacter cinaedi and 
Helicobacter canis. Therefore, we propose a modification of the previous nomenclature 
system in which the first three letters of the bacterial species in lowercases are placed after 
the capitalized first letter of the bacterial genus followed by CDT (Table 1.2). 
 
CDT operon  
The CDT holotoxin consists of a heterotrimeric complex of three subunits designated 
CdtA, CdtB and CdtC with corresponding approximate molecular masses of 23 to 30, 28 to 
29 and 19 to 21 kDa according to bacterial host species (Haghjoo & Galan, 2004; Hu & 
Stebbins, 2006).  In nearly all bacteria, CdtA, CdtB and CdtC subunits are encoded by 
adjacent or slightly overlapping cdtA, cdtB and cdtC genes which together form a 
constitutively expressed operon on the chromosome (Fig.1.1).  Escherichia coli is unique 
amongst CDT-producing bacteria in that at least five divergent variants of CdtB are found 
within this single species which also differentially segregate according to E. coli pathotypes 
[Table 1.2; (Janka et al., 2003)]. Since these variants refer to the CdtB subunit, and to be 
consistent with our proposed nomenclature, they should be designated EcolCdtB-I through -
V. Similar to other CDT-producing bacteria, EcolCdtB-I, -II, -IV and -V are encoded by 
chromosomal gene loci (Asakura et al., 2007a; Johnson et al., 2007; Oswald et al., 1994; 
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Peres et al., 1997; Toth et al., 2009).  However, analyses of sequences upstream and 
downstream of operons encoding CdtB-I and -IV variants revealed lambdoid prophage genes 
(Asakura et al., 2007a; Toth et al., 2009), whereas homologues of bacteriophages P2 and 
lambda are found in strain O157:H
-
 493/89 harboring CdtB-V (Janka et al., 2003). These 
gene arrangements are reminiscent of bacteriophage-encoded CdtB orthologs found amongst 
facultative endosymbionts of sap-feeding insects in which acquisition of cdtB has been 
attributed to horizontal gene transfer [HGT;(Degnan & Moran, 2008)].  Indeed, carriage of 
the CDT operon by certain enteropathogenic E. coli with EcolCdtB-I on a lysogenic phage 
background mediates HGT among related species, and confers enhanced bacterial toxicity 
during phage induction (Asakura et al., 2007a; Johnson et al., 2007; Oswald et al., 1994; 
Peres et al., 1997; Toth et al., 2009).  Also unique to E. coli, is the location of the operon 
encoding EcolCdtB-III which is found on a large conjugative plasmid called pVir (Johnson et 
al., 2009).  Finally, a notable exception to the heterotrimeric CDT model is Salmonella 
enterica serotype Typhi in which the genes encoding CdtA and CdtC are missing (Haghjoo & 
Galan, 2004). In keeping with our proposed CDT nomenclature, and since only the CdtB 
subunit is present in S. Typhi, the toxin should be designated StypCdtB. The cdtB gene of S. 
Typhi is located in a region of the chromosome with features consistent with a pathogenicity 
islet acquired by HGT and delineated by insertion sequences and a transposase gene 
(Haghjoo & Galan, 2004). Although the significance of these various CDT gene 
arrangements are incompletely understood, it is likely that they represent mechanisms of 
HGT which together might play a role in expanding the range of pathogenic bacteria that can 
establish persistent colonization and potentially cause infection and disease. 
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Figure 1.1.  Organization of the CDT gene locus. In nearly all CDT-producing bacteria, the 
CDT gene cluster consists of three adjacent or slightly overlapping cdtA, cdtB and cdtC genes 
encoding the corresponding CdtA, CdtB and CdtC protein subunits is located on the 
chromosome (A), except for EcolCdtB-III in which the CDT gene cluster is found on a large 
conjugative plasmid called pVir. In Salmonella enterica serotype Typhi, the genes encoding 
CdtA and CdtC are missing (B), instead the StypCdtB protein subunit is encoded by cdtB 
gene located upstream of pltA and pltB genes which respectively encode pertussis-like toxin 
A (PltA) and PltB, homologs of the pertussis toxin ADP-ribosylating “A” subunit and one of 
the 5 components of its heteropentameric “B” subunit, respectively, which together are 
located on a pathogenicity islet delineated by insertion sequences (IS).  
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Figure 1.1 
 
 16 
 
CDT protein structure and function  
On the basis of structural and functional characteristics of reconstituted recombinant 
heterotrimeric CDT subunits, Lara-Tejero and Galan (2001) proposed an AB toxin molecular 
model for CDT-induced cellular toxicity (Lara-Tejero & Galan, 2001). Accordingly, the 
catalytically active “A” subunit is attributable to the CdtB subunit, whereas the CdtA and CdtC 
subunits, which together display a high degree of sequence diversity, are assembled as a 
heterodimeric binding “B” subunit mediating target host cell membrane specificity and cellular 
uptake of CdtB effector protein (Hu et al., 2006; Hu & Stebbins, 2006; Nesic et al., 2004). In S. 
Typhi, the cdtB gene which encodes the “A” subunit StypCdtB is located on a pathogenicity islet 
upstream of pltA and pltB genes, respectively encoding pertussis-like toxin A (PltA) and PltB 
which are homologs of the pertussis toxin ADP-ribosylating “A” subunit and one of the 5 
components of its heteropentameric “B” subunit, respectively [Fig. 1.2B; (Spano et al., 2008)]. 
The PltA and PltB form a heterotrimeric complex with StypCdtB, and together mediate the 
binding specificity or “B” subunit function required for cellular toxicity (Spano et al., 2008).  
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Figure 1.2. Interaction of CDT with mammalian cells. In nearly all CDT-producing bacteria, 
binding of  CdtA and CdtC protein subunits of functional holotoxin complex or “B” subunit to 
host cell membrane receptor is followed by internalization of CdtB protein subunit or active “A” 
subunit by clathrin coated pit-mediated endocytosis, nuclear translocation and host cell DNA 
damage (A). In Salmonella enterica serotype Typhi, intracellular uptake of bacteria into a 
Salmonella-containing vacuole is followed by concurrent expression of StypCdtB, PltA and PltB 
protein subunits, secretion and assembly into functional holotoxin complexes that are packaged 
into transport vesicles destined for extracellular secretion (B). Binding of PltA and PltB protein 
subunits or “B” subunit of functional holotoxin complex to the infected host cell (autocrine) and 
to uninfected neighboring (paracrine) host cell membrane receptors is followed by internalization 
of StypCdtB protein subunit or active “A” subunit, nuclear translocation and DNA damage. 
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Figure 1.2.  
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Consistent with the notion that CdtB is the active subunit, comparative in silico structural 
analysis of predicted cdtB-encoded amino acid sequences of human and animal bacterial 
pathogens revealed conserved endonuclease/exonuclease/phosphatase super family domain with 
approximately 25-40% sequence identity with phosphodiesterase enzymes including mammalian 
DNase-I (Elwell & Dreyfus, 2000; Lara-Tejero & Galan, 2000). Despite the limited overall 
sequence homology with DNase-I, cdtB-encoded catalytic, DNA- and divalent cation-binding 
residues are highly conserved among the various CDT-producing bacterial pathogens suggesting 
a critical role for this nuclease in host-pathogen interaction [Fig. 1.3; (Elwell & Dreyfus, 2000; 
Hu & Stebbins, 2006; Lara-Tejero & Galan, 2000; Nesic et al., 2004)].   
The catalytic residues corresponding to mammalian DNase-I-H134 (HducCdtB-H160), 
DNase-I-H252 (HducCdtB-H274) and DNase-I-D212 (HducCdtB-D238) are conserved among 
all bacterial CdtB (Nesic et al., 2004). Moreover, mutagenesis analysis of EcolCdtB-II-E86 
residue confirms the high degree of conservation of the corresponding DNase-I-E78 catalytic 
residue amongst all CdtB (Elwell & Dreyfus, 2000).  Conversely, those residues corresponding 
to divalent cation binding DNase-I-E39 (CjejCdtB-E60), DNase-I-D168 (CjejCdtB-D185) and 
DNase-I-D251 (CjejCdtB-D260) as well as those corresponding to critical DNA binding DNase-
I-R111 (HducCdtB-R144) and DNase-I-N170 (HducCdtB-N201) are highly conserved among all 
bacterial CdtB (Nesic et al., 2004; Pickett & Lee, 2005). One additional DNA binding DNase-I-
R117 (HducCdtB-R41) residue which is present in all CdtB also has been confirmed by 
mutational analysis in both AactCdtB and HducCdtB (Nesic et al., 2004; Shenker et al., 2007). 
These differences in DNA binding residue conservation between bacterial CdtB and mammalian 
DNase-I likely account for reduced in vitro nuclease activities found with AactCdtB, EcolCdtB-
II, and HhepCdtB (Dassanayake et al., 2005a; Elwell & Dreyfus, 2000; Mao & DiRienzo, 2002). 
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Figure 1.3. Comparative amino acid sequence of bacterial CdtB and mammalian DNase-I. 
Sequences alignment was done using ClustalW2. Numbers at the bottom correspond to amino 
acid positions of bovine or human DNAse-I. Residues required for enzymatic activity [catalytic 
(red), divalent cation binding (blue) and DNA binding (green)] in human DNase-I are indicated 
in bold. The residues predicted to be required for CdtB nuclease activity and which have been 
confirmed by site directed mutagenesis are highlighted in yellow. The numbers in parenthesis 
represent the number of intervening amino acid residues that are omitted (excluding gaps). 
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Figure 1.3.  
 
HducCdtB      QEAG(21)EYT(10)MVYIYYSRLDVGANRVNLA(17)HSLQSRP(12)TVHALATG(31)VGDFNRA(35)LDYA(31)SDHFPV 
HparCdtB     QEAG(23)EYV(10)NVYIYYSRLDVGANRVNLA(17)NSLTSRP(12)SIHALSSG(27)VGDFNRA(35)LDYA(28)SDHFPV  
AactCdtB  QEAG(21)EYT(10)MVYIYYSRLDVGANRVNLA(17)HSLQSRP(12)TVHALATG(31)VGDFNRA(35)LDYA(31)SDHFPV  
EcolCdtB-I  QEAG(21)EYI(10)ELFIYFSRVDAFANRVNLA(15)PPVVSRP(12)STHALANR(30)AGDFNRS(33)LDYA(28)SDHFPV 
EcolCdtB-II  QEAG(21)ELI(10)QVYIYFSAVDALGGRVNLA(15)SPQGGRP(12)TAHAIAMR(30)LGDFNRE(33)LDYA(27)SDHFPV 
EcolCdtB-III QEAG(21)ELI(10)QVYIYFSAVDAFGGRVNLA(15)RPQGGRP(12)TAHAIATR(30)LGDFNRE(33)LDYA(27)SDHYPV 
EcolCdtB-IV  QEAG(21)EYI(10)QLFIYFSRTDALSNRVNLA(15)SPVASRP(12)STHALANR(30)AGDFNRS(33)LDYA(28)SDHFPV 
EcolCdtB-V  QEAG(21)ELI(10)QVYIYFSAVDAFGGRVNLA(15)RPQGGRP(12)TAHAIATR(30)LGDFNRE(33)LDYA(27)SDHYPV 
CcolCdtB       QEAG(23)EYI(10)SVYIYYSRVDVGANRVNLA(15)PPVASRP(12)NIHALASG(25)LGDFNRE(33)IDYA(30)SDHFPV 
CfetCdtB       QEAG(21)EYI(10)MVYIYYSRVDVGANRVNLA(15)TPTLSRP(12)SAHALANG(25)GGDFNRE(33)LDYL(30)SDHIPV 
CvenCdtB  QESG(20)EYT(10)MVYIYHSRIDVGANRVNLA(15)YPAAARP(12)TAHALASG(25)GGDFNRE(33)LDYL(30)SDHVPV 
CjejCdtB  QEAG(21)EYE(10)RVFIYYSRVDVGANRVNLA(15)PPTVSRP(12)NIHALANG(25)AGDFNRD(33)LDYA(30)SDHFPV 
CupsCdtB  QEAG(21)EYI(10)SVYIYYSRVDVGANRVNLA(15)PPTASRP(12)SIHALARG(25)AGDFNRP(33)LDYA(30)SDHFPV 
HbilCdtB       QEAG(21)EYV(10)SVFIYYANIDAGARRVNLA(18)SQEVSRP(12)NIHALARG(25)AGDFNRD(36)LDYA(31)SDHFPV 
HcinCdtB        QEAG(22)EYT(10)MVYIYYSPVDVGANRVNLA(15)PPTVSRP(12)SIHALANG(25)LGDFNRS(33)LDYA(28)SDHFPV 
HhepCdtB          QEAG(21)EFT(10)TVYIYYSPVDVGANRVNLA(18)PPTVSRP(12)DIHALASG(25)AGDFNRD(36)LDYA(31)SDHSPV 
HpulCdtB          QEAG(21)EYI(10)SVFIYHADIDVGARRVNLA(18)HQEASRP(12)SLHALASG(25)AGDFNRE(36)LDYA(31)SDHFPV 
HwinCdtB  QEAG(21)EYT(10)SVFIYYANIDVGARRVNLA(18)RQDVSRP(12)NIHALASG(25)AGDFNRD(36)LDYA(31)SDHFPV 
SboyCdtB          QEAG(21)ELI(10)QVYIYFSAVDALGGRVNLA(15)SPQGGRP(12)TAHAIAAR(30)LGDFNRS(33)LDYA(27)SDHYPV 
SdysCdtB  QEAG(21)EYI(10)ELFIYFSRVDAFANRVNLA(15)PPVVSRP(12)STHALANR(30)AGDFNRE(33)LDYA(27)SDHFPV 
STypCdtB          QEAG(22)EYT(10)IRYIYHSAIDVGARRVNLA(15)RPVASRP(12)TAHALASG(27)AGDFNRS(34)LDYG(21)SDHYPV 
Bovine DNaseI     QEVR(23)YVV(10)ERYLFLFRPNKVS-----V(18)SREPAVV(12)AIVALHSA(29)MGDFNAD(35)YDRI(35)SDHYPV     
                   |             |                       |              |        |         |       | 
         39            78                      111           134      168        212     251   
                       
 22 
 
More recently, high resolution crystallographic analysis of reconstituted heterotrimeric 
HducCDT holotoxin from individually expressed recombinant subunits [2.0Å resolution; (Nesic 
et al., 2004)] or complete AactCDT operon expressed as a holotoxin in E. coli [2.4 Å resolution; 
(Yamada et al., 2006)] and a EcolCdtB-II subunit [(1.73Å resolution; (Hontz et al., 2006b)] have 
provided further support to earlier observations and confirmed that CdtB closely resembles 
mammalian DNAse-I. Comparative protein modeling confirmed the high degree of key structural 
features conservation, namely canonical four-layered fold of mammalian DNAse-I family, 
deeply grooved aromatic patch and active site of CdtB from diverse bacterial species including 
CjejCDT, HhepCDT, EcolCDT-I, EcolCDT-II, EcolCDT-III, AactCDT and HducCDT (Hu et 
al., 2006). While the heterotrimeric holotoxin forms a ternary complex between CdtB subunit 
and ricin-like lectin domains within CdtA and CdtB (Nesic et al., 2004), the lectin domains form 
a deeply grooved, highly aromatic surface (aromatic patch) which is critical for cellular toxicity, 
presumably through binding to target cell surface biomolecules (Nesic et al., 2004).  Interaction 
between the N-terminal 13 amino acids of CdtC with the active nuclease site of CdtB suggests an 
auto-inhibitory function. Accordingly, the CdtB nuclease would be active only after release from 
CdtC and target cell entry.  
Although the residues required for nuclease activity of CdtB are highly conserved, the overall 
amino acid sequence of CdtB varies among bacteria. While StypCdtB together with HducCdtB 
and AactCdtB form a distinct cluster, the CdtB produced by EHS and Campylobacter species are 
nearly similar forming a separate cluster which is distinct from CdtB produced by members of 
the E.coli/Shigella group (Degnan & Moran, 2008). Interestingly, a similar clustering pattern is 
seen when the amino acid sequences of CdtA and CdtC are compared between different bacterial 
pathogens (Eshraghi et al., 2010). The clustering pattern of CDT subunit amino acid sequences 
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suggests differential infection niches that may correlate with bacterial adaptation to persistent 
colonization in specific hosts. Alternatively, the possibility that these structural differences 
indicate variable bacterial target cell binding specificities and intracellular nuclease subunit 
signaling pathways remain to be determined. 
 
 Production of CDT 
Wide variations in biological activity of CDT are found among various CDT-producing 
bacteria. Moreover, biological activity is variously found either in culture supernatant (and thus 
presumably actively secreted), associated with bacterial cells or both (Table 1.3). Moreover, the 
activity of CDT recovered from these different fractions can range from relatively high, 
intermediate, low to absent, and this may be relevant to disease pathogenesis for individual 
bacterial pathogen. Similar to other virulence factors, alterations in CDT production might be 
attributable to high numbers of passages on artificial media and selection of strains that are less 
virulent.  
  
 24 
 
Table 1.3. Production of CDT by bacterial pathogens. 
 
CDT Bacterial  location†  Reference 
Secreted Cell-associated  
HducCDT Present  Present Ahmed et al., 2001; Cope et al., 1997; Gelfanova et al., 1999 
AactCDT Present Present Ahmed et al., 2001; Fabris et al., 2002; Ohguchi et al., 1998; Sugai et al., 
1998; Yamano et al., 2003 
EcolCdtB-I High  High  Toth et al., 2003 
EcolCdtB-II Present Present Pickett et al., 1994 
EcolCdtB-III Present Present Toth et al., 2003 
EcolCdtB-IV Absent  Present Toth et al., 2003  
EcolCdtB-V Present ND Bielaszewska et al., 2005; Janka et al., 2003 
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SboyCDT Present Present Hyma et al., 2005; Johnson & Lior, 1987 
SdysCDT Present ND Johnson & Lior, 1987 
CjejCDT High  High  Dassanayake et al., 2005b; Pickett et al., 1996 
CcolCDT Absent  Absent  Asakura et al., 2007b; Dassanayake et al., 2005b; Pickett et al., 1996 
CupsCDT Present High Mooney et al., 2001; Pickett et al., 1996 
ChyoCDT ND High Pickett et al., 1996 
ClarCDT ND Low Pickett et al., 1996 
CfetCDT Present High Asakura et al., 2007b; Ohya et al., 1993; Pickett et al., 1996 
EHS  ND Present Chien et al., 2000; Hanninen et al., 2005; Kostia et al., 2003; Shen et al., 
2005; Taylor et al., 2003 
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 †Secreted, CDT activity in unconcentrated culture supernatant; cell-associated, CDT activity in bacterial lysate or enriched outer 
membrane preparation; low, high, relative to secreted or cell-associated; ND, not determined; Strains of H. ducreyi, A. 
actinomycetemcomitans, E. coli, Shigella species, and enterohepatic Helicobacter species (EHS) that lack a full complement of CDT 
genes and/or activity have been described (Abuoun et al., 2005; Ahmed et al., 2001; Asakura et al., 2007b; Dassanayake et al., 2005b; 
Fabris et al., 2002; Hyma et al., 2005; Janka et al., 2003; Johnson & Lior, 1987; Solnick & Schauer, 2001; Yamano et al., 2003). 
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The early studies of Johnson and Lior (1988) assessed CjejCDT in culture supernatant; however, 
assessment of cell-associated CDT among clinical C. jejuni isolates revealed relatively high 
biological activities in most strains with few strains exhibiting comparatively lower levels of 
activity (Pickett et al., 1996). Strains of C. jejuni that harbor CDT genes but lack biological 
activity have also been found (Abuoun et al., 2005; Dassanayake et al., 2005b). Two types of 
mutations within the CDT operon account for a lack of CDT activity in these strains; a deletion 
across cdtA and cdtB, and a nonsynonymous mutation in cdtB gene sequence (Abuoun et al., 
2005). In the closely related species C. coli, the genes encoding each of the three subunits are 
present, and although this species lacks biological activity, the underlying mechanism has not 
been identified (Asakura et al., 2007b; Dassanayake et al., 2005b; Pickett et al., 1996). Clinical 
isolates which lack CDT genes and/or activity have also been found amongst H. ducreyi, A. 
actinomycetemcomitans, E. coli, Shigella species, and EHS (Abuoun et al., 2005; Ahmed et al., 
2001; Asakura et al., 2007b; Dassanayake et al., 2005b; Fabris et al., 2002; Hyma et al., 2005; 
Janka et al., 2003; Johnson & Lior, 1987; Solnick & Schauer, 2001; Yamano et al., 2003). 
Information concerning the molecular mechanism of bacterial synthesis and secretion of 
CDT is limited (Deng et al., 2001; Ueno et al., 2006). A difference of approximate 2 kDa 
between the observed and calculated molecular weights of EcolCdtB-II subunit attributable to 
cleavage of a putative N-terminal signal peptide sequence was suggested to facilitate the 
secretion across the inner membrane by a general export pathway (Dreyfus, 2003). Consistent 
with this observation, Ueno and coworkers demonstrated the presence of a lipid binding 
consensus motif (lipobox) and lipoprotein cleavage site in AactCdtA signal peptide (Ueno et al., 
2006). In addition to AactCdtA, putative lipobox motifs are also present in HducCdtA, 
CjejCdtA, HhepCdtA, EcolCdtA- I, -II and -III, EcoliCdtC-I, -II and -III (Ueno et al., 2006); 
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unpublished observations). While the periplasmic CDT holotoxin consists of the un-cleaved 
AactCdtA, AactCdtB, and AactCdtC subunits, the secreted holotoxin complex in culture 
supernatant have cleaved signal sequences (Ueno et al., 2006). 
Cell-associated CjejCDT is found primarily in the periplasmic space of C. jejuni, whereas 
culture supernatant contains primarily CjejCDT tightly associated with outer membrane vesicles 
(Lindmark et al., 2009). In the context of intestinal infection, packaging and release of CDT into 
outer membrane vesicles may serve a protective function against enzymatic digestion, thus 
allowing uptake of intact protein toxin by host absorptive enterocytes. Further studies on the 
mechanism of CDT production and release by bacterial pathogens should provide important 
insights for the design of therapeutic modalities aimed at inhibiting CDT production or 
neutralizing CDT activity during infection. 
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Molecular mechanisms of cellular toxicity 
Cellular entry of CdtB 
A causal relationship between the requirement for heterotrimeric CdtABC holotoxin and 
cellular toxicity is well established for AactCDT, CjejCDT, EcolCdtB-I and –II and HducCDT 
(Akifusa et al., 2001; Lara-Tejero & Galan, 2001; Pickett et al., 1994; Pickett et al., 1996; 
Purven et al., 1997; Scott & Kaper, 1994; Shenker et al., 2005). In these pathogens, CdtA and 
CdtC subunits bind host cell membrane lipid raft microdomains before internalization of CdtB 
(Boesze-Battaglia et al., 2006; Boesze-Battaglia et al., 2009; Carette et al., 2009; Cortes-Bratti et 
al., 2000; Lara-Tejero & Galan, 2001; Nesic et al., 2004; Shenker et al., 2005). The integrity of 
lipid raft microdomains is critical for binding of AactCDT onto Jurkat cell membrane, 
presumably involving binding of host cell membrane cholesterol by a putative AactCdtC subunit 
cholesterol recognition/interaction amino acid consensus (CRAC) domain (Boesze-Battaglia et 
al., 2009). As predicted, pretreatment of cells with CdtA-CdtC complex protects against 
intoxication by CdtABC holotoxin, but not by CdtB alone, again demonstrating that the 
internalization of CdtB is critical for toxicity (Deng & Hansen, 2003).   
 By using target cell lines with various surface membrane biomolecules, a cell surface 
polypeptide component rather than glycoconjugates identified in previous studies, appears as the 
most likely receptor responsible for CDT-host cell interaction (Eshraghi et al., 2010). Recently, a 
putative G protein-coupled transmembrane protein, designated TMEM181, which localizes to 
membrane lipid rafts has been proposed as the cell membrane receptor for EcolCdtB-I by using a 
novel loss-of-function haploid genetic screen in a highly sensitive myeloid leukemia cell line 
(Carette et al., 2009). However, the possibilities that TMEM181 is part of a complex that 
 30 
 
constitutes a functional receptor, or that it plays a role in trafficking of a receptor-CdtB complex, 
or represents a ligand unique to EcoliCdtB-I cannot be ruled out completely. The demonstration 
that the expression level of TMEM181 is rate limiting for intoxication of cell lines with various 
degrees of sensitivity to CDT provides a molecular basis that explains the differential 
susceptibility of cells from different lineages to intoxication. 
 Following receptor-mediated internalization in clathrin-coated pits, CdtB undergoes 
retrograde
 
transport to the endoplasmic reticulum (ER) via the Golgi complex [Fig. 1.4; (Cortes-
Bratti et al., 2000; Guerra et al., 2005)].  The lack of protease inactivation or serum 
neutralization of HducCdtB and HducCdtC within minutes of cell surface binding suggests 
conformational changes of cell surface-bound toxin are followed by rapid internalization. 
Consistent with this observation, irreversible inhibition of Chinese hamster ovary (CHO) cell 
proliferation occurs within 2 minutes of exposure to EcoliCdtB-II (Aragon et al., 1997). 
Pharmacological, chemical or genetic disruption of clathrin-mediated endocytic pathways, as 
well as- Golgi complex transport abolish CDT cytotoxicity (Cortes-Bratti et al., 2000). Once 
taken up by mammalian cells, the catalytic subunit CdtB localizes to the nucleus presumably via 
alternate nuclear localization signals [NLS; (Lara-Tejero & Galan, 2000; McSweeney & 
Dreyfus, 2004; Nishikubo et al., 2003)]. An N-terminal NLS has been proposed for AactCdtB, 
while two C-terminal NLS have been found in EcolCdtB-II (McSweeney & Dreyfus, 2004; 
Nishikubo et al., 2003). On the basis of highly conserved N-terminal amino acid sequences 
corresponding to the putative NLS of AactCdtB among all known bacterial CdtB orthologs, a 
modular structure consisting of an N-terminal domain responsible for nuclear transport and a C-
terminal DNase-like domain capable of exerting DSBs has been proposed (McSweeney & 
Dreyfus, 2004; Nishikubo et al., 2003). Unlike the “A” subunit of other AB toxins which 
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generally translocates from the endoplasmic reticulum (ER) directly into the cell cytosol by a 
process of ER-associated degradation (ERAD), translocation of HducCdtB is ERAD-
independent with the toxin subunit moving directly from the ER lumen to the nucleoplasm 
without unfolding (Guerra et al., 2009). 
In S. Typhi, bacterial internalization into Salmonella-containing vacuole of host cells leads to 
concurrent expression of StypCdtB, PltA and PltB which assemble into functional holotoxin 
complexes that are packaged into transport vesicles destined for extracellular secretion and 
intoxication of infected host cells (autocrine) and uninfected neighboring (paracrine) host cells 
(Spano et al., 2008).  The absence of CDT receptor on infected host cells might provide a 
protective mechanism against cytotoxicity which would allow intracellular survival of S. Typhi, 
and thus persistence in infected host tissues (Spano et al., 2008). 
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Figure 1.4. CDT uptake and intracellular transport in mammalian cell. Binding of the “B” 
subunit consisting of CdtA and CdtC protein subunits of CDT heterotrimeric holotoxin to a cell 
membrane receptor located within lipid rafts is followed by rapid endocytosis of the “A” active 
CdtB protein subunit in a clathrin-coated pit and retrograde transport via the Golgi complex and 
endoplasmic reticulum (ER) before nuclear localization signal-mediated active transport to the 
nucleus and DNA double strand breaks (DSB). 
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Figure 1.4 
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Nuclease and phosphatase activities of CdtB 
The structural features of CdtB that predict a nuclease function are in agreement with DSBs 
observed in mammalian cells intoxicated with either CjejCDT, EcolCdtB-II or HducCDT 
(Dassanayake et al., 2005a; Elwell & Dreyfus, 2000; Frisan et al., 2003; Lara-Tejero & Galan, 
2000). Transient expression, cellular transfection, or nuclear microinjection of CdtB cause 
fragmentation of mammalian cell nuclear DNA (Frisan et al., 2003; Lara-Tejero & Galan, 2000). 
Similarly, rescue of a mouse B cell line from AactCDT-induced cytotoxic death with the DNA 
endonuclease inhibitor aurintricarboxylic acid further confirms the endonuclease-mediated DNA 
damage requirement for CdtB-induced cellular toxicity (Ohguchi et al., 1998). 
While it is well-established that cellular toxicity is mediated by the nuclease function of 
CdtB, other studies suggest phosphatidylinositol (PI)-3,4,5-triphosphate (PIP3) phosphatase 
activity also might play a role in cellular toxicity (Shenker et al., 2007). This is based in part on 
in silico comparative analysis demonstrating that several phosphatases involved in cell cycle 
regulation and signal transduction including inositol phosphatases contain a protein fold similar 
to Mg2
+
-dependent endonucleases including mammalian DNase-I and bacterial CDT (Dlakic, 
2000). Demonstration of PIP3 phosphatase activity is more clearly seen when using human 
leukemia T-cell lines with constitutively elevated PIP3 levels because of mutations in SHIP1 
and/or PTEN (Shenker et al., 2007).  Therefore, an alternate mechanism of cellular toxicity 
might result from depletion of cell membrane PIP3 and suppression of protein kinase B 
(PKB)/Akt signaling pathway (Shenker et al., 2007). However, when compared with site specific 
phosphatase defective CdtB mutants or specific PIP3 phosphatase inhibitors, the nuclease activity 
of AactCdtB alone is sufficient for induction of cell cycle arrest and apoptosis of proliferating 
U937 macrophage cell line (Rabin et al., 2009).  Similarly, cell cycle arrest and death of haploid 
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S. cerevisiae yeast strains requires CdtB DNase-I-like catalytic residues and nuclear localization 
(Matangkasombut et al., 2009). Since yeasts lack PIP3, CdtB-induced DSBs alone are sufficient 
to account for toxicity in this model (Matangkasombut et al., 2009). Taken together the data 
suggest that the predominant mechanism of cellular toxicity varies according to target cell 
lineage with nuclease activity and DSBs as the most prevalent mechanism, and PIP3 phosphatase 
activity playing an accessory role in certain situations. 
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CDT-induced DNA repair response and cell cycle arrest 
Mammalian cell cycle regulation is responsible for the proper maintenance of several 
physiological processes, including the maintenance of intact mucosal epithelial barriers and 
clonal expansion of lymphocyte subsets during adaptive immune responses, both of which 
constitute important defense mechanisms against colonization and infection of mucocutaneous 
interfaces by bacterial pathogens (Oswald et al., 2005). Therefore, CDT-producing bacteria 
might have evolved a specialized mechanism to disrupt key mammalian cell functions in order to 
establish persistent colonization and cause disease in certain niches (Nougayrede et al., 2005; 
Oswald et al., 2005). On the basis of their ability to modulate the cell cycle and cause cell death, 
CDT has been classified as an inhibitory cyclomodulin (Eshraghi et al., 2010; Liyanage et al., 
2010; Nougayrede et al., 2005; Oswald et al., 2005). In fact, CDT was the first bacterial toxin 
shown to cause cell cycle arrest in mammalian cells (Toth et al., 2009). 
Cell cycle fidelity is maintained by redundant DNA damage checkpoint mechanisms, which 
are evolutionarily conserved signaling pathways that validate the integrity and accuracy of DNA 
replication at each phase of cell division (Bartek & Lukas, 2007; Jackson & Bartek, 2009). 
Activation of DNA damage checkpoints results in cell cycle arrest so that DNA can be repaired, 
or if damage is severe, progress to programmed cell death by apoptosis (Bartek & Lukas, 2007; 
Hoeijmakers, 2001). The DNA damage checkpoint network comprises upstream DNA damage 
sensors, signal transducers and downstream effectors (Bartek & Lukas, 2007). Specific pathways 
preferentially sense and respond to distinct types of DNA damage and initiate dedicated 
protective outputs (Hoeijmakers, 2001). Because DSBs are among the most severe DNA lesions, 
repair mechanisms involving error free homologous recombination (HR) and error prone non-
homologous end joining (NHEJ) mechanisms will act synergistically to repair DSBs (Ciccia & 
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Elledge, 2010). It is currently believed that CDT-induced DSBs trigger a DDR similar to that 
caused by ionizing radiation (IR)-induced DSBs and mediated by the phosphoinositide 3-kinase 
related kinase ataxia telangiectasia mutated (ATM), encoded by the gene mutated in the rare 
autosomal recessive genetic disorder ataxia telangiectasia [AT; (Bartek & Lukas, 2007; Cortes-
Bratti et al., 2001b; Derheimer & Kastan, 2010; Jackson & Bartek, 2009)]. 
The ATM-dependent IR-induced DDR involves both induction of cell cycle arrest and 
initiation of DNA repair (Derheimer & Kastan, 2010).  Major components of the ATM-
dependent DNA damage signaling pathway include (i) the multifunctional MRN protein 
complex consisting of Mre11, Rad50 and Nbs1, (ii) histone H2AX, (iii) the cell cycle checkpoint 
regulator protein kinase Chk2, and (iv) the transcription factor p53 [Fig. 1.5; (Bartek & Lukas, 
2007; Derheimer & Kastan, 2010; Jackson & Bartek, 2009)].  Initial DSBs are recognized by the 
MRN complex, which recruits ATM to the damage site (Bakkenist & Kastan, 2003; Bartek & 
Lukas, 2007; Hoeijmakers, 2001; Lavin & Kozlov, 2007; Lavin, 2008).  The serine-threonine 
protein kinase ATM which normally exists as inactive dimers, dissociates and is activated by 
autophosphorylation in the presence of DSBs. Activated ATM subsequently phosphorylates a 
large array of substrates including, histone H2AX, Chk2, and p53 (Matsuoka et al., 2007). 
Although the precise events surrounding ATM activation are incompletely understood, recent 
evidence suggests that ATM and MRN complex act in harmony to sense DSBs (Derheimer & 
Kastan, 2010). Activated MRN complex and phosphorylated H2AX (γH2AX) initiate and 
amplify the DNA repair process by stabilizing the DNA lesion and providing a platform for the 
binding of other DNA repair proteins (Derheimer & Kastan, 2010). Activated Chk2 reduces 
cyclin-dependent kinase (CDK) activity by several mechanisms including activation of the 
transcription factor p53 and subsequent induction of cyclin inhibitor p21 (Jackson & Bartek, 
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2009). CDKs are key regulators of cell cycle and the inhibition of CDKs can result in arrest of 
the cell-cycle progression at the G1-S, intra-S and G2-M checkpoints, allowing time for DNA 
repair before proceeding with replication or mitosis (Jackson & Bartek, 2009). Other ATM 
substrates additionally have key roles in affecting cell cycle checkpoint function, such as Smc1 
for intra-S phase, as reviewed elsewhere (Derheimer & Kastan, 2010). 
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Figure 1.5. Pathways of CDT-induced cell cycle arrest in mammalian cells. Following CDT-
induced DNA double strand breaks (DSB), the ATM-mediated DNA damage response is 
initiated with subsequent activation of the multifunctional protein complex consisting of Mre11, 
Rad50 and Nbs1 (MRN), histone H2AX, the cell cycle regulator checkpoint kinase 2 (Chk2), 
and the transcription factor p53. Downstream p53-induced activation of p21 and Chk2-mediated 
inactivation of cell division cycle 25 (CDC25) C phosphatase block cell cycle progression by 
inhibition of cyclin dependent kinases (CDK)-Cyclin complexes, and thus, preventing entry into 
mitosis while promoting repair of DNA.     
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Figure 1.5 
 
 
 
 
The main evidence in support of CDT-induced DDR is based on demonstration of MRN and 
γ-H2AX activation shortly following CDT exposure of susceptible cells. A large percentage of 
HeLa cells display γ-H2AX foci 2 h post-HducCDT exposure, and nearly all cells are positive 
for γ-H2AX foci within 6 to 8 h post-exposure (Li et al., 2002).  Both HducCDT and IR induce 
similar levels of Mre11 foci in HeLa cells and primary human dendritic cells (Li et al., 2002). 
Nuclear microinjection of purified recombinant HducCdtB into HeLa cells induces Mre11 foci to 
the same extent as HducCDT holotoxin treated cells within 1 h, suggesting that the active subunit 
CdtB is sufficient and necessary to elicit DDR (Li et al., 2002). Increased Rad50 foci and γ-
H2AX are also seen in primary human fibroblasts treated with CjejCDT (Hassane et al., 2003), 
in primary and established human endothelial cells treated with EcolCdtB-V (Bielaszewska et 
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al., 2005; Liyanage et al., 2010), and cultured human intestinal epithelial H407 cells exposed to 
HhepCDT (Bielaszewska et al., 2005; Liyanage et al., 2010). As expected, γ-H2AX is readily 
detected in immortalized wild type human B lymphocyte lines post-HducCDT exposure, but it is 
absent in Atm-defective leukemic B cell lines obtained from AT patients (Li et al., 2002). 
Analysis of diploid S. cerevisiae yeast strains provides additional evidence in support of CDT-
induced DDR. Strains of S. cerevisiae that lack Rad51, the repair protein of budding yeast 
equivalent to the MRN complex of mammalian cells, are exquisitely sensitive to CjejCdtB, 
suggesting a critical role for HR in repairing CDT-induced DNA lesions (Kitagawa et al., 2007). 
Other evidence in support of a CDT-induced DDR is based on demonstration of cell cycle 
checkpoint activation, which further confirms data obtained by monitoring DNA damage 
signaling. Human HL fibroblast and larynx carcinoma HEp-2 cell lines display similar cell cycle 
checkpoint response kinetics consisting of p53, Chk2 and cdc2 phosphorylation and upregulation 
of p21 and p27, following exposure to IR or HducCDT (Cortes-Bratti et al., 2001b). In common 
with IR, rat fibroblast cell lines exposed to HhepCDT exhibit c-Myc and ATM-dependent 
activation of DNA damage checkpoint responses (Guerra et al., 2010). Even though not a 
genotoxin-specific phenomenon; formation of actin stress fibers through the ATM-dependent 
activation of small GTPase RhoA is seen in HeLa cells following HducCDT-induced DSBs 
(Frisan et al., 2003). Formation of actin stress fibers is also seen in Hep-2 cells exposed to 
HpulCDT and CHO cells exposed to EcolCDT-II (Aragon et al., 1997; Ceelen et al., 2006). 
More recently, the formation of actin stress fibers in HeLa cells exposed to HducCDT was 
shown to result from the activation of nuclear RhoA-specific guanine nucleotide exchange factor 
(GEF) Net1 (Guerra et al., 2008). 
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Currently CDT is known to cause ATM-dependent cell cycle arrest at the G2/M and G1/S 
transitions, although definitive molecular analysis could further strengthen these observations 
(Fig.1.5). The CDT-mediated G2/M arrest is a result, at least in part, of the activation of Chk2 by 
activated ATM upon sensing DSBs. Activated Chk2 phosphorylates and inactivates cell division 
cycle 25 (CDC25) C phosphatase. The resulting accumulation of phosphorylated cyclin B-cyclin 
dependent kinase (CDK) 1 complex prevents mitotic entry (Ge et al., 2008; Smith & Bayles, 
2006). The mechanism for CDT-mediated G1/S arrest is thought to be p53-dependent.  Activated 
ATM phosphorylates p53, and the resulting upregulation of p21 inhibits cyclin E-CDK2, which 
blocks S-phase entry (Ge et al., 2008; Smith & Bayles, 2006). However, p53 independent 
upregulation of p21 following CDT treatment has been reported (Smith & Bayles, 2006). 
Although there is limited evidence supporting a CDT-mediated intra S-phase checkpoint 
activation in yeast, the potential contribution of this checkpoint has yet to be investigated in 
mammalian systems (Matangkasombut et al., 2009). 
Limitations in our understanding of the molecular mechanisms of CDT-induced cell cycle 
arrest lie in the techniques that are commonly employed to address this question. With the 
exception of a few instances indicating accumulation of phosphorylated Cdk1 (cdc2) prior to cell 
cycle arrest, CDT-induced arrest of the cell cycle relies primarily on demonstration of altered 
patterns of DNA staining with propidium iodide and analysis by florescence-activated cell 
sorting (Bielaszewska et al., 2005; Comayras et al., 1997; Cortes-Bratti et al., 2001b; Peres et 
al., 1997). At least two G2/M checkpoints exist in mammalian cells, an Atm-dependent transient 
checkpoint which activates in G2 phase cells immediately after DNA damage, and prolonged 
Atm-independent checkpoint which is activated several hours after damage and reflects the G2 
phase accumulation of cells that were initially damaged during S-phase (Weiss et al., 2003; Xu 
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et al., 2002).  Because CDT might induce arrest at multiple stages of the cell cycle, measurement 
of DNA content alone cannot distinguish between these two checkpoints highlighting the need of 
additional study of CDT-induced cell cycle arrest. 
 
CDT-mediated apoptosis 
Apoptosis is a physiological mechanism of cell death present in multicellular organisms for 
the controlled elimination of unwanted cells. Similar to creating a block in the cell cycle, 
bacterial toxins can induce apoptosis of host cells which can facilitate colonization, infection and 
disease (Nougayrede et al., 2005; Oswald et al., 2005).  Diverse factors and stimuli can initiate 
signaling pathways leading to apoptotic cell death by two major signaling pathways; the extrinsic 
pathway involving death receptor activation, and the intrinsic (or mitochondrial) pathway that 
can be activated by several stimuli (environmental toxicants, drugs, toxins) that provoke cell 
stress or damage (Taylor et al., 2008). The extrinsic pathway is activated by the binding of 
extracellular death ligands (for example FasL and TNFα) to the transmembrane death receptors 
(for example FAS), while the intrinsic pathway is activated by stimuli that alter the 
mitochondrial outer membrane permeability (Ow et al., 2008). In some cases, the extrinsic 
pathway can also be activated by certain DNA-damaging drugs (Roos & Kaina, 2006). The 
activation of the intrinsic pathway depends on the activation of one or more members of the BH3 
protein family including Bid, PUMA and NOXA (Taylor et al., 2008).  Accumulation of 
activated BH3 proteins beyond a critical level overrides the inhibitory effect of anti-apoptotic B-
cell lymphoma-2 (BCL-2) family proteins (such as Bcl-2 itself) and promotes the formation of 
pro-apoptotic BCL-2 family protein oligomers Bax-Bak on mitochondrial outer membrane (Ow 
et al., 2008; Taylor et al., 2008). Accumulation of Bax-Bak complex results in the release of 
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mitochondrial intermembrane proteins, including cytochrome c into the cytosol (Ow et al., 2008; 
Taylor et al., 2008).  A feature in common to both of these pathways is the activation of caspases 
that are involved in early signaling events as well as in final proteolysis phase of cell death 
(Creagh et al., 2003). Stimulation of the extrinsic pathway leads to activation of caspase-8 that 
can process and activate downstream caspase-3 and caspase-7 (Taylor et al., 2008). Stimulation 
of the intrinsic pathway involves multiple sequential alterations including signaling that results in 
release of cytochrome c from mitochondria and formation of the apoptosome (Ow et al., 2008). 
This structure facilitates cytochrome c-APAF-1 dependent activation of caspase-9 which in turn 
activates caspase-3 leading to the execution phase of cell death by apoptosis (Creagh et al., 2003; 
Taylor et al., 2008). 
The status of p53 is a key factor that determines the sensitivity of eukaryotic cells to 
apoptosis, and this is particularly critical for genotoxin-induced apoptosis where cells with wild-
type p53 genotype display greater sensitivity than cells with a p53-null genotype (Gudkov & 
Komarova, 2003; Roos & Kaina, 2006). In p53 wild-type cells, accumulation of phosphorylated 
p53 following DNA damage leads to the transcriptional activation of pro-apoptotic p53 targets 
including Bax, PUMA and NOXA, while in p53-null cells apoptosis sensitivity can be mediated 
through several mechanisms including the degradation  of anti-apoptotic Bcl-2 and Chk1/Chk2-
E2F1-p73 mediated upregulation of pro-apoptotic p53 targets (Gudkov & Komarova, 2003; Roos 
& Kaina, 2006). The p53-independent mechanism is somewhat less influential for facilitating 
apoptosis than direct activation of Bax by p53, and thus p53-null cells are generally more 
resistant to genotoxin-induced apoptosis (Roos & Kaina, 2006). Additionally, sensitivity to 
toxicant or drug-induced apoptosis has been shown to vary considerably in different cell lines, 
and this is attributed to differences in expression of Bcl-2 which has a protective function for 
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mitochondrial integrity (Zamzami et al., 1996). High Bcl-2 expression in lymphoid tumor cell 
lines is associated with resistance to chemotherapeutic drug- and bacterial toxin-induced 
apoptosis (Bloom et al., 2006; O'Brien et al., 2001). Thus, the level of Bcl-2 expression can play 
an important role in target cell sensitivity to bacterial toxin-induced apoptosis. This may be 
particularly important in the case of toxins that induce DNA damage and an intrinsic or 
mitochondrial-based apoptotic pathway regulated by Bcl-2 proteins. 
The mechanisms involved in CDT-induced apoptosis are incompletely understood and 
currently thought to be dependent on the particular type of target cell (Belibasakis et al., 2004; 
Dreyfus, 2003). Based on the observations of early DNA fragmentation and activation of DDR in 
several p53 wild-type and p53-defective cell lines, it is now clear that apoptosis is a downstream 
event of CdtB-induced DDR which can be mediated through both p53-dependent and p53-
independent mechanisms [Figure 1.6, Cortes-Bratti et al., 2001b; Frisan et al., 2003; Liyanage et 
al., 2010)]. Similar to other genotoxins, cells with wild-type p53 are more sensitive to CDT-
induced apoptosis than p53-deficient cells. For example, in human leukemia T-cell lines, 
caspases are activated earlier in p53 wild-type MOLT-4 cells (highly CDT sensitive) as 
compared to p53 mutated Jurkat cells (Cheng & Haas, 1990; Ohara et al., 2004). 
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Figure 1.6. Pathways of CDT-mediated apoptosis in mammalian cells. Following CDT-induced 
DNA double strand breaks (DSB), the ATM-mediated DNA damage response is activated which 
directly or through Chk2 phosphorylates and activates p53 leading to activation of the intrinsic 
apoptotic pathway. Accumulation of fully phosphorylated active p53 overrides anti-apoptotic 
Bcl-2, while promoting the formation of pro-apoptotic Bcl-2-associated X (Bax) and Bcl-2 
homologous antagonist killer (Bak) protein oligomers on the mitochondrial outer membrane by 
transcriptional upregulation of pro-apoptotic BH3-only proteins.  These interactions result in the 
release of cytochrome c from mitochondria and activation of caspase-9 within the apoptosome. 
Activated caspase-9 in turn activates the executioner caspases-3 and -7 leading to apoptotic cell 
death.  Activation of the extrinsic apoptotic pathway following DSB through caspase-8 has been 
suggested in human B lymphoblastoid JY and monocytic 28SC cell lines (Hickey et al., 2005; 
Shenker et al., 2001).  In a p53-mutated background, the intrinsic apoptotic pathway may be 
activated by either caspase-2-mediated Bax/Bak translocation, Chk2 causing E2F1/p73-mediated 
transcriptional upregulation of pro-apoptotic BH3-only proteins causing Bax/Bak mitochondrial 
translocation or degradation of Bcl-2 (putative interactions are drawn as dotted lines). 
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Figure 1.6 
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The CDT produced by several bacteria can induce apoptosis in a broad range of cell types 
including established cell lines, proliferating and non-proliferating primary cells of epithelial, 
endothelial, fibroblastic and hematopoietic lineages (Bielaszewska et al., 2005; Gelfanova et al., 
1999; Hickey et al., 2005; Liyanage et al., 2010; Mooney et al., 2001; Ohara et al., 2004; 
Shenker et al., 1999; Shenker et al., 2001; Yamamoto et al., 2004). Activation of caspases 
following CDT exposure has been documented in cultured epithelial, endothelial and 
hematopoietic cell lines and caspase inhibitors protect cells from CDT-induced apoptosis 
(Alaoui-El-Azher et al., 2010; Bielaszewska et al., 2005; Gelfanova et al., 1999; Hickey et al., 
2005; Ohara et al., 2004; Shenker et al., 2001; Wising et al., 2005; Yamamoto et al., 2004). 
Recently, we reported that activation of the intrinsic (mitochondrial) apoptotic pathway follows 
DDR activation by HhepCDT treatment of human intestinal epithelial H407 cells (Liyanage et 
al., 2010); sequential up-regulation of Bax and down-regulation Bcl2 led to cytochrome c release 
and the subsequent activation of caspase-9 within 5 h following exposure to HhepCDT 
(Liyanage et al., 2010).  While the activation of caspase 9 peaked at 12h, caspase 3 was not 
activated until 24 h following HhepCDT exposure, and the activity of caspase 8 did not change 
(Liyanage et al., 2010).  Based on caspase activation patterns in this and other cell lines, and 
together with other experimental evidence, the major mechanism for CDT-induced apoptosis 
appears to be through the ATM-dependent intrinsic pathway (Alaoui-El-Azher et al., 2010; 
Bielaszewska et al., 2005; Hickey et al., 2005; Ohara et al., 2004; Shenker et al., 2001; 
Yamamoto et al., 2004). Inhibition of caspase-8 could block Fas-mediated apoptosis in Jurkat 
cells, but did not inhibit CDT-mediated apoptosis (Ohara et al., 2004). Overexpression of Bcl-2 
results in a significant reduction of CDT-mediated apoptosis in human B-cell lines, supporting 
the suggestion of an intrinsic pathway-dependent mechanism of apoptosis activation by CDT 
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(Ohguchi et al., 1998; Shenker et al., 2001). However, possible simultaneous activation of both 
intrinsic and extrinsic pathways has also been suggested for human B lymphoblastoid cell line, 
JY and the monocytic cell line, 28SC (Hickey et al., 2005; Shenker et al., 2001). 
The role of ATM in CDT-mediated apoptosis is incompletely characterized. There is limited 
evidence suggesting ATM wild-type SN-B1 and JAC-B2 cells are more susceptible to 
HducCDT-induced apoptosis as compared to Atm defective cell lines (Cortes-Bratti et al., 
2001b). Based on caspase activation patterns, pharmacological inhibition of ATM or siRNA 
knock down of Chk2, it was recently shown that apoptosis induced by AactCDT in human 
immortalized gingival keratinocytes is mediated through the ATM-dependent DDR pathway 
(Alaoui-El-Azher et al., 2010). 
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CDT cellular specificity and susceptibility 
It has been proposed that the effects of CDT are cell type dependent (Belibasakis et al., 2004; 
Dreyfus, 2003). Irrespective of the bacterial source of CDT and before characteristic nuclear and 
cytoplasmic distension are seen, cultured cell lines of epithelial and endothelial origins primarily 
arrest in the G2/M phase (Elwell et al., 2001; Lara-Tejero & Galan, 2001; Smith & Bayles, 2006; 
Whitehouse et al., 1998; Wising et al., 2005; Young et al., 2000b), whereas cells of fibroblastic 
origin arrest both in the G1/S and G2/M phases of the cell cycle (Belibasakis et al., 2004; Cortes-
Bratti et al., 2001b; Hassane et al., 2003; Smith & Bayles, 2006; Wising et al., 2005). By 
contrast, cell lines of hematopoietic lineage including lymphocytes, monocytes, macrophages 
and dendritic cells, not only are several orders of magnitude more susceptible to CDT (pg versus 
µg, Fig. 1.7), but also display rapid apoptosis after a very transient arrest of the cell cycle 
(Belibasakis et al., 2004; Cortes-Bratti et al., 2001b; Hassane et al., 2003; Smith & Bayles, 
2006). 
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Figure 1.7. Comparison of CDT-mediated cytotoxicity in a human epithelial (cervical carcinoma 
HeLa; ATCC CCL-2) and a lymphoid (acute lymphoblastic T cell leukemia MOLT-4; ATCC 
CRL-1582) cell lines. Campylobacter jejuni CDT holotoxin (CjejCDT) reconstituted from 
purified recombinant His-tagged CdtA, CdtB and CdtC subunit fusion proteins was incubated 
with HeLa cells before fixation and staining. Light photomicrographs (60X original 
magnification) of formalin-fixed and hematoxylin and eosin stained HeLa cells incubated with 
control medium (D-MEM; A) or D-MEM containing 25 μg ml-1 of CjejCDT (B) for 72 hours. 
Note the marked nuclear and cytoplasmic enlargement of CjejCDT-treated cells compared to 
normal control cells. Confocal laser scanning photomicrographs (40X original magnification) of 
un-fixed Hoechst 33342 and propidium iodide double stained MOLT-4 cells incubated with 
control medium (RPMI;C) or RPMI containing 100 ng ml
-1
 of CjejCDT (D) for 24 hours.  
Greater than 85% of the cells treated with CjejCDT (D) display early apoptotic changes 
characterized by condensed and fragmented chromatin (blue) or late apoptotic changes 
consisting of similar nuclear changes and cytoplasmic uptake of propidium iodide (pink) 
compared with less than 5% dead (red) cells in the control. 
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Figure 1.6 
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The lowest effective dose of recombinant CDT that can intoxicate cell lines of hematopoietic 
lineage ranges between 10 and 50 pg ml
-1
 compared to 1 and 5 µg ml
-1
 for other cell types 
(Shenker et al., 2007).  More than 90% of either human Jurkat T cells or THP-1 monocytic cells 
undergo apoptosis within 24 to 48 hours after treatment with 100 ng ml
-1
 HducCDT, while only 
30% of HeLa or HaCaT epithelial cells or primary human fibroblasts are affected under the same 
conditions (Wising et al., 2005). Based on their extreme susceptibility, lymphocytes have been 
proposed as the in vivo target of CDT, suggesting immunomodulation allowing persistence of 
bacterial colonization (Ge et al., 2005; Pratt et al., 2006; Shenker et al., 2007). Although CDT is 
a broad range genotoxin (Ge et al., 2005; Pratt et al., 2006; Shenker et al., 2007), it remains to be 
demonstrated whether this apparent cell type specificity is in part attributable to inherent 
differences in cell surface receptor binding of CdtA and CdtC to host cell membrane depending 
on host cell surface biomolecule density, intrinsic differences in CdtB uptake and nuclear 
translocation, or variable target cell lineage DDR capability  (Carette et al., 2009; Eshraghi et al., 
2010). However, other factors that can determine the outcome of CDT interactions with 
susceptible cells including receptor chemical compositions and intrinsic affinities, but also amino 
acid sequence divergence of CdtA and CdtC binding subunits encoded by different bacteria need 
further detailed analysis (Carette et al., 2009; Eshraghi et al., 2010). 
The mutational status of individual cell lines is another critical factor that can determine 
activation of specific checkpoint and apoptotic pathways, and thus the stage of cell cycle arrest 
and kinetic of progression to apoptosis in response to genotoxic injury. As described earlier, two 
of the most important mediators of CDT-induced DDR are ATM and p53, both of which play 
critical roles in determining the stage of cell cycle arrest and pathways to apoptotic execution.  
ATM is required for the initiation of G1/S, intra-S and G2/M checkpoint arrest (Derheimer & 
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Kastan, 2010; Xu et al., 2002). However, there are at least two distinct G2/M checkpoints, and 
only the rapid-transient checkpoint is ATM-dependent (Xu et al., 2002). Most established cell 
lines are tumor derived and frequently contain mutations in tumor suppressors, including p53 
(Cheng & Haas, 1990). Similar to ATM, p53 is required for the initiation and maintenance of 
G1/S checkpoint and can play a role in arrest at the G2/M stage of the cell cycle (Giono & 
Manfredi, 2006). As described earlier, p53 wild-type cells are more susceptible to apoptosis 
compared to p53 defective cells (Roos & Kaina, 2006). 
Since the cellular responses to CDT-induced damage are very similar to IR-induced DDR, 
the inherent differential tissue susceptibility to IR-induced DNA damage may also be involved in 
the pathogenesis of diseases caused by CDT-producing bacterial pathogens (Gudkov & 
Komarova, 2003; Smith & Bayles, 2006). Rapidly proliferating cells including haematopoietic 
and intestinal epithelial cells are the most radiosensitive cell types, while non-proliferating cells 
of the nervous, respiratory, urinary, endocrine, musculoskeletal and mesenchymal tissues are 
relatively radioresistant (Gudkov & Komarova, 2003).  The rate of cell division does not always 
correlate with cellular radiosensitivity, as extremely radiosensitive adult thymus, spleen, and 
bone marrow stem cells consist mostly of quiescent cells (Gudkov & Komarova, 2003). 
However, the expression levels of p53 and several p53-responsive pro-apoptotic genes including 
Bax and Fas/Apo1 correlate with tissue radiosensitivity, where highly radiosensitive tissues have 
higher expression levels of  p53 and p53-responsive pro-apoptotic genes (Gudkov & Komarova, 
2003). As a general rule, hematopoietic cells undergo rapid apoptosis following IR exposure, 
whereas fibroblasts undergo permanent growth arrest and epithelial cells with the exception of 
the intestinal epithelium, which undergo rapid p53-mediated apoptosis, exhibit reversible arrest, 
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while p53-deficient cells from all lineages tend to display a brief arrest (Gudkov & Komarova, 
2003). 
In this context it is interesting to note that the CDT-induced G1/S cell cycle arrest in 
fibroblasts have been observed exclusively in primary cell lines, which are likely to have wild 
type p53, and thus retain an intact G1/S checkpoint (Hassane et al., 2003). In contrast G2/M cell 
cycle arrest does not depend on p53 for initiation, and therefore it is possible for established p53-
deficient cell lines to retain a functional G2/M checkpoint (Giono & Manfredi, 2006). Indeed, 
the G2/M cell cycle arrest is the predominant type of cell cycle arrest associated with CDT 
toxicity (Smith & Bayles, 2006). At least in T-cell leukemia cell lines, susceptibility to CDT-
induced apoptosis is dependent on p53 status of the cell line, as p53 wild-type cells are more 
susceptible to apoptosis compared to p53 deficient cells (Ohara et al., 2004). 
The differential tissue susceptibility to IR mirrors the cell type susceptibility to CDT 
(hematopoietic lineage hyper-susceptibility, growth arrest in epithelial, endothelial or fibroblast 
lineages and CDT-resistance in p53 defective cells from all lineages). To our knowledge, 
epithelial cell lines primarily show G2/M phase cell cycle arrest and a slow progression to 
apoptosis which can take several hours to days after CDT treatment. Investigating the 
mechanism of CDT intoxication in primary intestinal epithelial cells would provide additional 
insights. 
It is conceivable that the CDT-induced DDR might be distinct from that induced by IR, yet 
some of the pathways may be overlapping. The ability of a cell line to generate DDR is also an 
important consideration which determines genotoxin susceptibility, particularly for agents that 
cause DSBs (Roos & Kaina, 2006).  While DSBs can be repaired by either relatively error free 
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HR or error prone NHEJ; the later may lead to chromosomal rearrangements particularly in cells 
in which this mechanism is preferentially utilized such as cells in G1 phase of the cell cycle (i.e. 
resting fibroblasts, hepatocytes) or in lymphocytes undergoing V(D)J recombination-associated 
DSB repair during development (Callen et al., 2007; Roos & Kaina, 2006). In HR-defective cells 
or cells that preferentially repair DSBs by NHEJ, the resulting chromosomal rearrangements can 
lead to apoptosis (Roos & Kaina, 2006). At least in S. cerevisiae yeast, two types of mutations 
display hyper-sensitivity to AactCdtB; strains defective in sensing DNA strand breaks and strains 
with defective HR repair (Matangkasombut et al., 2009). Since yeast use HR as primary means 
of DSB repair, the data suggest that cells defective in DSB repair are more sensitive to CdtB. 
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Role of CDT in disease 
Naturally-occurring infections with H. ducreyi and A. actinomycetemcomitans can elicit 
serum IgG antibodies to individual CdtABC protein subunits indicating development of a host 
adaptive immune response to toxin expressed during infection (Ando et al., 2010; Mbwana et al., 
2003; Xynogala et al., 2009).  Whether serum IgG antibodies play a role in recovery from 
infection and protect against subsequent re-infection has not been determined. However, the 
presence of antibodies that can neutralize the biological activity of CDT has been demonstrated 
in sera obtained from patients with chancroid [anti-HducCDT; (Mbwana et al., 2003)]; patients 
who are recovered from campylobacteriosis [anti-CjejCDT; (Abuoun et al., 2005)]; and people 
with periodontitis [anti-AactCDT; (Ando et al., 2010; Xynogala et al., 2009)].  It has been 
suggested that the absence of AactCdtC-specific IgG in sera of patients with localized aggressive 
periodontitis compared with those with generalized aggressive periodontitis might be attributable 
to either differences in CdtC expression by different strains or differences in the extent or 
duration of these infections in individual patient (Ando et al., 2010). Development of high levels 
of CDT-neutralizing IgG in serum and genital tissues of mice immunized with HducCDT toxoid 
compared to native toxin suggests a potential vaccine application for CDT toxoid in protection 
against chancroid (Lundqvist et al., 2010).  Aside from demonstrating adaptive humoral immune 
response to CDT following natural infection or immunization, nearly all studies on the role of 
CDT in disease have focused on in vitro models of eukaryotic cell genotoxicity and direct 
experimental evidence demonstrating the role of CDT in disease of human and animal hosts is 
lacking (Ge et al., 2005; Smith & Bayles, 2006; Stevens et al., 1999). 
Failure to demonstrate differences in skin colonization and lesion development amongst 
human volunteers and rabbits inoculated with wild-type H. ducreyi strain compared with a 
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isogenic strain with inactivated cdtC gene suggests that CDT is not required for cutaneous 
infection with this pathogen (Stevens et al., 1999; Young et al., 2001). While cdtA-, cdtB- and 
cdtC-negative mutant strains are no longer cytotoxic for cultured HeLa cells in vitro, a difference 
in the onset and degree of cutaneous changes elicited by mutant strains compared to the 
corresponding wild-type H. ducreyi parent strain in a rabbit model of chancroid could not be 
demonstrated, further confirming that CDT is unlikely to contribute to the early stage of skin 
infection (Lewis et al., 2001). Although a dose-dependent inflammatory response is seen 
following intradermal inoculation of rabbits with reconstituted recombinant HducCDT holotoxin, 
but not with individual subunits, incomplete characterization of the cellular infiltrate and 
mechanism of inflammation hinder proper interpretation of these observations (Wising et al., 
2002). Considering that HducCDT is highly toxic to a variety of mammalian cells in vitro, it is 
conceivable that local cellular damage might have been responsible for the dermal response seen 
with purified toxin in the rabbit model. 
Since CDT is produced by several intestinal bacterial pathogens, early studies examined the 
role of purified CDT and mutant strains in the pathogenesis of diarrheal disease. Development of 
profuse watery diarrhea accompanied with intestinal fluid accumulation and colonic epithelial 
cell damage within 12 h after intragastric inoculation of conventional suckling mice with purified 
SdysCDT expressed in E. coli suggests a role for CDT in diarrheal disease seen with Shigella 
dysenteriae (Okuda et al., 1997). These observations are further supported by demonstration of 
impaired translocation of C. jejuni CDT mutant compared with isogenic wild-type parent strain 
across the intestinal epithelial barrier of adult SCID mice at 2 h, but not at 6 h or 24 h after 
intragastrically inoculation with 10
9 
colony forming units of each bacterial strain (Purdy et al., 
2000). Although the data suggest a potential role of CDT in direct intestinal epithelial cell 
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damage and disease, intragastric administration of massive doses of toxin or bacteria, 
respectively in immature and immunocompromized hosts is not representative of the natural 
disease. Therefore, it is still unclear whether CDT contributes to intestinal epithelial barrier 
dysfunction and systemic spread of CDT-producing bacteria. 
Because HhepCDT is the only known virulence factor found in H. hepaticus, a host-adapted 
pathogen of mice (Suerbaum et al., 2003), laboratory mice have been used as a model to uncover 
pathogenetic mechanisms associated with CDT in infection and disease. Studies in laboratory 
mice, mostly with H. hepaticus (Ge et al., 2005; Pratt et al., 2006; Young et al., 2004), but also 
with H. cinaedi (Shen et al., 2009), and C. jejuni (Fox et al., 2004a) and others [reviewed by Ge 
and co-workers; (Ge et al., 2008)] suggest a potential contribution of CDT to bacterial virulence. 
On the basis of a more rapid intestinal clearance of H. hepaticus CdtB-negative mutants 
compared with wild-type parent strain in orally inoculated conventional and IL-10
–/–
 deficient 
mice, a role for HhepCDT in resistance against host defense mechanisms has been suggested (Ge 
et al., 2005; Pratt et al., 2006).  The lack of serum IgG1 and significantly lower IgG2c responses 
to H. hepaticus in IL-10
–/–
 mice infected with H. hepaticus CdtB-negative mutant compared to 
mice infected with wild-type H. hepaticus up to 8 months post-inoculation suggest an 
immunomodulatory role for HhepCDT in this model (Pratt et al., 2006). In these studies, IL-10
–/–
 
mice that recovered from infection with the CdtB-negative mutant strain were partially protected 
from subsequent challenge with either the mutant or wild-type H. hepaticus strains (Pratt et al., 
2006). However, because protection of mice recovered from infection with wild-type H. 
hepaticus was not evaluated, it is unknown whether partial protection is a function of a lack of 
exposure to CDT or a characteristic of H. hepaticus infection in IL-10
–/–
 mice.  In other studies 
using highly susceptible A/JCr male mice, the prevalence and level of cecal colonization by H. 
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hepaticus CdtB-negative mutant were reduced compared to wild-type parent strain at 4 and 10 
months post-inoculation, whereas hepatic colonization levels were similar for both strains at 4 
months, but reduced at 10 months post-inoculation in mice inoculated with the mutant strain (Ge 
et al., 2007). Either strain produced similar degrees of hepatic inflammation early post-infection, 
but only mice infected with wild-type strain progressed to developed dysplastic changes by 10 
months post-inoculation (Ge et al., 2007). Taken together these studies demonstrate a role for 
HhepCDT in modulating the host adaptive immune response so that persistent intestinal 
colonization leading to systemic translocation of bacteria, and localization to the liver where 
chronic infection results in cancer development. Future studies with laboratory mice should 
uncover more precisely at what stage in the pathogenesis of disease and the specific cellular 
targets of CDT that are responsible for persistent infection and development of disease. 
High concentrations of all three CjejCDT subunits are present in detergent extracts of 
purified outer membrane preparations of C. jejuni suggesting that it is primarily membrane-
associated (Hickey et al., 2000; Lindmark et al., 2009).  Incubation of C. jejuni in the presence 
of 25 mM or 0.1% bile acid sodium deoxycholate, a concentration physiologically relevant to the 
intestinal lumen, releases the membrane-associated CdtA, CdtB and CdtC subunits into the 
culture supernatant (Hickey et al., 2005). Since CjejCDT holotoxin can elicit established human 
intestinal epithelial cell lines to produce CXCL8, a potent pro-inflammatory chemokine 
responsible for recruitment of polymorphonuclear neutrophils in the intestinal mucosa, a role for 
CDT in initiation of host innate defense has been suggested (Hickey et al., 2000; Konkel et al., 
2001; Murphy et al., 2010; Young et al., 2007). However, since PMNs are expected to eliminate 
C. jejuni, the benefit of eliciting a pro-inflammatory response seems less desirable if bacterial 
infection is prevented. Given that massive translocation of PMNs across the intestinal 
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epithelium, as seen in the initial stages of campylobacteriosis, results in increased intestinal 
permeability and leakage of extracellular fluid into the gut lumen (Blikslager et al., 2007; Dasti 
et al., 2009), alterations in the gut microenvironment might indirectly promote local expansion of 
C. jejuni, thus allowing increased shedding of bacteria in feces, contamination of the 
environment and further spread of disease to susceptible hosts. 
Development of a host adaptive immune response to individual CDT protein subunit is 
seen following spontaneous infection and disease caused by CDT-producing A. 
actinomycetemcomitans, C. jejuni and H. ducreyi. However, experimental infections in a 
laboratory mouse model of H. hepaticus clearly show that CDT can modulate both the level and 
isotype antibody response of the host and establish persistent infection. Future studies should 
define which bacterial clearance mechanism is specifically targeted by CDT and its relationship 
to host immune response modulation. 
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Conclusions and future directions 
 Currently, CDT is the only member of a novel class of AB-type bacterial toxins that 
exhibits nuclease activity in vitro and translocates to the nucleus of mammalian cells where it 
exerts genotoxic damage resulting in cell cycle arrest and apoptosis. Nearly a quarter of a century 
since the discovery of CDT, our understanding of the biology of this genotoxin and molecular 
mechanisms of cellular toxicity has greatly improved; however, the natural history and 
contributions of CDT to mucocutaneous colonization, chronic infection and pathogenesis of 
disease in various niches within their respective hosts are still incompletely understood. Of 
paramount importance is the production of CDT by all major food- and water-borne pathogens 
including several pathotypes of E. coli and certain species of Campylobacter, Shigella, and 
Salmonella. Clearly, further studies are needed in order to more specifically establish the in vivo 
relevance of nuclease and phosphatase activities, particularly in the context of host immune 
response modulation and contribution to persistent bacterial infection. In the context of intestinal 
diseases, a largely unexplored and provocative area of study is the potential role of CDT-
producing Campylobacter and Helicobacter species in orchestrating host adaptive immune 
response leading to alterations in tolerance to gut microflora components and dietary antigens 
leading to development of inflammatory bowel disease.  Determining the cellular targets of CDT 
produced by various bacterial pathogens within their respective hosts in relation to specific 
stages of the disease process is critical to understanding the role of this toxin in host-pathogen 
interactions. Given that CDT is the only known virulence factor produced by H. hepaticus and H. 
bilis, and that chronically infected mice develop inflammation-associated hepatic and colon 
cancer cancer (Ericsson et al., 2010; Fox et al., 2011), a provocative area of future research 
endeavors will be to determine whether or not CDT-producing bacteria represent co-factor that 
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promote cancer development in humans. We hope that this review will generate interest amongst 
our colleagues and stimulate the next generation of microbiologists to tackle this evolving field 
of CDT-mediated microbial pathogenesis.   
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Rationale and hypothesis for the current study 
 
It is currently known that CDT-induces a DNA damage response (DDR) similar to that elicited 
by ionizing radiation (IR)-induced DNA double strand breaks (DSBs) leading to ATM-
dependent cell cycle arrest at the G2/M and G1/S transitions in mammalian cells. Moreover, on 
the basis of a higher sensitivity of hematopoietic cells to CDT, it has been suggested that CDT 
modulates the host immune response in vivo. However, the precise nature of the G2/M arrest in 
response to CDT has not been resolved and the possibility of CDT inducing the intra-S phase 
checkpoint has not been investigated. Additionally, role of ATM in pathogenesis of diseases 
caused by CDT-producing bacteria is not characterized. Furthermore, despite the critical 
importance of p53 in inducing apoptosis in response to genotoxic stress, the contribution of p53 
to CDT-mediated genotoxicity is incompletely understood and CDT-induced DDR is not well 
characterized in lymphoid cells. Therefore the central hypothesis of the current study is that 
lymphocytes from ATM defective mice have increased susceptibility to CDT in vitro and mice 
with a defective ATM pathway have increased susceptibility to disease caused by H. hepaticus, a 
mouse pathogen with CDT as the only know virulence factor. Similarly it is also hypothesized 
that p53 defective lymphocytes have increased resistance to CDT-induced apoptosis. 
 
In order to address these questions, several Atm
-/-
 and p53
-/-
 mouse thymic lymphoma cell lines 
were developed according to procedures described in chapter 1. Activation of the ATM-
dependent intra-S and G2/M checkpoint by Helicobacter hepaticus CDT (HhepCDT) were 
characterized in chapter 3. Additionally the role of p53 in HhepCDT-induced apoptosis was also 
characterized in chapter 3. To complement these studies, the role of p53 in the differential 
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susceptibility of several human lymphoid cell lines to CDT was evaluated in chapter 4 using 
CDT from Campylobacter jejuni.  Additionally, The CDT-induced DDR was further 
characterized in chapter 4. Finally the adaptive humoral immune response of Atm-defective mice 
was characterized chapter 5 following infection with H. hepaticus.  
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CHAPTER 2 
Derivation of thymic lymphoma T-cell lines from Atm
-/-
 and p53
-/-
 mice
1
  
Abstract 
Established cell lines are a critical research tool that can reduce the use of laboratory animals in 
research. Certain strains of genetically modified mice, such as Atm
-/-
 and p53
-/-
 consistently 
develop thymic lymphoma early in life (Barlow et al., 1996; Elson et al., 1996), and thus, can 
serve as a reliable source for derivation of murine T-cell lines. Here we present a detailed 
protocol for the development of established murine thymic lymphoma T-cell lines without the 
need to add interleukins as described in previous protocols (Barlow et al., 1996; Kuang et al., 
2005). Tumors were harvested from mice aged three to six months, at the earliest indication of 
visible tumors based on the observation of hunched posture, labored breathing, poor grooming 
and wasting in a susceptible strain (Barlow et al., 1996; Browne et al., 2004). We have 
successfully established several T-cell lines using this protocol and inbred strains of Atm
-/-
 
[FVB/N-Atm
tm1Led
/J] (Elson et al., 1996) and p53
-/-
 [129/S6-Trp53
tm1Tyj
/J] (Jacks et al., 1994) 
mice. We further demonstrate that more than 90% of the established T-cell population expresses 
CD3, CD4 and CD8.  Consistent with stably established cell lines, the T-cells generated by using 
the present protocol have been passaged for over a year.  
______________________________________________________________________________ 
1
This article has been published in the Journal of Visualized Experiments: 
Jinadasa, R., Balmus, G., Gerwitz, L., Roden, J., Weiss, R. & Duhamel, G. (2011). Derivation of thymic 
lymphoma T-cell lines from Atm
-/- 
and p53
-/-
 mice. J Vis Exp (50). 
Author contributions: R.N.J. and G. B. performed the experiments. L.M. G. performed video recording, 
directed the movie. J.L.R. narrated the movie. R.N.J. edited the final movie. R.N.J., R.S.W. and G.E.D. 
wrote the movie script and paper. R.S.W. and G.E.D. designed the experiments. 
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 Short Abstract 
In this video we demonstrate a protocol to establish mouse thymic lymphoma cell lines. By 
following this protocol, we have successfully established several T-cell lines from Atm
-/-
 and 
p53
-/- 
mice with thymic lymphoma.  
Materials  
 - Ice bucket 
- 70% ethanol  
- Dissection pad consisting of foam block covered with aluminum foil and pins  
- Two sets of small sterile scissors and forceps 
- Sterile 150 mm
2
 Petri dish (Thermo Fisher Scientific, Waltham, MA; cat. #08-757-13)  
- Sterile 18 gauge needles 
- 50 ml conical tubes (Corning Inc., Corning NY; cat # 430829) 
- 10% buffered formalin 
- Tissue culture flasks  
 T-25 (TPP, Trasadingen, Switzerland; cat # 90025)  
 T-75 (TPP, Trasadingen, Switzerland; cat # 90075) 
- 6-well plates (Corning Inc., Corning NY; cat # 3506) 
- Sterile phosphate buffered saline pH 7.2 (PBS) 
- Culture medium  
 RPMI 1640 with 25 mM HEPES, 200 mM L-glutamine (Lonza, Walkersville,  
  MD; cat#12-115F) supplemented with the following: 
10% heat inactivated (56°C, 30 min) fetal bovine serum (FBS; Hyclone, Logan, 
UT; cat# SH30088.03) 
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 1% penicillin and streptomycin (Mediatech, Manassas,VA; cat# 30-002-CI) 
 1% nonessential amino acids (Mediatech; cat#25-025-CI) 
 55 mM 2β-mercaptoethanol (Sigma, St Louis, MO; cat#M752)  
- Dimethyl sulfoxide (DMSO; Calbiochem, La Jolla, CA; cat # 317275) 
- Antibodies (eBioScience, San Diego, CA) 
 anti-CD3-FITC (cat. #11-0031-85) 
 anti-CD4-APC (cat. #17-0041-83) 
 anti-CD8-PE (cat.#12-081-85) 
- Bovine serum albumin (BSA; Life Technologies, Grand Island, NY; cat #. 11018-017) 
- Concanavalin A (Sigma cat# C5275) 
-1.8 ml freezing vials (Nunc, Roskilde, Denmark; cat# 368632) 
 Protocol 
1. Dissection of tumor 
1.1. For tumor dissection, a clean paper towel or disposable surgical drape is placed on the 
dissection pad and sprayed with 70% ethanol. 
1.2. Mice for this protocol are routinely euthanized with CO2. Place the euthanized mouse 
on the dissection pad and spray both sides of the animal with ethanol. The mouse is 
held in place onto the dissection pad by using four or more push pins inserted through 
the legs and sprayed thoroughly with 70% ethanol. 
1.3. The skin over the midline is cut from the pubis to the base of the head by using sterile 
scissors, while avoiding the underlying muscles and penetrating into the body cavities.  
1.4. Open the abdominal cavity with a new pair of sterile scissors and forceps being careful 
to not damage the internal organs.  
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1.5. Open the thoracic cavity by dissecting and deflecting the rib cage to reveal the tumor, 
without damaging blood vessels.  
1.6. Separate the tumor from other organs, and transfer a piece approximately 40-50% of 
the total tumor (approximately up to 1.5 X 0.8 X 0.8 cm) into cold PBS kept on ice.  
1.7. The remaining portion of the tumor can be saved for other assays and a complete 
necropsy can be performed at this time. 
2. Culturing lymphoma cells 
2.1. Spray the tube containing the dissected tumor with 70% ethanol and transfer to a 
biosafety cabinet.  
2.2. Add 10 ml of culture medium to a sterile 150 mm2 Petri dish.  
2.3. Transfer the piece of tumor into the Petri dish by gentle suction with a pipette.  
2.4. Bend two sterile 18 gauge needle facing the beveled side out.  
2.5. Dissociate the tumor using the bent needles. 
2.6. Swirl the dish, tap gently and place at an angle to collect the cell suspension to a side, 
while avoiding large pieces of tumor. 
2.7.  Aspirate the cell suspension and transfer into a 50 ml conical tube while avoiding large 
pieces of tumor. 
2.8. Wash the plate with 10 ml of medium and transfer into the same tube while avoiding 
large pieces of tumor.  
2.9. Mix the cell suspension composed of lymphocytes and stromal cells gently and transfer 
5 ml into a T-25 tissue culture flask and 10 ml into a T-75 tissue culture flask. Gently 
swirl the flasks. 
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2.10. Use the remaining cell suspension to make 2, 4, 10,100 and 1000 fold dilutions in 2.5 
ml final volume (culturing cells at different densities using several types of culture 
vessels maximizes the likelihood of establishing a T-cell line).  
2.11. Plate 2.0 ml of each dilution into individual wells of a 6-well plate. Gently swirl the 
plate.  
2.12. Incubate the cells for 48 h in humidified CO2 atmosphere in air.  
3. Feeding lymphoma cells 
3.1. After 48 h of incubation, add 5 ml of medium to the T-25 flask and 10 ml of medium to 
the T-75 flask along the wall with minimal disturbance of the cells.  
3.2.  Add 2 ml of medium to each well of the 6-well plate along the wall with minimal 
disturbance of the cells. 
3.3.  Incubate the cells for an additional 72 h. 
4. Passaging lymphoma cells  
4.1. Initial passage 
4.1.1.At the end of the fifth day of incubation, the cells are passaged at a 1:1 ratio, while 
retaining the original flasks and plates (maintaining the cell density at a concentration 
of approximately 3x10
6
/ml during the first passages promotes successful establishment 
of a continuous cell line). 
a. For the T-25 flask, transfer 5 ml of cell suspension into a new flask containing 5 
ml of medium. Add 5 ml of medium into the original flask. 
b. For the T-75 flask, transfer 10 ml of cell suspension into a new flask containing 
10ml of medium. Add 10 ml of medium into the original flask. 
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c. For the 6-well plate, transfer 2 ml of cell suspension from each well into 
corresponding wells of a new plate containing 2 ml of medium in each well. Add 
2 ml of medium into each well of the original wells. 
4.1.2. Incubate all flasks and plates for an additional 72 h. In our experience most cell lines 
are established from these passage one cultures (the presence of loosely adherent 
suspension cell aggregates over the attached stromal cells is an early indication of an 
established cell line). 
4.1.3. For the cultures with fewer or no loosely adherent suspension cell aggregates, feed 
the flasks or plates by carefully replacing approximately 50% of the medium every 72 
h. To avoid removing cells from the original culture, culture vessels are left standing 
and undisturbed for at least 5 min to let the cells sediment at the bottom by gravity 
before gentle aspiration of the supernatant medium.  
4.2. Maintaining established cell lines 
4.2.1. Established cell lines are passaged into new flasks and plates. For T-25 and T-75 
flasks, add 5 ml of the original or passage one suspension into 5 ml of medium. For 6-
well plates, add 3 ml of the original or passage one cell suspension into 7 ml of 
medium in a T-25 flask.  Feed and retain the original or passage one culture by 
replacing the volume removed with fresh culture medium. 
4.2.2. Passage established cell lines into new T-25 flasks. The cell lines have a doubling 
time of 18-24 h. The cultures are routinely maintained at a density of 1-3x10
6
/ml and 
passaged every 3 days. Add the required volume of previous passage culture to new 
medium to make up to 10 ml. Feed and retain the original culture. 
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4.2.3. After a few passages, the non-adherent cells will self-sustain without the adherent 
stromal cells and a smaller number of adherent cells are carried over with each 
passage. Beyond this point, the cultures can be maintained in non-tissue culture 
treated T-25 flasks.  
5. Freezing and recovering lymphoma cell lines 
5.1. The cell lines are frozen in freshly prepared RPMI 1640 medium containing 20% FBS 
and 10% DMSO. 
5.2. Cells from a 48 h old culture in T-25 flask (approximately 1.5x10
6
 cells/ml) are 
centrifuged at 1500 rpm for 5 min at room temperature. After discarding the supernatant, 
the cells are re-suspended in 2 ml of cold freezing medium. Two 1.0 ml volumes of cell 
suspension from each flask are placed in freezing vials, immediately frozen at -80°C, and 
transferred to liquid nitrogen the following day. 
5.3. Cells are recovered from liquid nitrogen storage by quick thawing, and resuspending the 
contents in 10 ml of fresh culture medium. Alternatively, freshly thawed cells are washed 
once in warm culture medium to remove the DMSO before resuspending in 10 ml of 
fresh culture medium. The cells are cultured for at least 72 h before subsequent passage. 
Representative results 
An Atm
-/-
 T-cell line developed using this protocol and designated DWJ-Atm-1 was 
characterized by staining with anti-CD3-FITC, anti-CD4-APC and anti-CD8-PE and flow 
cytometry analysis (Figure 2.1). More than 90% of the T-cells were CD3, CD4 and CD8 triple-
positive.   
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Figure 2.1: Characterization of a T-cell line developed using this protocol.  
The cell surface markers of an established Atm
-/-
 cell line designated DWJ-Atm-1 were 
characterized by staining with anti-CD3-FITC, anti-CD4-APC, anti-CD8-PE and flow cytometry 
analysis.  Briefly, 1X10
6
 fresh cells were washed once in cold PBS (1500 rpm/5 min), and 
incubated at 4°C for 10 min with 200 µl of antibody cocktail (each antibody at 1:200 dilution in 
PBS with 1% BSA. Cells can be examined immediately while fresh or fixed for later analysis. 
Fixed cells are prepared by adding neutral buffered formalin at a 4% (vol/vol) final concentration 
and incubated at 4°C for 30 min, harvested by centrifugation (1500 rpm/5 min) and resuspended 
in 200 µl of PBS with 1% BSA.  A total of 1 X 10
4
 cells were analyzed by using a BD FACS 
Calibur analyzer and CellQuest software (BD Biosciences, San Jose, CA). 
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Figure 2.1 
(A)      (B) 
  
  
Cell Surface 
Marker 
% Positive 
cells 
CD8
+ 
CD4
+
 96.2 
CD3
+ 
CD4
+
 85.7 
CD3
+ 
CD8
+
 91.9 
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Discussion 
In this protocol, we provide detailed procedures to establish murine T-cell lines from two 
different mouse genotypes; Atm
-/-
 [FVB/N-Atm
tm1Led
/J] and p53
-/-
 [129/S6-Trp53
tm1Tyj
/J]. By 
using this protocol, a total of 6 (out of 7 attempts) Atm
-/-
 and three (out of 5 attempts) p53
-/-
 
murine T-cell lines have been established in our laboratory.  Representative data demonstrating 
that cell line DWJ-Atm-1, an Atm
-/-
 cell line consists of a cell population in which greater than 
90% of the cells express CD3, CD4 and CD8 surface markers confirm that clonal T-cell line can 
be established using our protocol.  
Development of murine T-cell lines has been reported (Chervinsky et al., 2001; Kuang et 
al., 2005; Sharma et al., 2006); however, detailed protocols for establishing these lines have not 
been described previously. Although only two mouse genotypes were used for derivation of 
murine T-cell lines in our laboratory, we believe that these procedures are applicable to a wide 
range of spontaneous T-cell lymphomas found in other strains of mice such as Kras defective, 
and potentially other animal species.  Murine T-cell lines have potential applications in 
understanding basic questions in immunology and oncology. Currently, we are using these cell 
lines in studies aimed at characterizing host-pathogen interactions and genotoxin-induced 
cytotoxicity including mechanisms of cell cycle arrest and apoptosis. Given that murine T-cell 
lines share genomic alterations such as deletions of PTEN and FBXW7 in common with acute 
human T-cell lymphoblastic leukemias and lymphomas, they are particularly well suited for 
research in cancer biology (Maser et al., 2007), and may have further applications for rapid pre-
clinical efficacy screening of immunological and cancer chemotherapeutic agents in vitro.  
Whether or not these cell lines can be propagated in vivo in either syngeneic or 
immunocompromised mice has not been determined. 
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In contrast to previous protocols in which successful establishment of a T-cell line took 
up to three months (Chervinsky et al., 2001), cell lines developed using the current protocol were 
established within a month (between passage 2-8). We found that the presence of loosely 
adherent cell aggregates over attached stromal cells is a critical early indication of an established 
cell line. In order to allow murine T-cells to propagate indefinitely, we also found that it is 
important to leave the initial loosely adherent cell aggregates undisturbed during feedings.  In 
addition, maintaining the cell density at a concentration of approximately 3x10
6
/ml during the 
first passages also promotes successful establishment of a continuous cell line.  In our 
experience, culturing cells at different densities using several types of culture vessels maximizes 
the likelihood of establishing a T-cell line.  Most T-cell lines were established from T-75 flasks 
or 6-well plates and 10 or 100 fold dilutions which correspond to approximately 1x10
7
 or 1x10
6
 
cells/ml. A previous protocol recommended culturing cells at 5 x 10
6
, 1 x10
7
,
 
and 2 x 10
7
 cells 
per well in 6-well plates, and feeding after 7 days (7). We observed that feeding initial cultures at 
48 h and passage 72 h later, on day 5 is optimal. Waiting longer before the first feeding and 
passage will cause the cells to lose their viability and stop dividing. 
The last parameter which we found is critical to successful propagation of murine T-cells 
in vitro is the presence of FBS in the culture medium that can support rapid cell growth.  
Different lots and suppliers of FBS should be screened prior to initiating the derivation of T-cell 
lines for identification of an appropriate reagent.  If murine T-cell lines are not available for 
screening, primary cultures of thymic lymphocytes placed in wells of a 24-well plate at a 
concentration of 1x10
6 
per ml of test medium containing concanavalin A (1µg/ ml) to stimulate 
rapid cell growth is adequate.  In the presence of an optimal source of FBS, the number of cells 
should double every 18 to 24 h. 
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CHAPTER 3 
Activation of ATM-dependent Intra-S-phase and G2/M checkpoints and p53-dependent 
apoptosis in mouse lymphocytes by Helicobacter hepaticus CDT
1, 2
 
Abstract 
Cytolethal distending toxin (CDT) is an AB type genotoxin produced by several important Gram negative 
bacteria. The active subunit CdtB has structural homology with mammalian deoxyribonuclease I. CDT-
induces a DNA damage response (DDR) similar to that elicited by ionizing radiation (IR)-induced DNA 
double strand breaks (DSBs) leading to ATM-dependent cell cycle arrest at the G2/M and G1/S 
transitions in mammalian cells. The precise nature of the G2/M arrest in response to CDT has not been 
resolved and the possibility of CDT inducing the intra-S phase checkpoint has not been investigated. Here 
we demonstrate the activation of the ATM-dependent intra-S checkpoint by HhepCdtABC in primary 
mouse thymic lymphocytes and thymic lymphoma cell lines by observing a transient reduction in DNA 
synthesis.  Further, we demonstrate rapid ATM-dependent reduction in phosphorylated histone H3 in 
HhepCdtABC treated cells thereby definitively demonstrating CDT-induced checkpoint mediated G2/M 
cell cycle arrest. Additionally we also demonstrate the CDT-induced apoptosis in thymic lymphoma cell 
lines is p53-dependent. Activation of intra-S checkpoint by CDT may contribute to bacterial virulence by 
modulating rapidly dividing lymphocytes and thus adaptive immune response following infection. Taken 
together, we provide first evidence to suggest that CDT induces a broad DDR including cell cycle arrest 
in all phases of the cell cycle. 
_____________________________________________________________________________________ 
Manuscript in preparation: 
 
1
Rasika N. Jinadasa, Gabriel Balmus, Stephen S. Bloom, Robert S. Weiss and Gerald E. Duhamel.  
2
Author contributions: R. N. J and G. B performed the experiments (individual contributions are indicated 
in figure legends). R. S. W. and G. E. D. designed the experiments. R. N. J., S. E. B., R. S. W. and G. E. 
D. wrote the manuscript.
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Introduction 
Cytolethal distending toxin (CDT) is a heterotrimeric AB type toxin produced by several 
clinically important Gram negative bacteria (Ge et al., 2008; Guerra et al., 2011; Jinadasa et al., 
2011b).  The active subunit CdtB has structural homology with phosphodiesterase family of 
enzymes including mammalian deoxyribonuclease I (Elwell & Dreyfus, 2000; Hu et al., 2006; 
Hu & Stebbins, 2006; Lara-Tejero & Galan, 2000; Nesic et al., 2004; Yamada et al., 2006). 
Intoxication of mammalian cells with CDT causes DNA double strand breaks (DSBs) that 
initiates a DNA damage response (DDR) similar to that elicited by ionizing radiation (IR) and 
leading to irreversible cell-cycle arrest and apoptosis.  Currently CDT is the only known AB type 
toxin with deoxyribonuclease activity (Alouf, 2006). Interestingly, CDT is the only known 
virulence factor in mouse pathogen Helicobacter hepaticus, which establishes long-term 
colonization of the lower intestinal and hepatobiliary tract resulting in chronic inflammation and 
ultimately hepatocellular and colonic carcinomas in susceptible strains (Fox et al., 1994; Hailey 
et al., 1998; Ihrig et al., 1999; Suerbaum et al., 2003; Ward et al., 1994a; Ward et al., 1994b).  
 
Chronic colitis associated with  H. hepaticus infection in mice mimics human inflammatory 
bowel disease (IBD), and therefore is widely used as a model for IBD (Fox et al., 2011). Further, 
H. hepaticus is closely related to the major food-and-waterborne human pathogen 
Campylobacter jejuni. Since there are no effective mouse models to reproduce the pathogenesis 
of human C. jejuni infection, H. hepaticus infection in mice has been used as a surrogate model 
for human campylobateriosis (Suerbaum et al., 2003; Young et al., 2007). C. jejuni is the most 
frequently isolated food-and-water borne human pathogen worldwide, particularly in developed 
countries (Lindmark et al., 2009; Young et al., 2007). Even though the clinical illness may 
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manifest as mild non-inflammatory self-limiting enterocolitis, it can lead to severe inflammatory 
bloody diarrhea and fever (Lindmark et al., 2009; Young et al., 2007). Additionally, C. jejuni 
infection is also considered as a risk factor for subsequent development of Guillain-Barré 
syndrome; an acute inflammatory demyelization of the peripheral nervous system (Hughes & 
Cornblath, 2005; Lindmark et al., 2009; Young et al., 2007). The role of CDT in disease 
pathogenesis is incompletely understood; however, experimental infection of laboratory mice 
with H. hepaticus suggests that CDT plays an essential role in persistent infection and has 
adaptive immunomodulatory properties (Ge et al., 2005; Ge et al., 2008; Pratt et al., 2006). On 
the basis of these in vivo observations and the comparatively lower dose-response of 
hematopoietic cells to CDT intoxication in vitro, lymphoid cells have been hypothesized as 
likely physiological targets of CDT (Ge et al., 2005; Pratt et al., 2006; Shenker et al., 2007). 
 
In response to DNA damage, DDR signaling cascades activate several checkpoints and prevent 
the cells from entering into S phase (G1/S checkpoint), slow the progression through S phase 
(intra-S or S-phase checkpoint), and block entry into mitosis [(G2/M checkpoint); (Weiss et al., 
2003)]. It is currently believed that CDT-induced DSB trigger a DDR mediated by the 
phosphoinositide 3-kinase related kinase ataxia telangiectasia mutated (ATM), encoded by the 
gene mutated in the rare autosomal recessive genetic disorder ataxia telangiectasia [AT;(Bartek 
& Lukas, 2007; Cortes-Bratti et al., 2001; Derheimer & Kastan, 2010; Jackson & Bartek, 2009)]. 
It is also believed that the effects of CDT are cell type specific (Cortes-Bratti et al., 2001; 
Hassane et al., 2003; Li et al., 2002; Liyanage et al., 2010). On the basis of its ability to 
modulate the cell cycle and cause cell death, CDT has been classified as an inhibitory 
cyclomodulin (Nougayrede et al., 2005; Oswald et al., 2005). In fact, CDT was the first bacterial 
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toxin shown to cause cell cycle arrest in mammalian cells (Toth et al., 2009). Cell lines of 
epithelial and endothelial origins has been reported to primarily arrest in the G2/M phase 
following CDT exposure  (Elwell et al., 2001; Jinadasa et al., 2011b; Lara-Tejero & Galan, 
2001; Smith & Bayles, 2006; Whitehouse et al., 1998; Wising et al., 2005; Young et al., 2000), 
whereas cells of fibroblastic origin arrest both in the G1/S and G2/M phases of the cell cycle 
(Belibasakis et al., 2004; Cortes-Bratti et al., 2001; Hassane et al., 2003; Smith & Bayles, 2006; 
Wising et al., 2005). By contrast, hematopoietic lineage cell lines including lymphocytes, 
monocytes, macrophages and dendritic cells, are several orders of magnitude (10–50 pg/ml 
compared to 1–5 µg/ml for other cells) more susceptible to CDT, and undergo rapid apoptosis 
after a brief cell cycle arrest (Belibasakis et al., 2004; Cortes-Bratti et al., 2001; Hassane et al., 
2003; Smith & Bayles, 2006; Wising et al., 2005). Human epithelial and fibroblastic cells that 
survive the acute phase of CDT intoxication demonstrate the markers of cells that undergo 
cellular senescence (Blazkova et al., 2010).  
 
Currently CDT is known to cause ATM-dependent cell cycle arrest at the G2/M and G1/S 
transitions of the cell cycle. The CDT-mediated G2/M arrest is mediated through the activation 
of Chk2 by ATM upon sensing DSBs. Activated Chk2 phosphorylates and inactivates CDC25 C 
and the resulting accumulation of phosphorylated cyclin B-CDK 1 complex prevents mitotic 
entry (Ge et al., 2008; Smith & Bayles, 2006). The mechanism for CDT-mediated G1/S arrest is 
thought to be primarily p53-dependent.  Activated ATM phosphorylates p53, and the resulting 
upregulation of p21 inhibits cyclin E-CDK2, which blocks S-phase entry (Ge et al., 2008; Smith 
& Bayles, 2006). However, p53-independent upregulation of p21 following CDT treatment has 
also been reported (Smith & Bayles, 2006).  
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Although there is limited evidence supporting CDT-mediated intra S-phase checkpoint activation 
in yeast, it has yet to be investigated in mammalian systems (Matangkasombut et al., 2009). 
DNA damage during S phase initiates a down-regulation of DNA synthesis, a phenomenon first 
evidenced by the failure of Atm-defective cells to inhibit DNA synthesis in response to IR 
[(radio-resistant DNA synthesis); (Weiss et al., 2003)]. Additionally, the precise nature of the 
G2/M arrest in response to CDT has not been fully resolved, as at least two G2/M checkpoints 
exist in mammalian cells, an ATM-dependent transient checkpoint which activates in G2 phase 
cells immediately after DNA damage, and prolonged ATM-independent checkpoint which is 
activated several hours after damage and reflects the G2 phase accumulation of cells that were 
initially damaged during S-phase (Xu et al., 2002).    
 
In the current study we demonstrated the activation of the ATM-dependent intra-S checkpoint by 
HhepCdtABC in primary mouse thymic lymphocytes and thymic lymphoma cell lines by 
observing a transient reduction in DNA synthesis.  Further, we demonstrate rapid ATM-
dependent reduction in phosphorylated histone H3 in HhepCdtABC treated cells thereby 
definitively demonstrating CDT-induced checkpoint mediated G2/M cell cycle arrest. 
Additionally we also demonstrate the CDT-induced apoptosis in mouse thymic lymphoma cell 
lines is p53-dependent. Activation of intra-S checkpoint by CDT may contribute to bacterial 
virulence by modulating rapidly dividing host lymphocytes and thus adaptive immune response 
following infection. Taken together, we provide first evidence to suggest that broadly conserved 
genotoxin CDT is capable of inducing a broad DDR including cell cycle arrest in all phases of 
the cell cycle. 
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Materials and Methods 
Cell lines and culture conditions. The cell lines used in this study were listed in Table 3.1. The 
derivation and maintenance of these cell lines was described earlier (Jinadasa et al., 2011a). All 
cell lines were maintained in RPMI 1640 (Lonza, Basel, Switzerland) supplemented with heat 
inactivated 10% fetal bovine serum (Hyclone, South Logan, UT) and 1% penicillin streptomycin 
(Mediatech, Manassas, VA) at 37°C in a humidified atmosphere of 5% carbon dioxide in air. All 
experiments were performed using cells cultured for 18 to 24 h after transfer to 24-well tissue 
culture plates unless otherwise indicated. Primary mouse thymic lymphocytes were cultured in 
same media with 1µg/ml concanavalin A (Sigma cat. # C2272) stimulation.  
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Table 3.1. Characterization of cell lines used in this study. 
 Atm-1 Atm-2 Atm-3 p53-1 p53-2 p53-3 
CD4+/CD8+  92.4 (3.8) 94.5(2.5) 91.5(1.2) 96.1(3.7) 91.0 (6.5) 88.1(5.5) 
CD3+/CD4+  85.5(0.2) 91.8(0.6) 89.7 (0.7) 99.7(0.1) 88.3(0.4) 85.2(2.2) 
CD3+/CD8+  87.5 (6.2) 93.9 (2.8) 90.4 (1.7) 99.5 (0.1) 93.8 (1.3) 88.7(3.4) 
The cell surface markers of established Atm
-/-
 and p53
-/-
 were characterized by staining with anti-
CD3-FITC, anti-CD4-APC and anti-CD8-PE by low cytometry as described earlier (1). Data is 
expressed as mean percentage and standard deviation of cells staining positive for each marker in 
two independent experiments (R. J).     
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Recombinant reconstituted H. hepaticus CDT (HhepCdtABC). The his-tagged proteins were 
expressed in E. coli. HhepCdtABC was produced as described earlier (Dassanayake et al., 2005; 
Liyanage et al., 2010). Expression was induced when cultures grown at 37°C in Luria-Bertani 
medium containing kanamycin (Sigma, St. Louis, MO) reached an optical density at 600 nm of 
0.6-0.8 by adding 1 mM isopropyl-β-D-thiogalactopyranoside (Invitrogen) and grown an 
additional 5 h at 25°C. HhepCdtA and HhepCdtB were purified under denaturing conditions 
while HhepCdtC was purified under native conditions.  The purity of each recombinant protein 
preparation was determined by SDS-PAGE followed by Coomassie blue staining and Western 
blot as previously described  (Dassanayake et al., 2005). The CDT holotoxin was reconstituted 
as previously described (Liyanage et al., 2010) and stored at -80°C in 1:1 sterile glycerol.  
Fornegative controls, reconstituted recombinant HhepCdtABC was heat inactivated (HI) for 10 
min at 70°C and stored at -80°C in 1:1 sterile glycerol. Briefly, the gene sequence encoding each 
CjejCDT sub-unit was amplified by using specific primer pairs (Table 2) and high fidelity Pfx 
DNA polymerase (AccuPrime, Invitrogen, Carlsbad, CA) according to the manufacturer’s 
instructions. The amplified products were cloned in the pET-28a(+) expression vector (Novagen, 
Darmstadt, Germany) and transformed into E. coli BL21 DE (New England BioLabs, Ipswich, 
MA). Expression was induced when cultures grown at 37°C in Luria-Bertani medium containing 
kanamycin (Sigma, St. Louis, MO) reached an optical density at 600 nm of 0.6-0.8 by adding 1 
mM isopropyl-β-D-thiogalactopyranoside (Invitrogen) and grown an additional 5 h at 25°C. 
CjejCdtA and CjejCdtB were purified under denaturing conditions while CdtC was purified 
under native conditions. The purity of each recombinant protein preparation was determined by 
SDS-PAGE followed by Coomassie blue staining and Western blot as previously described  
(Dassanayake et al., 2005). The CDT holotoxin was reconstituted as previously described 
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(Liyanage et al., 2010) and stored at -80°C in 1:1 sterile glycerol.  For negative controls, 
reconstituted recombinant CjejCdtABC was heat inactivated (HI) for 10 min at 70°C and stored 
at -80°C in 1:1 sterile glycerol. 
 
Western blotting. Approximately 3x10
6
 cells (5 ml cultures in T25 flasks) were incubated with 
100 ng/ml native or HI CjejCdtABC or γ-irradiated (5Gy; positive control). Western immunoblot 
was performed as described earlier with modifications (Liyanage et al., 2010). Briefly, cells were 
lysed in RIPA buffer with protease and phosphatase inhibitors (aprotinin, leupeptin, 
phenylmethanesulfonyl fluoride and sodium orthovanadate (all from Sigma, 1 mM each) and 
incubated on ice for 10 min. The lysate was briefly sonicated (1 min at 0.5-2 power setting on a 
Misonix 3000 sonicator (Misonix Inc. Farmingdale, NY). Protein concentrations were 
determined by Bradford’s method (Bradford, 1976). Proteins were separated on 12-13% (4% for 
ATM) SDS PAGE, transferred to PVDF membranes and immunoblotted with following 
antibodies; anti-phospho ATM (Rockland, cat. #200-301-400), anti- γ-H2AX (Millipore, cat.# 
05-636), anti-beta actin (Sigma, cat.# A5441). Bands were detected with ECL (Advansta, cat. # 
K-12045) according to manufacturer’s instructions using Versa Doc (Bio Rad) gel imaging 
system.   
 
Detection of γ-H2AX fluorescence-activated cell sorter (FACS). Approximately 1x106 cells 
were incubated with 100 ng/ml native or HI HhepCdtABC for 2 h to 8 hand phosphorylation of 
γ-H2AX was detected by flow cytometry as described earlier (Zhu & Weiss, 2007). A total of 
2x10
4 
cells were analyzed on a BD LSR II flow cytometer using BD FACSDiva software (BD 
Biosciences). 
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Determination of apoptosis by fluorescence-activated cell sorter (FACS) analysis. Cultures 
grown to a density of 1x 10
6
 cells/ml were incubated in the presence of native or HI CjejCdtABC 
(100 ng/ml) for 24 h and the number of apoptotic cells was determined by FACS analysis. 
Characteristic apoptotic conformational change in cell membrane associated with 
phosphatidylserine translocation was assessed by using annexin-V and propidium iodide (PI) 
staining  according to previously described protocols with modifications (Martin et al., 1995; 
Shounan et al., 1998). Briefly, cells were washed once in cold PBS and resuspended in 1X 
binding buffer containing 10 mM HEPES, 140 mM NaCl, 2.5 mM CaCl2 and 0.1% bovine serum 
albumin (BSA), pH 7.4 at room temperature (RT). Cells were stained with 50 µg/ml annexin V-
FITC (Santa Cruz Biotechnology, Santa Cruz, CA) and PI (Sigma) for 10 min at RT in the dark. 
A total of 2x10
4 
cells were analyzed using a BD LSR II flow cytometer using BD FACSDiva 
software (BD Biosciences, San Jose, CA) and classified as early or late apoptotic, necrotic or 
viable as previously described (Shounan et al., 1998; Vermes et al., 1995).  
 
Direct detection of apoptotic nuclear morphology using Hoechst 33342 and PI double 
staining. Cell cultures at a density of 1x10
6
 cells/ml were incubated with 100 ng/ml CjejCdtABC 
or heat inactivated CDT. Apoptotic cell death was assessed by microscopic detection of 
characteristic apoptotic nuclear morphology using a double fluorescence method as described 
previously (Muscarella & Bloom, 1997; Muscarella & Bloom, 2003; O'Brien et al., 2001).  
Briefly, 200 µl of cell suspension were stained with 20 µg/ml PI (red fluorescence, Sigma) and 
100 µg/ml Hoechst 33342 (blue fluorescence; Sigma) for 10 min at 37°C in the dark. For each 
sample, a total of 200 cells were counted using a Leitz Aristoplan fluorescence microscope with 
long-pass filter cube A at 400X magnification. Apoptotic cells were identified based on the 
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presence of characteristic condensed, segregated chromatin bodies in intact but shrunken cells, 
which were discriminate from necrotic cells that were swollen, with irregular or damaged 
membranes and propidium iodide positive. Early apoptotic changes were characterized by 
condensed and fragmented chromatin (with blue fluorescence) and late apoptotic changes 
consisted similar nuclear changes and cytoplasmic uptake of propidium iodide (pink 
fluorescence) and classified as either apoptotic, necrotic, or normal/viable (O'Brien et al., 2001). 
 
Detection of phospho-Histone H3 by (FACS). Approximately 1x10
6
 cells were incubated with 
100 ng/ml native or HI HhepCdtABC for 6 h with or without nocodazole. Phosphorylation of H3 
was detected by flow cytometry as described earlier (Xu et al., 2002). A total of 2x10
4 
cells were 
analyzed on a BD LSR II flow cytometer using BD FACSDiva software (BD Biosciences).  
 
Radioresistant DNA synthesis (intra-S checkpoint activation) assay. The assay was 
performed as previously described with modifications (Weiss et al., 2003). Briefly, triplicate 
cultures of 1x10
6
 cells in 200 µl volumes in 96 well plates were incubated with 100 ng/ml native 
or HI HhepCdtABC for 30 mins and the cells. The cells were pulsed for 1 h with 0.5 µCi/ml 3H-
thymidine (Amersham Biosciences, Buckinghamshire, UK) and harvested onto glass-fiber filters 
(Brandel, Gaithersberg, MD) using  a Brandel M-12 cell harvester (Brandel, Gaithersberg, MD). 
Radioactivity was measured by scintillation counting using a Beckman LS6500 scintillation 
counter (Beckman, Fullerton, CA).  
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Statistical analysis. Statistical analysis was performed using JMP Pro version 9.02 (SAS 
Institute Inc, Cary, NC). Data are presented as mean ± SD. A p value < 0.05 was considered as 
significant.    
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Results 
HhepCdtABC activates an ATM-dependent DNA damage responses (DDR). The CDT-
induced DDR, particularly the phosphorylation of ATM in response to CDT-induced DNA 
damage is not well characterized in lymphoid cell lines. Therefore, HhepCdtABC-induced DDR 
was initially characterized using Atm
+/+
, Atm
+/- 
, and Atm
-/-
 primary mouse thymic lymphocytes  
or thymic lymphoma cell lines.  Phosphorylation of ATM in primary mouse thymic lymphocytes 
as early as 2 h and 6 h after RecHhCdtABC treatment (Figure 3.1A). It was interesting to 
observe that the lymphocytes from Atm
+/-
 mice have a lower level of CDT-induced ATM 
phosphorylation compared to those from wild type mice. This is the first demonstration (along 
with our parallel demonstration of ATM phosphorylation by CjejCdtABC in human lymphoid 
cell lines; chapter 4) of the phosphorylation of ATM by CDT from any bacteria providing direct 
evidence for initiating ATM dependent DDR by CDT-mediated DNA damage. Similarly, 
increase in γH2AX was observed by western blot 2 h post exposure to HhCdtABC in p53-/- 
(Atm
+/+
 control) cell line compared to Atm
-/-
 cell line. However, slight increase in γH2AX was 
evident at 2 h post exposure in Atm
-/-
 cell line (Figure 3.1B). Significantly higher (**, p< 0.05) 
increase in γH2AX positive cells were observed in p53-/- (Atm+/+ control) cell line compared to 
Atm
-/-
 cell line 6 h after incubation with HhCdtABC (Figure 3.1C).   
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Figure 3.1: HhepCdtABC activates an ATM-dependent DNA damage responses (DDR). 
Representative Western blots from two independent experiments showing the phosphorylation of 
ATM in primary mouse thymocytes (A) and γ-H2AX in TLC (B) following HhepCdtABC 
exposure.  Proteins were separated on 13% (4% for p-ATM) SDS PAGE and blotted with mouse 
mAb anti- p-ATM and anti- γ-H2AX. Membranes were blotted with mouse mAb anti- β-actin as 
loading control. Phosphorylation of γ-H2AX in TLC analyzed by flow cytometry (C). TLC 
incubated with native or HI RecHhCDT (100ng/ml) for 6 h, fixed in 70% ethanol and stained 
with mAb anti-γH2AX and FITC labeled secondary antibody. Data represents means of two 
independent experiments. Significance of differences between treated and control cultures were 
tested by using the two way ANOVA test [(***, p < 0.001; NS, not significant), (G. B and R. N. 
J)]. 
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Fig.3.1. 
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HhepCdtABC activates G2/M cell cycle arrest leading to p53-dependent apoptosis. The 
activation of G2/M checkpoint and apoptosis was initially characterized by flow cytometry using 
thymic lymphoma cell lines. The initial cell cycle experiments revealed the accumulation of 
significantly higher levels of cells with 4N DNA content in both Atm
-/-
 and p53
-/-
 thymic 
lymphoma cell lines treated with HhepCdtABC for 24 h (Figure 3.2A). However, as expected, 
the apoptosis (Sub G0 DNA content) was only significant in Atm
-/-
 cell lines (Figure 3.2B). CDT-
induced apoptosis was further characterized by double staining the cells with Annexin V and PI.  
Only the Atm
-/-
 cell lines had a significant increase in apoptosis (figure 3.2C), which confirmed 
the previous observations with cell cycle experiments. These findings suggest that the 
HhepCdtABC activates G2/M checkpoint leading to apoptosis in thymic lymphoma cell lines.  
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Figure 3.2: HhepCdtABC activates G2/M cell cycle arrest leading to p53-dependent 
apoptosis. A total of 1x10
6
 TLC were incubated in the presence of native or heat inactivated 
HhepCdtABC (100 ng/ml) for 24 h and percentages of cells arresting at G2/M as detected by the 
4N DNA content (A), and apoptosis as detected by Sub G1 DNA content (B) by analyzing 2x10
4 
cells fixed in 70% ethanol and stained with propidum iodide (PI). The percent apoptotic cell 
death was assessed by flow cytometric analysis of 2x10
4 
cells stained with annexin V-FITC and 
PI (C).  Each bar represents the mean percent apoptosis ± SD by adding the percent cells positive 
for annexin V-FITC only (early apoptosis) with the percent cells positive for both annexin V-
FITC and PI (late apoptosis) in three separate experiments. For each cell line, the mean percent 
apoptosis of treated and control cultures were analyzed by using two way ANOVA test [(***, p 
< 0.001; NS, not significant), (R. N. J.)]. 
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Fig.3.2. 
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The p53-dependent HhepCdtABC-induced apoptosis is time- and dose-dependent. In order 
to confirm the p53-dependent apoptosis observed in Figure 3.2, the kinetics of CDT-induced 
apoptosis was further investigated by simultaneous microscopic detection  of characteristic 
apoptotic nuclear morphology and plasma membrane integrity by dye exclusion to detect 
necrosis according to well validated previously described methods (Bloom et al., 2006; Jinadasa 
et al., 2011b; Muscarella & Bloom, 1997; Muscarella et al., 2003; O'Brien et al., 2001).  In 
agreement with our flow cytometry data, the Atm null cell lines with wild-type p53 displayed 
increased time- and dose-dependent susceptibility to CDT-induced apoptosis as compared to p53 
null cell lines (Figure 3.3). When incubated with 100ng/ ml CDT, p53-/- cell lines had 
significantly less apoptosis compared to Atm 
-/-
 (p53 wild type) cell lines up to 72 h (Figure 3.3 
A). The dose response to CDT was also highly correlated to the p53 status of the cell lines 
(Figure 3.3 B). The Atm 
-/-
 (p53 wild type) cell lines were significantly more susceptible to CDT 
within the entire 0.1 -100 ng/ml range of toxin concentrations (Figure 3.3 B).  
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Figure 3.3: The p53-dependent HhepCdtABC-induced apoptosis is time- and dose-
dependent. A total of 1x10
6
 TLC were incubated in the presence of native or heat inactivated 
HhepCdtABC (100 ng/ml) and apoptotic cell death was assessed by simultaneous detection of 
plasma membrane integrity by dye exclusion and examination of characteristic apoptotic nuclear 
morphology.  Apoptotic cells were identified based on the presence of characteristic condensed, 
segregated chromatin bodies in intact but shrunken cells, which were discriminate from necrotic 
cells that were swollen, with irregular or damaged membranes. Early apoptotic changes were 
characterized by condensed and fragmented chromatin (with blue fluorescence) and late 
apoptotic changes consisted similar nuclear changes and cytoplasmic uptake of propidium iodide 
(pink fluorescence). A total of 200 cells were scored for each sample and classified as either 
apoptotic, necrotic, or normal/viable. Values are means ±SD (n=3). For each time point or CDT 
concentration, the significance of differences between treated and control cultures were tested by 
using the two way ANOVA test with Bonferroni correction (***, p < 0.001; NS, not 
significant).Cells incubated with100 ng/ml HhepCdtABC up to 72 h (A).Cells incubated with 
varying concentrations of HhepCdtABC for 72 h [(B), (R. N. J)] 
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Fig.3.3. 
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HhepCdtABC activates of intra-S checkpoint in an ATM-dependent manner. In order to 
explore the ability of CDT to activate intra-S checkpoint, we then characterized the transient 
reduction in DNA synthesis (classical marker for intra S-phase checkpoint) in HhepCdtABC 
treated cell lines. We observed a significant reduction in DNA synthesis in HhepCdtABC treated 
wild type and heterozygous primary mouse thymic lymphocytes and p53
-/-
 thymic lymphoma 
cell lines compared to Atm null cells and cell lines (Figure 3.4). This is the first definitive 
demonstration of the activation of intra S-checkpoint by the broadly conserved bacterial 
genotoxin CDT, and we conclude that CDT is capable of inducing arrest at all phases of cell 
cycle. 
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Figure 3.4: HhepCdtABC activates of intra-S checkpoint in an ATM-dependent manner. A 
total of 1x10
6
 primary mouse thymic lymphocytes obtained from 6-8-week-old mice stimulated 
for 24 h with Concanavalin A (1µg/ml) (A), or thymic lymphoma cell lines (B) were incubated 
in the presence of native or heat inactivated HhepCdtABC (100 ng/ml) for 30 min. Transient 
reduction of DNA synthesis was measured by pulsing 1 h with 
3
H-thymidine. Data is expressed 
as the mean and standard deviation of three independent experiments.  Significance of 
differences between cell lines were tested by using the two way ANOVA test with Bonferroni 
correction (R. N. J). 
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Fig. 3.4. 
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HhepCdtABC activates ATM-dependent G2/M checkpoint. In order to further characterize 
the ATM-dependent G2/M checkpoint, we analyzed the HhepCdtABC treated cells by flow 
cytometry for the phophorylation of histone H3 (phospho-H3), which is a specific marker for 
mitotic cells. Nocodazole was used as a control to block the cells in mitosis (M phase).  As 
expected, we observed a reduction in phospho-H3 positive cells in p53
-/-
 cells as compared to 
Atm
-/-
 cells. This is the first definitive demonstration of CDT-mediated G2/M cell cycle arrest 
(Figure 3.5).   
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Figure 3.5. HhepCdtABC activates ATM-dependent G2/M checkpoint. A total of 1x10
6
 
primary mouse thymic lymphocytes obtained from 6-8-week-old mice stimulated for 24 h with 
Concanavalin A (1µg/ml) (A), or thymic lymphoma cell lines (B) were incubated with native or 
heat inactivated HhepCdtABC (100 ng/ml) with or without nocodazole for 6 h. Cells were fixed 
and stained with anti-Histone H3 antibody, FITC labeled secondary antibody and counter stained 
with PI for DNA content. Data represents means of two experiments [(**, p < 0.01; NS, not 
significant), (R. N. J.)]. 
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Fig. 3.5. 
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Discussion 
Mammalian cell cycle regulation is responsible for the maintenance of intact mucosal epithelial 
barriers and clonal expansion of lymphocyte subsets during adaptive immune response, both of 
which are important defense mechanisms against colonization and infection of mucocutaneous 
interfaces by bacterial pathogens (Oswald et al., 2005). Therefore, CDT-producing bacteria 
might have evolved a specialized mechanisms to disrupt key mammalian cell cycle functions in 
order to establish persistent colonization and cause disease in certain niches (Nougayrede et al., 
2005; Oswald et al., 2005). Cell cycle fidelity is maintained by redundant DNA damage 
checkpoint mechanisms (Bartek & Lukas, 2007; Jackson & Bartek, 2009). Activation of DNA 
damage checkpoints results in cell cycle arrest so that DNA can be repaired, or if damage is 
severe, progress to programmed cell death by apoptosis(Bartek & Lukas, 2007). The DNA 
damage checkpoint network comprises upstream DNA damage sensors, signal transducers and 
downstream effectors (Bartek & Lukas, 2007).   
 
The ATM-dependent IR-induced DDR involves both induction of cell cycle arrest and initiation 
of DNA repair (Derheimer & Kastan, 2010).  Major components of the ATM-dependent DNA 
damage signaling pathway include the multifunctional MRN protein complex consisting of 
Mre11, Rad50 and Nbs1, histone H2AX, the cell cycle checkpoint regulator protein kinase Chk2, 
and the transcription factor p53(Bartek & Lukas, 2007; Derheimer & Kastan, 2010; Jackson & 
Bartek, 2009).  Initial DSBs are recognized by the MRN complex, which recruits ATM to the 
damage site (Bakkenist & Kastan, 2003; Bartek & Lukas, 2007; Lavin & Kozlov, 2007; Lavin, 
2008).  The serine-threonine protein kinase ATM which normally exists as inactive dimers, 
dissociates and is activated by autophosphorylation in the presence of DSBs. Activated ATM 
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subsequently phosphorylates a large array of substrates including, histone H2AX, Chk2, and 
p53(Matsuoka et al., 2007). Although the precise events surrounding ATM activation are 
incompletely understood, recent evidence suggests that ATM and MRN complex act in harmony 
to sense DSBs (Derheimer & Kastan, 2010). Activated MRN complex and phosphorylated 
H2AX (γ-H2AX) initiate and amplify the DNA repair process by stabilizing the DNA lesion and 
providing a platform for the binding of other DNA repair proteins (Derheimer & Kastan, 2010). 
Activated Chk2 reduces cyclin-dependent kinase (CDK) activity by several mechanisms 
including activation of the transcription factor p53 and subsequent induction of cyclin inhibitor 
p21 (Jackson & Bartek, 2009). CDKs are key regulators of cell cycle and the inhibition of CDKs 
can result in arrest of the cell-cycle progression at the G1-S, intra-S and G2-M checkpoints, 
allowing time for DNA repair before proceeding with replication or mitosis (Jackson & Bartek, 
2009). Other ATM substrates additionally have key roles in affecting cell cycle checkpoint 
function, such as Smc1 for intra-S phase, as reviewed elsewhere (Derheimer & Kastan, 2010). 
 
The role of Atm in CDT induced cell cycle arrest and apoptosis was previously demonstrated 
only in several human leukemic cell lines. Atm wild-type SN-B1 and JAC-B2 cells were more 
susceptible to CDT-induced apoptosis compared to four cell lines Atm defective cell lines. γ-
H2AX was readily detectable in Atm
+/+
 cells but not in Atm
-/- 
cells exposed to HducCDT. Taken 
together, current study is the first demonstration of the activation of ATM-dependent DNA repair 
response by CDT using well defined Atm defective primary cells or cell lines.  Our observations 
on HhepCdtABC-induced γ--H2AX activation agrees with previous demonstrations of CDT-
induced DDR. A large percentage of HeLa cells display γ-H2AX foci 2 h post-HducCDT 
exposure, and nearly all cells are positive for γ-H2AX foci within 6 to 8 h post-exposure (Li et 
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al., 2002).  Increased Rad50 foci and γ-H2AX are also seen in primary human fibroblasts treated 
with CjejCDT (Hassane et al., 2003), in primary and established human endothelial cells treated 
with EcolCdtB-V (Bielaszewska et al., 2005), and cultured human intestinal epithelial H407 
cells exposed to HhepCDT (Liyanage et al., 2010). Higher levels of  γ-H2AX was detected in 
immortalized wild type human B lymphocyte lines post-HducCDT exposure, but it is absent in 
Atm-defective leukemic B cell lines obtained from AT patients (Li et al., 2002).  
 
Currently accepted consensus for CDT-mediated G2/M arrest is the phosphorylation of ATM 
followed by Chk2 activation, which phosphorylates and inactivates CDC25C. Resulting 
accumulation of phosphorylated cyclin B-CDK1 complex prevents mitotic entry. Limitations in 
our understanding of the molecular mechanisms of CDT-induced cell cycle arrest are partially 
due to the techniques that are commonly employed to address this question. With the exception 
of a few instances indicating accumulation of phosphorylated Cdk1 (cdc2) prior to cell cycle 
arrest, CDT-induced arrest of the cell cycle relies primarily on demonstration of altered patterns 
of DNA staining with propidium iodide and analysis by florescence-activated cell sorting 
(Bielaszewska et al., 2005; Comayras et al., 1997; Cortes-Bratti et al., 2001; Peres et al., 1997). 
At least two G2/M checkpoints exist in mammalian cells, an ATM-dependent transient 
checkpoint which activates in G2 phase cells immediately after DNA damage, and prolonged 
ATM-independent checkpoint which is activated several hours after damage and reflects the G2 
phase accumulation of cells that were initially damaged during S-phase (Weiss et al., 2003; Xu 
et al., 2002).  Because CDT might induce arrest at multiple stages of the cell cycle, measurement 
of DNA content alone cannot distinguish between these two checkpoints highlighting the need to 
delineate the mechanism of CDT-induced cell cycle arrest in greater details. Therefore, we 
 125 
 
analyzed the CDT treated cells by flow cytometry for the phophorylation of histone H3 
(phospho-H3), and this is the first definitive demonstration of CDT-mediated G2/M cell cycle 
arrest. 
 
We characterized the kinetics of CDT-induced apoptosis using simultaneous microscopic 
detection of characteristic apoptotic nuclear morphology and plasma membrane integrity by dye 
exclusion to detect necrosis according to well validated previously described methods and flow 
cytometry.  Although there is limited evidence supporting the CDT-mediated intra S-phase 
checkpoint activation, the underlying mechanism is not completely investigated. We 
demonstrated the activation of the ATM-dependent intra-S checkpoint in primary mouse thymic 
lymphocytes and thymic lymphoma cell lines. This is the first definitive demonstration of the 
activation of intra S-checkpoint by the broadly conserved bacterial genotoxin CDT. Activation of 
intra-S checkpoint by CDT may contribute to bacterial virulence by modulating rapidly dividing 
host lymphocytes and thus adaptive immune response following infection. Taken together, we 
provide first evidence to suggest that broadly conserved genotoxin CDT is capable of inducing 
cell cycle arrest in all phases of the cell cycle.  
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CHAPTER 4 
Contribution of human lymphoid cell line p53 status to genotoxicity induced by 
Campylobacter jejuni cytolethal distending toxin
1, 2
  
Abstract 
Cytolethal distending toxin (CDT) is an AB type genotoxin produced by several clinically important human 
and animal pathogens including Campylobacter jejuni, a major cause of infectious diarrheal illness 
worldwide. Intoxication of mammalian cells with CDT causes DNA double strand breaks (DSBs) elicits a 
DNA damage response (DDR) characterized by irreversible cell cycle arrest and apoptosis. Although the 
DNA damage responsive tumor suppressor protein p53 is critical to the response of mammalian cells to 
genotoxins, the contribution of p53 to CDT-mediated genotoxicity is incompletely understood. Therefore the 
purpose of the current study was to further characterize the role of p53 in the differential susceptibility of 
several human lymphoid cell lines with different p53 status to the DDR induced by CDT in vitro. The human 
leukemic T-cell lines MOLT-3 and MOLT-4 with functionally wild-type p53 displayed increased time- and 
dose-dependent susceptibility to CDT-induced apoptosis compared to p53 mutated Jurkat and CEM cell 
lines. But in contrast, the p53 mutated and proapoptotic Bcl-2 protein Bax deficient
 
CA 46 Burkitt lymphoma 
cell line was resistant to CDT-induced apoptosis. The comparable γ-H2AX activation observed in all cell 
lines after CDT treatment confirmed similar levels of CDT-induced DSBs irrespective of p53 status. Taken 
together, the data suggest that p53 mutational status correlates with the differential CDT-susceptibility of 
human lymphoma and leukemia cell lines. 
______________________________________________________________________________  
Manuscript in preparation: 
1
Rasika N. Jinadasa, Gabriel Balmus, Rohana P. Dassanayake, Stephen S. Bloom, Robert S. Weiss and 
Gerald E. Duhamel.  
2
Author contributions: R. P. D constructed E. coli BL21 with p28a(+)CjejCdtB while R. N. J and G. B 
performed all other experiments (individual contributions are indicated in figure legends). R. S. W. and G. E. 
D. designed the experiments. R. N. J., S. E. B., R. S. W. and G. E. D. wrote the manuscript.  
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Introduction 
Cytolethal distending toxin (CDT) is a heterotrimeric AB type genotoxin produced by several 
species of Gram negative Gamma and Epsilon classes of Proteobacteria (Alouf, 2006; Ge et al., 
2008; Guerra et al., 2011; Jinadasa et al., 2011; Lara-Tejero & Galan, 2001).  Included in this 
group are members of Campylobacter, Shigella, Salmonella and certain E. coli pathotypes which 
together represent all major food and water borne bacterial pathogens of clinical importance 
worldwide (den Bakker et al., 2011; Haghjoo & Galan, 2004; Jinadasa et al., 2011; Okuda et al., 
1995; Pickett et al., 1994; Pickett et al., 1996). In this context, Campylobacter jejuni is the 
leading cause of infectious diarrheal illness worldwide (Lindmark et al., 2009; Young et al., 
2007).  The clinical presentation with campylobacteriosis can range from a mild self-limiting 
enterocolitis to severe inflammatory bloody diarrhea and fever (Lindmark et al., 2009; Young et 
al., 2007). Infection with C. jejuni is also a major risk factor for subsequent development of 
Guillain-Barré syndrome; an acute inflammatory demyelinating disease of the peripheral nervous 
system (Hughes & Cornblath, 2005; Janssen et al., 2008; Lindmark et al., 2009; Young et al., 
2007). The role of CDT in the pathogenesis of disease caused by C. jejuni is incompletely 
understood; however, experimental infection of laboratory mice by the related intestinal 
pathogen Helicobacter hepaticus suggests that CDT plays an essential role in persistent infection 
and has adaptive immunomodulatory properties (Ge et al., 2005; Ge et al., 2008; Pratt et al., 
2006). On the basis of these in vivo observations and the comparatively lower dose-response of 
hematopoietic cells to CDT intoxication in vitro, lymphoid cells have been hypothesized as 
likely physiological targets of CDT (Ge et al., 2005; Pratt et al., 2006; Shenker et al., 2007). 
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With the exception of Salmonella enterica serovars which only has the active subunit CdtB, all 
other bacterial pathogens produce CDT holotoxin consisting of a complex of three subunits 
designated CdtA, CdtB and CdtC (Jinadasa et al., 2011). The CDT subunits are encoded by 
adjacent or slightly overlapping cdtA, cdtB and cdtC genes forming a constitutively expressed 
operon (Jinadasa et al., 2011) which in C. jejuni have approximate molecular masses of 27-, 30- 
and 20-kDa, respectively (Pickett et al., 1996).  Because the active subunit of CDT, CdtB has 
structural and functional homology with members of the phosphodiesterase family of enzymes 
including mammalian deoxyribonuclease I, it is the only known AB type toxin that has DNase 
activity (Alouf, 2006; Elwell & Dreyfus, 2000; Hu et al., 2006; Hu & Stebbins, 2006; Lara-
Tejero & Galan, 2000; Nesic et al., 2004; Yamada et al., 2006). 
 
Intoxication of mammalian cells with CDT causes DNA double strand breaks (DSBs) that 
initiates a DNA damage response (DDR) similar to that elicited by ionizing radiation (IR) and 
characterized by activation of γ-H2AX leading to irreversible cell-cycle arrest and apoptosis. The 
genotoxic effects of CDT in vitro are cell-type specific (Cortes-Bratti et al., 2001; Eshraghi et 
al., 2010; Hassane et al., 2003; Li et al., 2002; Smith & Bayles, 2006). Intoxicated epithelial and 
endothelial cells primarily arrest in the G2/M phase (Elwell et al., 2001; Jinadasa et al., 2011; 
Lara-Tejero & Galan, 2001; Smith & Bayles, 2006; Whitehouse et al., 1998; Wising et al., 2005; 
Young et al., 2000), whereas mesenchymal cells like fibroblasts typically arrest both in the G1/S 
and G2/M phases of the cell-cycle (Belibasakis et al., 2004; Cortes-Bratti et al., 2001; Hassane et 
al., 2003; Smith & Bayles, 2006; Wising et al., 2005). By contrast, cells of hematopoietic lineage 
including lymphocytes, monocytes, macrophages and dendritic cells, are several orders of 
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magnitude more susceptible to CDT, and undergo rapid apoptosis (Belibasakis et al., 2004; 
Cortes-Bratti et al., 2001; Hassane et al., 2003; Smith & Bayles, 2006; Wising et al., 2005).  
 
The molecular mechanism of CDT-induced apoptosis remains incompletely understood; 
however, some evidence suggests the involvement of both p53-dependent and -independent 
pathways (Jinadasa et al., 2011; Liyanage et al., 2010; Ohara et al., 2004; Ohara et al., 2008). 
Following CDT exposure, epithelial cells appear to undergo both p53-dependent and -
independent apoptosis with comparable kinetics, while lymphocytes, a primarily p53-dependent 
mitochondrial pathway has been suggested (Jinadasa et al., 2011; Ohara et al., 2004). However, 
the contribution of p53 mutational status of cell lines to CDT-mediated genotoxicityin general 
and CDT-induced DDR of lymphoid cells in particular are incompletely characterized. While it 
is well-established that cellular toxicity of CDT is due to the nuclease activity of CdtB, a recent 
study suggests a potential role of phosphatidylinositol (PI)-3,4,5-triphosphate (PIP3) phosphatase 
activity in CdtB in cellular toxicity through AKT pathway in human leukemia T-cell lines with 
constitutively elevated PIP3 levels (Shenker et al., 2007). 
 
Although the DNA damage responsive tumor suppressor protein p53 is critical to the response of 
mammalian cells to genotoxic stress leading to cell-cycle arrest and apoptosis, the contribution of 
p53 to CDT-mediated genotoxicity in general, and the increased susceptibility of lymphoid cells 
in particular, is incompletely understood.  In the current study we investigated the role of p53 in 
CDT-susceptibility of human lymphoma and leukemia cell lines. Consistent with a recently 
proposed modification of a widely accepted nomenclature of CDT proteins produced by various 
bacteria originally proposed by Cortes-Bratti and co-workers this revised nomenclature will be 
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used throughout this paper (Cortes-Bratti et al., 1999; Jinadasa et al., 2011). Cell lines with 
functionally wild-type p53 displayed increased time- and dose-dependent susceptibility to 
recombinant reconstituted C. jejuni  CDT (CjejCdtABC) induced apoptosis as compared to p53 
mutated cell lines. The comparable γ-H2AX activation observed in all cell lines after 
CjejCdtABC treatment confirmed similar levels of CjejCdtABC-induced DNA damage 
irrespective of p53 status. Additionally we did not observed any detectable change in 
phosphorylated Akt levels following CjejCdtABC treatment, suggesting that nuclease activity of 
CjejCdtABC is the primary contributor of genotoxicity. Taken together, these results suggest that 
p53 mutational status may be a major determinant of the differential CjejCdtABC-susceptibility 
of human lymphoma and leukemia cell lines. 
 
  
 138 
 
Materials and Methods 
Cell lines and culture conditions. The cell lines used in the present study and their respective 
p53 genomic status are presented in Table 4.1. All cell lines were maintained in RPMI 1640 
(Lonza, Basel, Switzerland) supplemented with heat inactivated 10% fetal bovine serum 
(Hyclone, South Logan, UT) and 1% penicillin streptomycin (Mediatech, Manassas, VA) at 
37°C in a humidified atmosphere of 5% carbon dioxide in air. All experiments were performed 
using cells cultured for 18 to 24 h after transferring to 24-well culture plates unless otherwise 
indicated.  
Table 1: Lymphoma and leukemia cell lines used in this study. 
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Table 4.1. Cell lines used in this study. 
Cell line ATCC #a p53 genomic 
status 
Reference 
MOLT-3  CRL-
1552 
Wild type (Cai et al., 2001) 
MOLT-4  CRL-
1582 
Heterozygous (Cheng & Haas, 1990; Hasegawa et al., 2009; Ohara et 
al., 2004; Rodrigues et al., 1990) 
Jurkat  TIB-152 Mutant (Cheng & Haas, 1990; Hasegawa et al., 2009; Ohara et 
al., 2004) 
CCRF-CEM  CCL-119 Mutant (Cheng & Haas, 1990)   
CA 46  CRL-
1648
  
Mutant
 b (Cherney et al., 1997; Gutierrez et al., 1999; O'Brien et 
al., 2001) 
a
ATCC, American Type Culture Collection, Manassas, Virginia 
b
 also Bax deficient 
 
  
  
 140 
 
Reconstituted recombinant C. jejuni CDT (CjejCdtABC). Individual His-tagged C. jejuni 
CDT subunits were expressed in E. coli, and CDT holotoxin was reconstituted according to 
previously described protocols for Helicobacter hepaticus CDT with modifications 
(Dassanayake et al., 2005; Liyanage et al., 2010). Briefly, the gene sequence encoding each 
CjejCDT sub-unit was amplified by using specific primer pairs (Table 4.2) and high fidelity Pfx 
DNA polymerase (AccuPrime, Invitrogen, Carlsbad, CA) according to the manufacturer’s 
instructions. The amplified products were cloned in the pET-28a(+) expression vector (Novagen, 
Darmstadt, Germany) and transformed into E. coli BL21 (New England BioLabs, Ipswich, MA). 
Expression was induced when cultures grown at 37°C in Luria-Bertani medium containing 
kanamycin (Sigma, St. Louis, MO) reached an optical density at 600 nm of 0.6-0.8 by adding 1 
mM isopropyl-β-D-thiogalactopyranoside (Invitrogen) and grown an additional 5 h at 25°C. 
CjejCdtA and CjejCdtB were purified under denaturing conditions while CdtC was purified 
under native conditions.  The purity of each recombinant protein preparation was determined by 
SDS-PAGE followed by Coomassie blue staining and Western blot as previously described  
(Dassanayake et al., 2005). The CDT holotoxin was reconstituted as previously described 
(Liyanage et al., 2010) and stored at -80°C in 1:1 sterile glycerol.  For negative controls, 
reconstituted recombinant CjejCdtABC was heat inactivated (HI) for 10 min at 70°C and stored 
at -80°C in 1:1 sterile glycerol.  
  
 141 
 
Table 4.2: Primers for expression of Campylobacter jejuni cytolethal distending toxin subunits.  
Primer
a
 Sequence
b
  
CjejCdtA F: 5'-CGGAATTCTTTGAAAATG TAAATC -3' 
CjejCdtA R: 5'-CCGCTCGAGTCATCGTACCTCTC-3' 
CjejCdtB F: 5'- CGGAATTCCAATTTAGAAAATTTTAATGTTGGC -3' 
CjejCdtB R: 5'-CCGCTCGAGCTAAAATTTTCTAAAATTTACTG -3' 
CjejCdtC F: 5'-CGGAATTCACTCCTACTGGAG -3' 
CjejCdtC R: 5'- CCGCTCGAGTTATTCTAAAG -3'  
a
 CjejCdtA, B, C: C. jejuni cytolethal distending toxin A, B and C; F, forward; R, reverse. 
b
 5'-EcoR I and 3'-Xho I restriction sites incorporated for directional cloning are underlined. 
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Nuclease assays. Digestion of plasmid DNA with recombinant CjejCdtB was performed as 
described previously with modifications (Dassanayake et al., 2005). Briefly, a plasmid (pCaggs) 
with a single Sal I restriction site was linearized with FastDigest Sal I (Fermentas, Glen Burnie, 
MA) according to the manufacturer’s instructions. Complete digestion of plasmid DNA was 
confirmed by gel electrophoresis before purification by phenol-chloroform extraction. Intact 
super coiled plasmid DNA (1µg) or linearized plasmid DNA (1µg) were incubated with either 
CjejCdtB (1μg) or bovine DNaseI (1 unit; Fermentas) at 37oC for up to 6 h in two independent 
experiments. In each experiment, control plasmid DNA (1µg) was incubated at 37
o
C for 6 h in 
digestion buffer alone. Approximately 100 ng of each sample was loaded onto a 0.8% agarose 
gel, and after electrophoresis, the DNA was visualized by staining with ethidium bromide. 
 
Cell proliferation. Duplicate cultures of MOLT-4, Jurkat, CEM and CA 46 cell lines grown to a 
density of 1x10
6
 cells per mL in 2 mL volume in 6-well plates were incubated with native or HI 
CjejCdtABC (100 ng/mL) at 37°C in a humidified atmosphere of 5% carbon dioxide in air for 72 
h. Every 24 h, a volume of 75 µL of cell suspension was mixed with 25 µL of 0.4% trypan blue 
stain (Invitrogen), and the total number of viable cells per mL was determined by counting cells 
that excluded the dye using a hemacytometer (Hausser Scientific, Horsham, PA) and a light 
microscope at 100X magnification. Data was expressed as mean total numbers of viable cells ± 
SD of three independent experiments. For each time point, the total numbers of viable cells in 
treated and control cultures were compared by using two way ANOVA test with Bonferroni 
correction.  
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Determination of apoptosis by fluorescence-activated cell sorter (FACS) analysis. Cultures 
grown to a density of 1x 10
6
 cells/mL were incubated in the presence of native or HI 
CjejCdtABC (100 ng/mL) for 24 h and the number of apoptotic cells was determined by FACS 
analysis. Characteristic apoptotic conformational change in cell membrane associated with 
phosphatidylserine translocation was assessed by using annexin-V and propidium iodide (PI) 
staining  according to previously described protocols with modifications (Martin et al., 1995; 
Shounan et al., 1998). Briefly, cells were washed once in cold PBS and resuspended in 1X 
binding buffer containing 10 mM HEPES, 140 mM NaCl, 2.5 mM CaCl2 and 0.1% bovine serum 
albumin (BSA), pH 7.4 at room temperature (RT). Cells were stained with 50 µg/ml annexin V-
FITC (Santa Cruz Biotechnology, Santa Cruz, CA) and PI (Sigma) for 10 min at RT in the dark. 
A total of 2x10
4 
cells were analyzed using a BD LSR II flow cytometer using BD FACSDiva 
software (BD Biosciences, San Jose, CA) and classified as early or late apoptotic, necrotic or 
viable as previously described (Shounan et al., 1998; Vermes et al., 1995).  
 
Direct detection of apoptotic nuclear morphology using Hoechst 33342 and PI double 
fluorescence staining. Cell cultures at a density of 1x10
6
 cells/mL were incubated in the 
presence of CjejCdtABC (100 ng/mL) for up to 72 h and the percent apoptotic cell death was 
determined sequentially by fluorescent microscopy following double staining with PI and 
Hoechst 33342. In separate experiments, each cell line was incubated in control medium or 
medium containing increasing concentrations of CjejCdtABC from 0.1 up to 100 ng/mL and 
examined after 72 h.  Briefly, 200 µl of cell suspension was stained by adding PI (red 
fluorescence; 20 µg/mL final concentration; Sigma) and Hoechst 33342 (blue fluorescence;100 
µg/mL final concentration; Sigma) and incubation for 10 min at 37°C in the dark. For each 
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sample, a total of 200 cells were classified as either viable, apoptotic or necrotic on the basis of 
characteristic cellular morphology by direct examination using a Leitz Aristoplan fluorescence 
microscope with long-pass filter cube A at 400X magnification as previously described (Jinadasa 
et al., 2011; Muscarella & Bloom, 1997; Muscarella & Bloom, 2003; O'Brien et al., 2001). 
Viable cells were characterized by intact cytoplasmic and nuclear membranes with homogenous 
light blue chromatin pattern, while cells that had undergone early apoptotic changes had intact 
but shrunken cell margins with condensed, segregated or fragmented blue white chromatin 
pattern. Cells in late apoptosis displayed nuclear changes similar to those in early apoptosis, but 
also showed diffuse pink cytoplasmic uptake of PI.  By contrast, necrotic cells appeared swollen 
with irregular cytoplasmic membranes and were positive for PI uptake (red).  
 
Immunofluorescence staining. Cell cultures at a density of 1 x10
6
 cells/mL were incubated in 
the presence of CjejCdtABC (100 ng/mL) for up to 72 h or γ-irradiated (5Gy; positive control) 
and incubated for 2 h. Cells were fixed in 4% paraformaldehyde (pH 7.4) for 1h at 4 °C, blocked 
with 3% BSA in PBS with 0.2% Triton X-100 for 1h at 37 °C, stained with mouse monoclonal 
(mAb) anti- γ-H2AX (Millipore, cat.# 05-636) antibody (1:500 dilution) in PBS with 3% BSA  
and 0.02% Triton X-100 for 2h at room temperature (RT). Cells were washed twice (2000 rpm/ 5 
min) in PBS with 3% BSA and stained with anti-mouse IgG-Alexa Flour 488 (1:1000 dilution, 
Invitrogen, cat. # A11017) at RT in 3% BSA with PBS and 0.02% Triton X-100. Cells were 
washed twice (2000 rpm/ 5 min) in PBS with 3% BSA, nuclei were stained with DAPI and spun 
down (400 rpm/ 4 min) on to glass slides using a CytoSpin III cytocentrifuge (Shandon Inc., 
Pittsburgh, PA). The slides were imaged with Leica DMRE fluorescence microscope at 1000X 
magnification. 
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Western blotting. Approximately 3x10
6
 cells (5 ml cultures in T25 flasks) were incubated with 
100 ng/ml native or HI CjejCdtABC or γ-irradiated (5Gy; positive control). Western immunoblot 
was performed as described earlier with modifications (Liyanage et al., 2010). Briefly, cells were 
lysed in RIPA buffer with protease and phosphatase inhibitors (1 mM each aprotinin, leupeptin, 
phenylmethanesulfonyl fluoride and sodium orthovanadate; Sigma) while incubating on ice for 
10 min. The lysate was sonicated for 1 min at 0.5-2 power setting (Misonix 3000 Sonicator; 
Misonix Inc. Farmingdale, NY), centrifuged for 15,000 rpm for 5 min . Protein concentrations 
were determined by Bradford’s method (Bradford, 1976). Proteins were separated on 12-13% 
(4% for ATM) SDS PAGE, transferred to PVDF membranes and immunoblotted with following 
antibodies; anti-phospho ATM (Rockland, cat. #200-310-400), anti- γ-H2AX (Millipore, cat.# 
05-636), anti-DNA PKcs (abcam, cat. # ab18356), anti-phospho Chk1 (Cell Signaling, cat. 
#2341), ani-Chk2 (Millipore, cat. # 05-649), anti-phospho Akt (Cell Signaling, cat.# C31E5E), 
anti-beta actin (Sigma, cat.# A5441). Bands were detected with ECL (Advansta, cat. # K-12045) 
according to manufacturer’s instructions using Versa Doc (Bio Rad) gel imaging system.   
 
Metaphase chromosomal spreads. Chromosomal spreads were prepared and scored as 
described earlier with following modifications (Toller et al., 2011; Zhu & Weiss, 2007). 
Approximately 1x10
6
 MOLT-4 or Jurkat cells were incubated with 100 ng/ml native or HI 
CjejCdtABC for 7 h. Colcemid was added to the cells (0.1μg/ml final concentration, Gibco, cat.# 
15210-040) and incubated for an additional 1 h. Cells were harvested by centrifugation 
(2000rpm/ 5 min) and incubated with 14 ml of pre-warmed hypotonic 75mM KCl at 37 °C for 15 
min. Cells were fixed by adding 1 ml of freshly prepared methanol/acetic acid (3:1)  and gently 
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inverting the tubes. Cells were recovered by centrifugation (2000rpm/ 5 min) and washed three 
times with freshly prepared methanol/acetic acid (3:1) at room temperature. At the final wash, 
cell pellet was resuspended in 400 µl of methanol/acetic acid (3:1) and spotted on to glass slides 
in humid chamber, by dropping 40 µl of cell suspension on to each slide. The slides were stained 
with Giemsa stain as described previously and examined under a light microscope at 1000X 
magnification (Zhu & Weiss, 2007).  
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Statistical analysis 
Statistical analysis was performed using JMP Pro version 9.02 (SAS Institute Inc, Cary, NC). 
Data are presented as mean ± SD. A p value < 0.05 was considered significant.   
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Results 
There are some evidence indicating that CDT-induced apoptosis by HhepCDT and AactCDT 
primarily involves activation of p53-mediated mitochondrial pathway in epithelial cells and 
lymphoid cells, respectively (Jinadasa et al., 2011; Liyanage et al., 2010; Ohara et al., 2004). 
However, this has not been clearly established for CjejCDT and the contribution of individual 
cell line p53 mutational status to CDT susceptibility remains to be clearly established. In this 
study, the contribution of p53 to CjejCDT-induced apoptosis of human leukemic T-cell lines 
with either functionally wild type p53 (MOLT-3 and MOLT-4) or mutated p53 (Jurkat, CEM) 
was investigated in details (Table 4.1).  By evaluating CA 46 cell line, a Burkitt’s lymphoma cell 
line which has an additional defective Bax, a key component of the mitochondrial apoptotic 
pathway that confers a highly resistant phenotype to a wide range of genotoxins and 
chemotherapeutic drugs, the activation of p53-mediated mitochondrial pathway of lymphoid 
cells by CjejCDT was further characterized.  
 
Recombinant CjejCdtB subunit display nuclease activity in vitro.  The nuclease activity of 
the CjejCdtB was confirmed by qualitative assessment of changes in band intensity after 
digestion of either supercoiled or linearized plasmid DNA (Figure 4.1). Nicking of super coiled 
DNA was clearly evident at 1 h, with the onset of DNA smearing in both supercoiled and 
linearized DNA. By 6 h, there were prominent DNA smearing in both super coiled and linearized 
DNA samples. By comparison, one unit of bovine DNaseI almost completely digested both super 
coiled and linearized DNA by 1 h incubation suggesting that CjejCdtB has nuclease activity in 
vitro. 
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Fig. 4.1. Nuclease activity of recombinant Campylobacter jejuni CdtB subunit (CjejCdtB) in 
vitro.  Intact super coiled plasmid DNA (1µg) or linearized plasmid DNA (1µg) by prior 
digestion with Sal I were incubated in the presence of CjejCdtB (1μg) or bovine DNaseI (1 unit) 
for up to 6 h at 37
o
C. Control plasmid DNA (1µg) was incubated for 6 h in digestion buffer 
alone. Each lane was loaded with approximately 100 ng of DNA.  Representative gel from two 
independent experiments (R. N. J). 
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Fig. 4.1.  
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Inhibition of human lymphoma and leukemia cell line proliferation by CjejCdtABC is p53-
dependent. The CDT susceptibility of lymphoid and leukemia cell lines was initially determined 
by the ability of CjejCdtABC to inhibit proliferation in MOLT-4, CEM, Jurkat and CA 46 cell 
lines (Figure 4.2). As expected, p53 mutated cell lines (CEM, Jurkat and CA 46) had 
significantly less growth inhibition (except for Jurkat cells at 24 h) compared to p53 wild type 
MOLT-4 cells. The MOLT-4 cell line was highly susceptible to CDT and failed to proliferate 
following 24 h post CDT exposure. The cell number did not regain the base line and CDT-
treated MOLT-4 cells were completely non-viable by 72 h. In contrast the p53 mutated Bax 
deficient CA 46 cell line was almost completely resistant to CDT and was able to proliferate at a 
rate comparable to control cells at 24 and 48 h.  The p53 mutated cell lines Jurkat and CEM 
displayed intermediate levels of CDT susceptibility, where Jukat cells were more susceptible 
than CEM. The Jurkat cells showed limited proliferation initially (at 24 h), but more substantial 
proliferation was observed at 48 and 72 h. The CEM cell line continued to proliferate at a lower 
rate, suggesting that CDT-susceptibility in human lymphoma and leukemia cell lines could be 
dependent on p53 mutational status of the cell line. 
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Fig. 4.2. Inhibition of human lymphoma and leukemia cell line proliferation by 
CjejCdtABC is p53-dependent. The number of viable MOLT-4, Jurkat, CEM and CA 46 in 
duplicate cultures incubated in the presence of native (A) or heat-inactivated (B) CjejCdtABC 
(100 ng/ml) at 37°C were determined by trypan blue dye exclusion every 24 h for up to 72 h.  
Data is expressed as mean total numbers of viable cells ± SD of three independent experiments. 
For each time point, the numbers of viable cells in treated and control cultures were compared by 
using two way ANOVA test with Bonferroni correction [(**, p < 0.01; ***, p < 0.001; NS, not 
significant), (R. J)].  
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Fig. 4.2.  
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CjejCdtABC-induced apoptosis of human lymphoma and leukemia cell lines is p53-
dependent. CjejCdtABC-induced apoptosis was then assessed in all cell lines by flow 
cytometry, 24 h following CDT exposure. Apoptotic cell death was assessed by analysis of 
conformational changes in membrane phospholipid phosphatidylserine (PS) following annexin-V 
and PI staining.  As expected p53 wild type MOLT-3 and MOLT-4 cell lines displayed the 
highest susceptibility to CDT-induced apoptosis (approximately 80% apoptosis). The p53 
mutated Jurkat cell line displayed approximately 50% apoptosis  at 24 h post CDT treatment, 
while the CEM and CA 46 cell line were extremely resistant (less than 15% apoptosis) to CDT-
induced apoptosis (Figure 4.3), suggesting that CDT-induced apoptosis in human lymphoma and 
leukemia cell lines is dependent on p53 mutational status of the cell line.   
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Fig. 4.3. CjejCdtABC-induced apoptosis of human lymphoma and leukemia cell lines is 
p53-dependent. A total of 1x10
6
 of each cell line were incubated in the presence of native or 
heat-inactivated CjejCdtABC (100 ng/ml) for 24 h and the percent apoptotic cell death was 
determined by flow cytometric analysis of 2x10
4 
cells stained with annexin V-FITC and 
propidium iodide (PI).  Each bar represents the mean percent apoptosis ± SD of cells positive for 
annexin V-FITC only (early apoptosis) and both annexin V-FITC and PI (late apoptosis) in three 
separate experiments. The mean percent apoptosis of control and treated cells were compared by 
using two way ANOVA test [(***, p < 0.001; NS, not significant) (R. N. J)].  
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Fig. 4.3.  
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The p53-dependent CjejCdtABC-induced apoptosis of human lymphoma and leukemia cell 
lines is time- and dose-dependent. The kinetics of CDT-induced apoptosis was further 
investigated by simultaneous microscopic detection  of characteristic apoptotic nuclear 
morphology and plasma membrane integrity by dye exclusion to detect necrosis according to 
well validated previously described methods (Bloom et al., 2006; Jinadasa et al., 2011; 
Muscarella & Bloom, 1997; Muscarella et al., 2003; O'Brien et al., 2001). In agreement with our 
flow cytometry data, the MOLT-3 and MOLT-4 cell lines with functionally wild-type p53 
displayed increased time- and dose-dependent susceptibility to CDT-induced apoptosis as 
compared to p53 mutated Jurkat, CEM, CA46 cell lines (Figure 4.4 A and B). When incubated 
with 100ng/ ml CDT, all p53 mutated cell lines had significantly less apoptosis compared to p53 
wild type cell lines up to 48 h (Figure 4.4 A). At 72h post CDT exposure, there were no 
significant differences between the apoptotic populations in Jurkat cells compared to MOLT-3 
and MOLT-4 cells. However, even at 72 h post exposure there were significant differences 
between CEM and CA 46 cells compared to MOLT-3 and MOLT-4 cells (Figure 4.4 A). The 
dose response to CDT was also highly correlated to the p53 status of the cell lines (Figure 4.4 B). 
The p53 wild type MOLT-3 and MOLT-4 cells were significantly more susceptible to CDT 
within the entire 0.1 -100 ng/ml range of toxin concentrations (Figure 4.4 B). Furthermore, 
among the p53 mutated cell lines Jurkat and CEM displayed increasing time and dose dependent 
susceptibility to CDT while the Bax deficient CA 46 cell line showed significant resistance to 
CDT-induced apoptosis. 
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Fig. 4.4.  The p53-dependent CjejCdtABC-induced apoptosis of human lymphoma and 
leukemia cell lines is time- and dose-dependent. A total of 1x10
6
 of each cell line were 
incubated in the presence of CjejCdtABC (100 ng/mL) for up to 72 h and the percent apoptotic 
cell death was determined sequentially by fluorescent microscopy following double fluorescence 
staining with PI and Hoechst 33342 (A). In separate experiments, each cell line was incubated in 
control medium or medium containing increasing concentrations of CjejCdtABC from 0.1 up to 
100 ng/mL and examined after 72 h (B). For each time point (A) or CjejCdtABC concentration 
(B), a total of 200 cells were counted and the data was expressed as percent mean apoptosis ± SD 
of three independent experiments. The mean percent apoptosis of each cell line at different times 
after addition of CDT or different concentrations of CDT were compared by using the two way 
ANOVA test with Bonferroni correction [(*, p < 0.05; **, p < 0.01; ***, p < 0.001), (R. J)].   
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Fig. 4.4.  
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Induction of p53 phosphorylation by CjejCdtABC correlates with upregulation of p53 
target PUMA in wild-type p53 but not p53 mutated human lymphoid cell lines.  
 
We found that p53 was phosphorylated within 2 h of incubation in the presence of CjejCdtABC 
in MOLT-3 and MOLT-4 cells, whereas phosphorylated p53 was not detected in treated Jurkat 
or CEM cells (Fig. 5).  By contrast, CA 46 cells had comparatively higher basal level of 
phosphorylated p53 and the level did not change in response to treatment with CjejCdtABC 
indicating that phosphorylated p53 is constitutively elevated in this cell line (Figure 4.5). In order 
to demonstrate the activation of p53 dependent apoptotic pathway, we then looked at the up 
regulation of p53 upregulated modulator of apoptosis (PUMA), a pro-apoptotic protein and a 
member of the Bcl-2 protein family that is upregulated by p53 in response to DNA damage. As 
expected, increased levels of PUMA were found in MOLT-3 and MOLT-4 cells 2 h after 
incubation in the presence of CjejCdtABC, while the level of PUMA expression did not change 
in Jurkat and CEM (Fig. 4.5). Consistent with our earlier interpretation that phosphorylated p53 
is constitutively elevated in CA 46 cells, high level of PUMA expression was present in control 
CA 46 cells, and the level was not affected by treatment with CjejCdtABC for 2 h (Figure 4.5). 
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Fig. 4.5. CjejCdtABC induction of p53 phosphorylation correlates with upregulation of p53 
target PUMA in wild-type p53 but not p53 mutated human lymphoid cell lines. 
A total of 5x10
6
 of each cell line were incubated in the presence of CjejCdtABC (100 ng/mL) for 
2 h and after lysis, proteins were separated by gel electrophoresis, transferred to PVDF 
membranes and after blocking were immunoblotted with polyclonal rabbit IgG antibody to 
phosphorylated p53 or PUMA. Membranes were blotted with mouse monoclonal antibody to β-
actin as loading control. Representative Western blots from two independent experiments (R. N. 
J). 
  
 162 
 
Fig. 4.5 
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The DNA damage response of human lymphoid cell lines to CjejCdtABC is similar to 
irradiation and independent of p53 cellular status. To confirm that observed differences in 
apoptosis susceptibility was due to the mutational status of cell lines and not to differences in the 
amount of DNA damage sustained by individual cell lines, we then investigated the activation of 
histone H2AX (γ-H2AX, a hallmark of DNA damage) in cells exposed to CDT (Figure 4.5). The 
background level of γ-H2AX levels slightly varied among cell lines, possible due to differences 
in spontaneous DNA damage levels in individual cell lines. Nevertheless, Comparable levels of 
γ-H2AX activation were observed in all cell lines by Western blot (Figure 4.5) and 
immunofluorescence (Figure 4.6)  2 h after CDT treatment suggesting comparable levels of 
CDT-induced DNA damage (and DDR activation) in various cell lines irrespective of p53 status. 
  
 164 
 
 
 
 
 
 
 
 
 
Fig. 4.6. The DNA damage response of human lymphoid cell lines to CjejCdtABC is similar 
to irradiation and independent of p53 cellular status. A total of 1x10
6
 of each cell line were 
incubated in the presence of CjejCdtABC (100 ng/mL) or γ-irradiated (5Gy), and incubated for 2 
h before fixation and staining with mouse monoclonal antibody anti-γ-H2AX followed by anti-
mouse IgG-Alexaflour 488 and nuclear staining with DAPI. At least 100 cells were counted in 
control and treated cell lines and the data were expressed as percent γ-H2AX positive (green 
nuclear foci). Representative photomicrographs of control MOLT-4 cells incubated in the 
presence of HI (control), native CjejCdtABC or after irradiating (IR) for 2 h before double 
staining and fluorescent microscopy (A). Each bar represents mean percent γ-H2AX positive 
cells with 0-2, 3-5, 6-9 and >10 nuclear γ-H2AX foci per cell ± SD from two independent 
experiments [(B), (R. N. J)]. 
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Fig.4.6. 
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The CjejCdtABC-induced DNA damage response of human lymphoid cell lines does not 
alter AKT phosphorylation level. There is some evidence that CDT might act as a PIP3 
phosphatase, and thus, according to this hypothesis, CDT genotoxity would be mediated through 
depletion of PIP3 levels resulting in reduced pAKT (Shenker et al., 2007).  Consequently, the 
human leukemic T-cell lines MOLT-4, Jurkat and CEM with known mutations in SHIP/PTEN 
and constitutively elevated PIP3 levels were highly susceptible to CDT (Shenker et al., 2007). 
As expected, MOLT-4, Jurkat and CEM cells lines had similarly elevated baseline levels of 
pAKT while CA 46 cells did not (Shenker et al., 2007). However, despite comparable levels of 
γ-H2AX activation after 2 h incubation in the presence of CjejCdtABC, and thus a well-
established DDR, the levels of pAkt did not change in any of the cell lines (Figure 4.7). These 
results suggest that changes in the level of AKT phosphorylation either do not play a significant 
role or play a minor role in CjejCdtABC-mediated apoptosis of both p53-functional MOLT-4 
and p53-mutated Jurkat and CEM human leukemic T-cell lines. 
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Fig. 4.7.  The CjejCdtABC-induced DNA damage response of human lymphoid cell lines 
does not alter AKT phosphorylation level. A total of 5x10
6
 of each cell line were incubated in 
the presence of CjejCdtABC (100 ng/mL) for 2 h and after lysis, proteins were separated by gel 
electrophoresis, transferred to PVDF membranes and after blocking were immunoblotted with 
mouse monoclonal antibody to γ-H2AX and rabbit polyclonal IgG antibody to phosphorylated 
AKT (p-AKT). Membranes were blotted with mouse monoclonal antibody to β-actin as loading 
control. Representative Western blots from two independent experiments (R. N. J). 
  
 168 
 
Fig. 4.7.  
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CjejCdtABC activates MOLT-4 cellular ATM- and ATR-dependent DDR without causing 
chromosomal breaks. Even though it has been previously suggested that CDT-induced DDR in 
lymphoid cells is ATM-dependent, phophorylation of ATM due to CDT-induced DNA damage 
has not been demonstrated. Therefore, in order to provide direct evidence to show that CDT-
induced DDR is ATM-dependent, the DDR in lymphoid cells was further characterized by using 
MOLT-4 cells. For the first time, we demonstrate the phosphorylation of ATM (pATM) in 
lymphoid cells 2 h post CjejCdtABC exposure, suggesting the activation of ATM-dependent 
DDR (Figure 4.8). Increased pATM levels were observed in CDT-treated cells at 8 h post 
exposure, however irradiated cells demonstrated highest level of pATM at 2 h post exposure. 
Comparable with this, increased γ-H2AX was observed in 8 h post CjejCdtABC exposure 
compared to cell 2 h post exposure to CjejCdtABC (Figure 4.8).   
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Fig. 4.8.  CjejCdtABC activates MOLT-4 cellular ATM and ATR responses. A total of 
5x10
6
 of MOLT-4 cells were incubated in the presence of CjejCdtABC (100 ng/mL) or γ-
irradiated (5Gy) for 2 or 8 h and after lysis, proteins were separated by gel electrophoresis, 
transferred to PVDF membranes and after blocking were immunoblotted with either mouse 
monoclonal antibody to either phosphorylated ATM (A), CHK2, or γ-H2AX and rabbit 
polyclonal IgG antibody to phosphorylated CHK1 (B). Membranes were blotted with mouse 
monoclonal antibody to β-actin as loading control. Representative Western blots from two 
independent experiments (G.B). 
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Fig. 4.8. 
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Since we and others have shown here and elsewhere that CdtB from various bacterial species can 
cause in vitro DSBs and activate H2AX and ATM in several cell lines, we examined the 
metaphase chromosomal spreads made from MOLT-4 (or Jurkat) cells incubated with 
CjejCdtABC for the presence of chromosomal breaks. Interestingly, we did not find obvious 
evidence for chromosomal breaks in either of the cell lines tested, up to 8 h post CjejCdtABC-
exposure (data not shown), suggesting that CjejCdtABC induced DNA damage is more subtle 
than chromosomal breaks, probably involving single stranded DNA breaks. However, there was 
a clear reduction in the number of metaphases per slide in CjejCdtABC-treated cells compared to 
controls, indirectly indicating the cells undergoing G2/M arrest with CjejCdtABC treatment (data 
not shown). Encouraged by these results, and cell cycle checkpoints can be activated by related 
kinases ATM,  ATR or DNA-PK, we then investigated the phosphorylation of DNA-PK, Chk1 
and Chk2 in CjejCdtABC-treated MOLT-4 cells. The phosphorylation of Chk1 is a classical 
marker for the activation of ATR. We did not find a detectable increase in phosphorylation of 
DNA-PK (data not shown). As expected, significant increase in phosphorylation of Chk2 was 
observed 2 h post CDT (or IR) exposure, further confirming the activation of ATM-dependent 
DDR by CDT (Figure 4.8). Interestingly, we also observed the phosphorylation of Chk1 2 h post 
CDT-exposure. Phosphorylation of Chk1 is a primary indication of ATR activation, and here we 
suggest the activation of ATR by CjejCdtABC-induced DNA damage. 
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Discussion 
The mutational status of p53 is a major determinant of the sensitivity of mammalian cells to 
apoptosis, particularly for genotoxin-induced apoptosis where p53 wild type cells display greater 
sensitivity than p53 null cells (Gudkov & Komarova, 2003; Roos & Kaina, 2006). Despite its 
potentially critical importance, the contribution of p53 mutational status of cell lines to CDT 
susceptibility has not been fully investigated. Additionally, CDT-induced DDR is not well 
characterized in lymphoid cell lines. In order to address these questions, we utilized two p53 
wild type cell lines (MOLT-3 and MLOT-4) and three cell lines with mutated p53 (Jurkat, CEM 
and CA 46) to further investigate the role of p53 in CDT-induced apoptosis in human lymphoid 
cell lines.  
 
The nuclease activity of the CjejCdtB was initially confirmed by in vitro digestion of plasmid 
DNA as described earlier (Dassanayake et al., 2005). In vitro digestion of plasmid DNA by 
recombinant CdtB was previously observed with EcolCdtB-II, ActCDT, and HhepCdtB (Cao et 
al., 2005; Dassanayake et al., 2005; Elwell & Dreyfus, 2000; Nishikubo et al., 2006). Here we 
extend these observations by demonstrating the weak in vitro nuclease activity of CjejCdtB. By 
using linearized plasmid DNA as a control, we confirm for the first time that CjejCdtB is capable 
of creating double stranded DNA breaks (DSBs) in vitro. Additionally appearance of DNA 
smears in both super coiled and plasmid DNA with 6 h digestion suggests that CdtB-induced 
DSBs are not sequence specific. 
 
The CjejCdtABC susceptibility of lymphoid cell lines was initially assed using viable cell 
counts.  As expected p53 wild type MOLT-4 cells were extremely susceptible to CjejCdtABC. 
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All p53 mutated cell lines (Jurkat, CEM and CA-46) had significantly higher growth rates after 
CjejCdtABC exposure (except for Jurkat cells at 24 h) compared to p53 wild type MOLT-4 cells 
indicating that p53 mutational status correlates with CjejCdtABC susceptibility in human 
lymphoma and leukemia cell lines.  Similar to the initial findings, further characterizing of the 
kinetics of  CjejCdtABC-induced apoptosis revealed that p53 wild type cell lines (MOLT-3 and 
MOLT-4) are highly susceptible to CjejCdtABC-induced apoptosis   compared to p53 mutated 
cell lines (Jurkat, CEM and CA 46). These findings extend the early observations on p53 wild 
type MOLT-4 and p53 mutated Jurkat cells (Ohara et al., 2004), where caspases were activated 
earlier in MOLT-4 cells. Additionally we further observed that p53 mutated Jurkat cell line 
displayed an intermediate susceptibility to CjejCdtABC.  The p53 mutated CEM and CA 46 cell 
lines, particularly the Bax-deficient CA 46 cell were extremely resistant to apoptosis, suggesting 
that CjejCdtABC-induced apoptosis in human lymphoid cell lines is dependent on p53 
mutational status of the cell line.   
 
Interestingly, among the p53 mutated cell lines Jurkat and CEM displayed noticeable time and 
dose dependent increasing susceptibility to CjejCdtABC while the Bax deficient CA 46 cell line 
showed minimal time and dose dependent increasing susceptibility to CjejCdtABC, suggesting 
the potential late activation of p53-independent mechanisms. Additionally, the extreme 
CjejCdtABC resistance in CA 46 cell line having a Bax deficient genotype, indirectly suggest 
that CjejCdtABC-induced apoptosis in human lymphoid cell lines can be mediated through 
mitochondrial pathway.  These observations are comparable with previous demonstrations by us 
and others that CDT-induced apoptosis is primarily mediated through mitochondrial pathway 
(Alaoui-El-Azher et al., 2010; Bielaszewska et al., 2005; Hickey et al., 2005; Liyanage et al., 
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2010; Ohara et al., 2004; Shenker et al., 2001; Wising et al., 2005; Yamamoto et al., 2004). We 
previously reported sequential up-regulation of Bax and down-regulation Bcl-2 leading to 
cytochrome c release and the subsequent activation of caspase-9 by HhepCDT in human 
intestinal epithelial H407 cells (Liyanage et al., 2010).  Activation of mitochondrial apoptotic 
pathway was also suggested by the significant reduction of CDT-induced apoptosis in human B-
cell lines over-expressing Bcl-2 (Ohguchi et al., 1998; Shenker et al., 2001).   
 
To confirm the differential apoptosis susceptibility in human lymphoma and leukemia cell lines 
is due to the mutational status of cell lines and not the amount of DNA damage sustained by 
individual cell lines, we then characterized the phosphorylation of histone H2AX. Comparable 
levels of γ-H2AX were observed in all cell lines by immunofluorescence and Western blot 2 h 
after CjejCdtABC treatment suggesting comparable levels of CjejCdtABC-induced DNA 
damage (and activation of DDR) in various cell lines irrespective of p53 status. CDT-induced γ-
H2AX activation was previously demonstrated in  HeLa cells 2 h post Haemophilus ducreyi 
CDT (HducCDT) exposure, and nearly all cells are positive for γ-H2AX foci within 6 to 8 h 
post-exposure (Li et al., 2002).  Increased γ-H2AX foci are seen in primary human fibroblasts 
treated with CjejCDT (Hassane et al., 2003), in primary and established human endothelial cells 
treated with Escherichia coli CdtB-V (EcolCdtB-V), and human  intestinal epithelial H407 cells 
exposed to HhepCDT (Bielaszewska et al., 2005; Liyanage et al., 2010).  
 
In this study for the first time we provide direct evidence that CjejCdtABC-induced DDR in 
human lymphoma and leukemia cell lines involve ATM activation. Phosphorylation of ATM 
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was detectable at 2 h in CjejCdtABC treated MOLT-4 cells and became more prominent by 8 h 
post exposure to CjejCdtABC. In comparison IR induced similarly higher levels of phopho-ATM 
at 2 h post exposure, and had reduced phopho-ATM levels by 8 h. Similar kinetics were 
observed for the γ-H2AX levels in MOLT-4 cells, where CjejCdtABC induced γ-H2AX level 
increased from 2 h to 8h while it remained constant or appeared be lower by 8 h following IR 
exposure. The delayed onset of CjejCdtABC-induced phopho-ATM and γ-H2AX levels 
compared to IR exposure could be attributable to the fact that the extent and severity of 
CjejCdtABC-induced DNA lesions depends on the efficiency of cell surface binding, cellular 
internalization, delivery and enzymatic action of CjejCdtB, while IR is a rapid and almost 
instantaneous mechanical injury to DNA. In the same notion, the reduction of phopho-ATM and 
γ-H2AX levels in IR-exposed MOLT-4 cells by 8 h (compared to IR-exposed cells at 2 h) could 
be attributable to the activation of DNA repair mechanisms. Induction of ATM-dependent DDR 
by CDT in human lymphocytes has been indirectly demonstrated by characterizing the γ-H2AX 
levels in previous studies (Li et al., 2002). Immortalized ATM-wild type human B lymphocyte 
lines had readily detectable γ-H2AX levels following HducCDT exposure, but it was absent in 
ATM- defective leukemic B cell lines obtained from AT patients (Li et al., 2002).   
 
Since nuclease activity of CdtB is the well-established molecular basis of cellular toxicity, and 
CDT is potentially causing DNA strand breaks, we then investigated the mediators besides ATM 
that can be involved in CDT-induced DDR. Three major phosphoinositide 3-kinase related 
kinases (PIKKs) involved in DDR are ATM, ATR and DNA-PK (Bartek & Lukas, 2007). We 
observed the phosphorylation of Chk 1in MOLT-4 cells 2h post exposure to CjejCdtABC, 
providing evidence to suggest that the CjejCdtABC-induced DDR can also be mediated through 
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ATR. We did not find any evidence to suggest the activation of DNA-PK by CjejCdtABC in 
MOLT-4 cells. Interestingly, even though we observe weak in vitro plasmid DNA digestion by 
CjejCdtB, we did not observe chromosomal breaks in CjejCdtABC-treated cells, and together 
with the observation of the activation of ATR, it is possible to suggest that CjejCdtABC-induces 
a more subtle type of DNA damage such as single strand DNA breaks in vivo, as suggested by 
previous studies (Cortes-Bratti et al., 2001; Sert et al., 1999). Sert and colleagues did not observe 
DNA strand breaks in EcolCDT treated HeLa cells analyzed by single cell gel electrophoresis 
(comet) assay (Sert et al., 1999).  Additionally, based on the evidence that nearly half of the 
CjejCDT sensitive mutants are not sensitive to HO endonuclease (which is known to cause 
DSBs) in a Saccharomyces cerevisiae systematic transformation array it has been suggested that 
at least in yeast CjeCdtB primarily induces single strand DNA breaks (SSB), which will be 
converted to DSBs during the replication of nicked strand (Kitagawa et al., 2007).  However, 
chromosomal DNA fragmentation by CDT has been observed in epithelial cells exposed to 
relatively high doses of CDT (Frisan et al., 2003; Lara-Tejero & Galan, 2000). Similar, we also 
observed chromosomal breaks in 3T3 fibroblasts with relatively very high (25 ug/ml) levels of 
CjejCdtABC (data not shown). 
 
In p53 wild type cells, DNA damage results in the accumulation of fully phosphorylated active 
p53, which leads to the transcriptional activation of the pro-apoptotic p53 targets including Bax, 
Bid, Puma and Noxa (Gudkov & Komarova, 2003; Roos & Kaina, 2006). In p53-null cells 
apoptosis sensitivity is mediated through several alternative mechanisms including the 
degradation of anti-apoptotic Bcl-2 (Gudkov & Komarova, 2003; Roos & Kaina, 2006). The 
p53-independent mechanism is relatively less efficient for facilitating apoptosis than direct 
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activation of Bax by p53, and thus p53-null cells are generally more resistant to genotoxin-
induced apoptosis (Roos & Kaina, 2006). Additionally, sensitivity to toxin or drug-induced 
apoptosis can vary considerably in different cell lines depending on the differences in the 
expression levels of other mediators in apoptotic pathway, for example the anti-apoptotic protein 
Bcl-2 which has a protective function for mitochondrial integrity (Zamzami et al., 1996).  
 
The CDT-induced apoptosis in p53 mutated cell lines may be mediated through several 
pathways. One of the possible pathway is through Chk1/Chk2 and E2F1/p73(Jinadasa et al., 
2011). The Chk1/Chk2-E2F1/p73 pathway is one of the major pathways leading to apoptosis in 
p53 mutated cells in response to DNA damage (Roos & Kaina, 2006). Additionally, Chk1 also 
play a major role in replication stress induced apoptosis, which can be mediated independent of 
p53 and Chk2 (Myers et al., 2009; Rodriguez & Meuth, 2006; Sidi et al., 2008).  Since we 
observed the activation of Chk1 in MOLT-4 cells, and we did not observe chromosomal breaks 
in either MIOLT-4 or Jurkat cells, suggesting a more subtle DNA damage induced by CDT, it is 
highly likely that apoptosis in p53 mutated cells will mediated through Chk1. 
 
While it is well-established that the nuclease activity of CdtB is the molecular basis of CDT 
cellular toxicity, other than structural and biochemical evidence of PIP3 phosphatase activity 
with purified recombinant AactCdtB, the evidence for this activity playing a role in cellular 
toxicity is limited (Dlakic, 2000; Shenker et al., 2007). The PIP3 phosphatase activity was 
demonstrated only in human leukemia cell lines with constitutively elevated PIP3 levels due to 
mutations in SHIP1 and/or PTEN and the suppression of protein kinase B (PKB)/AKT pathway 
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(due to the depletion of PIP3) was speculated as the mechanism of cellular toxicity (Shenker et 
al., 2007).  Our data suggest that changes in the level of AKT phosphorylation either do not play 
a significant role or play a minor role in CjejCdtABC-mediated apoptosis of both p53-functional 
MOLT-4 and p53-mutated Jurkat and CEM human leukemic T-cell lines.  While we show that 
the pAKT levels of these leukemic cell lines is constitutively elevated (Figure 4.7), the 
hypothesis that this accounts for their greater susceptibility to CdtB phosphatase is not consistent 
with the observed resistance of CEM and to a lesser degree Jurkat cell lines (Figure 4.3), both 
with defective p53 pathway when treated with CjejCdtABC.  Based on previous suggestions that 
the interaction of CjejCDT with cellular receptors is different from that of AactCDT (Eshraghi et 
al., 2010), the possibility that these discrepancies are attributed to different molecular 
mechanisms of genotoxicity cannot be excluded completely.  However, our data is consistent 
with previous studies with site specific phosphatase defective AactCdtB mutants or specific PIP3 
phosphatase inhibitors demonstrating that nuclease activity is sufficient for induction of cell 
cycle arrest and apoptosis in proliferating human monocytic cell line U937 (Rabin et al., 2009).  
Further studies using haploid S. cerevisiae that lacks PIP3, confirmed that AactCdtB-induced 
DSB is sufficient to cause cell cycle arrest and death (Matangkasombut et al., 2009). 
Additionally, cellular toxicity in S. cerevisiae requires DNase-I-like catalytic residues of CdtB 
and its nuclear localization (Matangkasombut et al., 2009). Taken together the data suggest that 
the predominant mechanism of cellular toxicity of CDT is the CdtB nuclease activity and DSB, 
and PIP3 phosphatase plays an accessory role in certain situations.  
Although we cannot rule out the contribution of mutations in genes other than p53, our data 
clearly indicate that p53 mutational status correlates with the differential CjejCdtABC-
susceptibility of human lymphoma and leukemia cell lines. For the first time we show the 
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activation of ATM-dependent DDR in human lymphoma and leukemia cell lines and provide the 
first evidence of involvement of CHK1 in CDT-induced DDR. The absence of detectable change 
in phosphorylated Akt levels following CjejCdtABC treatment suggesting that nuclease activity 
of CjejCdtABC is the primary contributor for cytotoxicity.   
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CHAPTER 5 
ATM is essential for development of adaptive immune responses to bacterial whole cell antigens 
and cytolethal distending toxin in a laboratory mouse model of Helicobacter hepaticus infection
1, 2 
Abstract 
It is well-established that the bacterial genotoxin, cytolethal distending toxin (CDT) causes DNA damage 
in a wide range of eukaryotic cells in vitro leading to a robust DNA damage response (DDR) in which 
ATM plays a central role. Moreover, on the basis of a higher sensitivity of hematopoietic cells to the 
cytotoxic effects of CDT, it has been suggested that CDT modulates the host immune response in vivo. 
Here we assess the adaptive humoral immune response of laboratory mice with a defective DDR 
following infection with H. hepaticus. Assessment of serum IgG1 responses to H. hepaticus whole cell 
lysate (WCL) and CdtB subunits revealed differential responses in Atm wild type (Atm
+/+
) compared with 
Atm-defective (Atm
+/-
) and null (Atm
-/-
) genotypes. While infected Atm
+/+ 
and Atm
+/-
 mice had high levels 
of IgG1 antibodies to H. hepaticus WCL, Atm
-/-
 mice had a greater than a 50% reduction in their serum 
antibody responses to both WCL and CdtB.  Histopathological examination of control uninfected and 
infected mice of any genotype euthanized four or 10 weeks post challenge revealed no significant 
intestinal inflammation.  The data suggest that DDR mechanisms are essential for bacterial and CDT-
specific host adaptive immune responses.      
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Introduction 
Enterohepatic Helicobacter species (EHS) are a major cause of enterocolitis, hepatitis and 
bacteremia several laboratory animal species particularly mice and non-human primates 
(Duhamel et al., 2003; Fox et al., 2001a; Fox et al., 2001b; Fox et al., 2011; Ge et al., 2008a; 
Kemper et al., 1993; Liyanage et al., 2010; Solnick & Schauer, 2001); however, their 
pathogenicity in human beings is incompletely understood (3, 20, 53). The prototype for EHS is 
Helicobacter hepaticus, which establish long-term colonization of the lower intestinal and 
hepatobiliary tract resulting in chronic inflammation and ultimately hepatocellular and colonic 
carcinomas in susceptible strains of mice including A/JCr, SCID/NCr, C3H/HeNCr (Fox et al., 
1994; Hailey et al., 1998; Ihrig et al., 1999; Suerbaum et al., 2003; Ward et al., 1994a; Ward et 
al., 1994b). The chronic colitis associated with  H. hepaticus infection has features of 
inflammatory bowel disease (IBD), and thus, it has been widely used as a model to define 
aspects of IBD pathogenesis (Fox et al., 2011). Further, H. hepaticus is closely related to the 
major food- and waterborne human pathogen Campylobacter jejuni, and because of a lack of 
laboratory animal models, H. hepaticus infection in mice has been used as a surrogate model for 
human campylobateriosis (Suerbaum et al., 2003; Young et al., 2007).  
 
Although cytolethal distending toxin (CDT) is the only known virulence factor produced by H. 
hepaticus, the contribution of this genotoxin to disease pathogenesis has remained incompletely 
understood (Ge et al., 2008a; Jinadasa et al., 2011; Liyanage et al., 2010; Suerbaum et al., 2003). 
CDT is a heterotrimeric AB type toxin produced by over two dozens of clinically important 
Gram negative bacteria beside H. hepaticus, that inhabit a wide range of hosts’ mucocutaneous 
surfaces (Alouf, 2006; Ge et al., 2008a; Guerra et al., 2011; Jinadasa et al., 2011; Johnson & 
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Lior, 1987; Johnson & Lior, 1988a; Johnson & Lior, 1988b; Lara-Tejero & Galan, 2001; Purven 
& Lagergard, 1992; Smith & Bayles, 2006; Sugai et al., 1998; Young et al., 2000). The active 
subunit CdtB has structural homology with phosphodiesterase family of enzymes including 
mammalian deoxyribonuclease I (Elwell & Dreyfus, 2000; Hu et al., 2006; Hu & Stebbins, 2006; 
Lara-Tejero & Galan, 2000; Nesic et al., 2004; Yamada et al., 2006). The CdtB subunit is 
necessary and sufficient to cause cellular toxicity (Elwell & Dreyfus, 2000; Lara-Tejero & 
Galan, 2000). Currently CDT is the only known AB type toxin with deoxyribonuclease activity 
(Alouf, 2006). Mammalian cells exposed to CDT initiate a DNA damage response (DDR) 
similar to that elicited by ionizing radiation (IR)-induced DNA double strand breaks (DSBs) 
leading to irreversible cell cycle arrest and apoptosis (Cortes-Bratti et al., 2001; Hassane et al., 
2003; Li et al., 2002; Liyanage et al., 2010). Based on its ability to modulate mammalian cell 
cycle, CDT has been proposed as a cyclomodulin, a novel group of bacterial toxins which are 
capable of modulating the host cell cycle during the pathogenesis of disease (Nougayrede et al., 
2005). Cell lines of epithelial and endothelial origins primarily arrest in the G2/M phase 
following CDT exposure  (Elwell et al., 2001; Jinadasa et al., 2011; Lara-Tejero & Galan, 2001; 
Smith & Bayles, 2006; Whitehouse et al., 1998; Wising et al., 2005; Young et al., 2000), 
whereas cells of fibroblastic origin arrest both in the G1/S and G2/M phases of the cell cycle 
(Belibasakis et al., 2004; Cortes-Bratti et al., 2001; Hassane et al., 2003; Smith & Bayles, 2006; 
Wising et al., 2005). By contrast with all other cell types, cells of hematopoietic lineage 
including lymphocytes, monocytes, macrophages and dendritic cells are several orders of 
magnitude (10–50 pg/ml compared to 1–5 µg/ml for other cells) more susceptible to the action of 
CDT and undergo rapid apoptosis after a brief cell cycle arrest (Belibasakis et al., 2004; Cortes-
Bratti et al., 2001; Hassane et al., 2003; Smith & Bayles, 2006; Wising et al., 2005).  
 192 
 
The CDTs produced by several bacteria have been shown to inhibit the proliferation and cause 
functional impairment and apoptosis of immune cells.  Aggregatibacter actinomycetemcomitans 
CdtB (AactCdtB) inhibits the proliferation of mitogen stimulated human B cells, impairs the 
production of IgG and IgM, and causes G2/M arrest and apoptosis in mitogen stimulated human 
T lymphocytes (Shenker et al., 1991; Shenker et al., 1999; Shenker et al., 2001). Inhibition of 
proliferation and apoptotic cell death of were observed in Haemophilus ducreyi CDT(HducCDT) 
treated mitogen stimulated human peripheral blood mononuclear cells (PBMCs) and enriched T 
cells, and also in Jurkat cells (Gelfanova et al., 1999). Inhibition of proliferation was also 
observed in viral-stimulated human B cells exposed to HducCDT, with a decrease in IgG and 
IgM production (Svensson et al., 2001).  Similarly, viral-stimulated human B cell lines are also 
undergoing apoptosis when treated with HducCDT (Cortes-Bratti et al., 2001; Frisan et al., 
2003).    
 
In addition to the extreme in vitro CDT susceptibility of hematopoietic cells, CDT has also been 
associated with immunomodulation in vivo (Pratt et al., 2006; Young et al., 2004). Infection of 
interleukin 10 deficient (IL-10
-/-
) C57BL/6 mice with H. hepaticus lacking CdtB resulted in the 
clearance of infection in four months, while the wild type bacteria persisted for over eight 
months (Young et al., 2004). The mice infected with wild type H. hepaticus developed severe 
typhlocolitis and produced significantly higher levels of IgG1 and IgG2 compared to the animals 
infected with CDT-deficient mutant H. hepaticus suggesting that CDT is having an 
immunomodulatory effect (Pratt et al., 2006).  It has also been shown that CDT is essential for 
the colonization of H. hepaticus in outbred Swiss Webster mice (Ge et al., 2005). The infection 
was cleared in eight weeks post infection (w.p.i) in females and 16 w.p.i. in males infected with 
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isogenic CDT-deficient H. hepaticus, whereas the wild type bacteria persisted in both males and 
females for over 16 w.p.i. (Ge et al., 2005). Based on the extreme in vitro CDT susceptibility of 
hematopoietic lineage cells and association of CDT with immunomodulation in vivo, it has been 
proposed that hematopoietic lineage cells could be the in vivo target of CDT (Pratt et al., 2006; 
Shenker et al., 2007).  
 
Even though the precise nature of secretion of CDT during bacterial infection is not completely 
understood, increasing evidence suggests that CDT is secreted in bacterial outer membrane 
vesicles (Lindmark et al., 2009; Rompikuntal et al., 2012).  Additionally, physiological levels of 
bile acid sodium deoxycholate enhance the outer membrane vesicle mediated secretion of CDT 
in vitro (Hickey et al., 2005). Natural infections with H. ducreyi and A. actinomycetemcomitans 
can elicit serum IgG antibodies to individual CdtABC subunits indicating development of an 
adaptive immune response to toxin during infection (Ando et al., 2010; Mbwana et al., 2003; 
Xynogala et al., 2009).  Serum antibodies that can neutralize the biological activity of CDT have 
been demonstrated in patients with chancroid (Mbwana et al., 2003); those with periodontitis 
(Ando et al., 2010; Xynogala et al., 2009), and patients recovered from campylobacteriosis 
(Abuoun et al., 2005).  Moreover, development of high levels of CDT-neutralizing IgG in sera 
and genital tissues of mice immunized with HducCDT toxoid compared to native toxin suggests 
a potential vaccine application for CDT toxoid in protection against chancroid (Lundqvist et al., 
2010).   
 
Development of a host adaptive immune response to individual CDT protein subunits is seen 
following spontaneous infection and disease caused by CDT-producing A. 
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actinomycetemcomitans, C. jejuni and H. ducreyi. However, experimental infections in a 
laboratory mouse model of H. hepaticus clearly show that CDT can modulate both the level and 
isotype antibody response of the host and establish persistent infection (Ge et al., 2005; Pratt et 
al., 2006). The purpose of the current study is to determine the effect of ATM on the immune 
response to H. hepaticus infection. The Atm
–/–
 mice used in this study were initially designed and 
characterized by Elson et al., 1996 and has defective immune systems characterized by smaller 
thymi compared to wild type mice, reduced number of thymocyets,  reduced cortex and a large 
medulla (Elson et al., 1996). Additionally, Atm
–/–
 mice develop spontaneous thymic lymphomas 
between 3-4 months of age (Elson et al., 1996).  Further, spleen and peripheral blood from Atm
–/–
 
mice had significant reduction in T cells; however, no significant alterations were observed in 
the relative proportion of B cells (Elson et al., 1996). An independent Atm
–/–
 mice model 
developed by Barlow et al., 1996 had similar observations regarding lymphocyte development 
and T cell maturation while no significant defects were observed in B cell development (Barlow 
et al., 1996). However, independent studies have demonstrated similar developmental defects in 
B cells (Xu et al., 1996).  
 
We characterized the immune responses against H. hepaticus bacterium and CdtB. Further this 
study also explores the effect of a high cholate diet in modulating the host immune response. 
Assessment of serum IgG1 responses to H. hepaticus WCL and CdtB subunits revealed 
differential responses in Atm
+/+
 compared with Atm
+/-
 and null Atm
-/-
 genotypes. While infected 
Atm
+/+
 and Atm
+/-
 mice had high levels of IgG1 antibodies to H. hepaticus WCL, Atm
-/-
 mice 
had a greater than a 50% reduction in their serum antibody responses to both WCL and CdtB.  
Histopathological examination of control uninfected and infected mice of any genotype 
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euthanized four or 10 weeks post challenge revealed no significant intestinal inflammation.  The 
data suggest that DDR mechanisms are essential for bacterial and CDT-specific host adaptive 
immune responses. Additionally, a diet that alters the bile acid composition resulted in an overall 
reduced immune response against Hhep WCL and CdtB.   
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Materials and Methods 
Mice and H. hepaticus infection 
The Atm
–/–
 mice used in this study were originally designed and characterized by Elson et al., 
1996 (Elson et al., 1996) and a kind gift to R. S. W from Dr. Phillip Leder and maintained on 
FVB background. The colony was re-derived at the Cornell University transgenic mouse facility 
(TMCF) to generate Helicobacter-free mice colony by embryo transfer and maintained in the 
high security Cornell University East Campus Research Facility (ECRF) for breeding and 
transferred to a barrier facility for infection. The mice were fed either normal Harlan rodent 
chow or diet containing 1.0% cholesterol, 0.5% cholic acid, and 15% dairy (Harlan diet 
TD.88051) as described earlier (Maurer et al., 2006). Mice in each experimental group are listed 
in tables 5.1 and 5.2. 
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Table 5.1. Mice in the conventional diet group.  
Genotype Weeks p.i 
  4 8 10 
  Infected Control Infected Control Infected Control 
Atm
+/+
 8 4 7 4 7 4 
Atm
+/-
 8 8 6 6 6 6 
Atm
-/-
 10 6 7 4 3 4 
 
Table 5.2. Mice in the high cholate diet group. 
Genotype Weeks p.i 
  4 8 10 
  Infected Control Infected Control Infected Control 
Atm
+/+
 3 3 2 2 2 2 
Atm
+/-
 8 5 4 4 4 4 
Atm
-/-
 4 2 1 1 1 1 
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The H. hepaticus strain (TMCF 5664) used in this study had been isolated from Cornell 
university transgenic mouse core facility (TMCF) according to previously described protocols 
(Fox et al., 1994). The presence of cdtB and HH252, HH260 and HH275within H. hepaticus 
pathogenicity island 1 (HHGI1) was confirmed by PCR assays according to previously described 
protocols (Dassanayake et al., 2005a; Ge et al., 2008b). The in vitro CDT biological activity also 
was confirmed by treating  HeLa cells with whole cell lysate (HhepWCL) and demonstrating cell 
cycle arrest and apoptosis as previously earlier (Dassanayake et al., 2005b). Six to eight week 
old weaned mice received 3 doses (0.5ml of approximately 2x10
8
 bacteria/ml suspension in 
brucella broth) of H. hepaticus by oral gavage every other day according to protocols described 
earlier (Ge et al., 2008b). The infection was verified by PCR for HhepCdtB gene two weeks post 
infection (p.i.) using individual fecal pellets. Serum was collected by submandibular bleeding 4 
and 8 weeks post infection (p.i) and at 10 weeks p.i. during necropsy by allowing the blood to 
clot at room temperate and centrifuging at 10000g for 10 min. The serum samples were 
immediately frozen until further use.  Bacterial load in cecal tissue was determined by 
quantitative real time PCR as described earlier (Ge et al., 2001). All animal procedures were 
approved by Cornell University institutional animal care and use committee (IACUC).  
 
Recombinant H.hepaticus CdtB (HhepCdtB) and HhepWCL antigens 
His-tagged HhepCdtB was expressed in E. coli and purified under denaturing conditions 
according to previously described protocols (Dassanayake et al., 2005a; Liyanage et al., 2010). 
The purity of proteins was characterized by SDS-PAGE and Coomassie blue staining and/or 
Western blot as described  (Dassanayake et al., 2005a).  HhepWCL was prepared according to 
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previously described protocols (Dassanayake et al., 2005b). Concentrations of the antigens were 
adjusted to 200 µg/ml in PBS with 10% glycerol and stored at -80 °C. 
 
ELISA 
Immulone flat bottom 96 well plates (Fisher, cat. #3455) were coated with 100 µl of antigen 
(diluted 1:100 in NaCO3 pH 9.6) and incubated at 4°C overnight. After washing the plate 4 times 
with wash buffer (8.5% NaCl with 0.1% Tween 20), 100 µl of dilute serum [1:100 dilution in 
PBST (PBS with 1% BSA and 0.1% Tween 20)] was added to triplicate wells and incubated at 
37°C for 2h. Plates were washed 4 times with wash buffer and incubated with 100 µl of dilute 
(1:2000 in PBST) secondary antibody (goat anti-mouse IgG1-HRP, Santa Cruz Biotechnology 
cat. # sc2969) at 37°C for 1h. Plates were washed 4 times with wash buffer and 100 µl of ABTS 
peroxidase substrate (KPL cat. # 50-66-18) was added and incubated at room temperature for 
color development (5-20 mins). The reaction was stopped by adding 5% SDS (100 µl per well) 
when the negative control wells were just beginning to show color. Absorbance at 405 nm was 
recorded using a Synergy 2 multi-mode microplate reader (BioTek instruments). 
 
Histopathology 
Histopathological analysis was performed by a pathologist blind to the identity of the samples 
and a score was given to each sample based on the intensity and severity of the lesions. 
 
Statistical analysis 
Statistical analysis for FACS data was performed using JMP Pro version 9.02 (SAS Institute Inc, 
Cary, NC). Data are presented as mean ± SD. A p value < 0.05 was considered as significant.   
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Results 
Isolation and characterization of H. hepaticus strain TMCF 5664.  
A field strain of H. hepaticus was isolated from the liver of a mouse from a conventional mouse 
colony at TMCF. The strain was PCR positive for CdtB and selected components of the HHGI 1 
genes HH252, HH260 and HH275 (Figure 5.1). The in vitro CDT activity of the infecting strain 
was verified by the ability to induce cell cycle arrest in HeLa cells. The HhepWCL from the 
strain TMCF 5664 induced significantly higher G2/M cell cycle arrest in HeLa cells confirming 
the CDT activity (Figure 5. 2). 
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Figure 5.1. Detection of HHGI 1 genes HH252, HH260 and HH275 by PCR.  
Each lane of the 0.8% agarose gel was loaded with 12 µl of PCR product and visualized by 
ethidium bromide staining. Lane 1, molecular weight marker; lane 2, HH252; lane 3, HH260; 
lane 4, HH275 (R. N. J.). 
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Fig. 5.1. 
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Figure 5.2. Hhep TMCF 5664 displays CDT activity in vitro. 
HeLa cells were exposed to 20ug/ml Hhep TMCF 5664 WCL for 72 h. Cell cycle arrest was 
determined by FACS. Data shows the mean percentage of cells arresting at G/M phase as 
determined by the presence of 4N DNA content. Data represent the means of two independent 
experiments. The mean values were compared by using Student’s t test [(***, p<0.001), S. Y. 
C.]. 
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Fig. 5.2. 
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H. hepaticus infection elicits an Atm-dependent immune response. 
Even though it is well established that Atm null mice have defective immune responses 
characterized by lower serum IgG levels, role of Atm in developing specific adaptive immune 
response against a bacterial infection has not been characterized. Particularly, it is of particular 
interest to characterize the response of Atm heterozygous mice, as 1-2 % of human population is 
heterozygous for Atm, they might be in an increased risk for infection with CDT producing 
bacteria (Smilenov et al., 2001). Control mice had minimal levels of serum IgG against 
HhepWCL or HhepCdtB.  The responses against HhepWCL always higher as compared to 
responses against HhepCdtB (Figure 5.3). As expected wild type and heterozygous mice had a 
significantly higher IgG1 response compared to Atm-null mice. Interestingly, the heterozygous 
mice had a marginally lower IgG1 response as compared to wild type and Atm-null mice; 
however, this difference was not statistically significant. The specific IgG responses against 
HhepWCL and HhepCdtB had a slight increase over time; however, the increase was not 
statistically significant. 
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Figure 5.3. H. hepaticus infection elicits an Atm-dependent immune response 
Serum IgG1 responses (absorbance at 405 nm) were measured by ELISA against HhepWCL (A) 
and HhepCdtB (B) in mice fed with conventional diet over 10 weeks p.i. The plates were coated 
with 0.02 µg of antigen and incubated with 1:100 diluted sera for 2 h at 37 °C. Following wash, 
the plates were incubated with 1:2000 dilutes anti-mouse IgG1-HRP. Following wash, 
peroxidase substrate was added to the plates and color development up to 20 mins was detected 
by spectrophotometer after adding 5% SDS stop reagent. The data represent mean values of three 
technical replicates for each data point. Number of mice used in each group is listed in table 5.1. 
For each time point, the mean values were compared by using two way ANOVA test with 
Bonferroni correction [(***, p < 0.001; NS, not significant), (R. N. J. and G. E. D). 
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Fig. 5.3.  
(A)  
  
(B)  
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H. hepaticus elicited Atm-dependent immune response is modulated by host diet. 
Even though the precise nature of secretion of CDT during bacterial infection is not completely 
understood, increasing evidence suggests that CDT is secreted in bacterial outer membrane 
vesicles (Lindmark et al., 2009; Rompikuntal et al., 2012).  Additionally, physiological levels of 
bile acid sodium deoxycholate enhance the outer membrane vesicle mediated secretion of CDT 
in vitro (Hickey et al., 2005). Similar to mice fed with conventional diet, control mice had a 
basal level IgG response. The high cholate diet had an overall effect of reducing IgG1 responses 
against HhepWCL and HhepCdtB compared to conventional diet. Further, the response did not 
increase over time as compared to mice fed with conventional diet. Similar to mice fed with 
conventional diet, wild type mice had a significantly higher IgG1 response compared to Atm-null 
mice and the heterozygous mice had an intermediate IgG1 response as compared to wild type 
and Atm-null mice. The difference between IgG1 responses of wild type and heterozygous mice 
were more pronounce in high cholate diet fed mice compared to mice fed with conventional diet 
and reached statistical significance at 4 weeks p.i. and 10 weeks p. i. time points (Figure 5.4).  
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Figure 5.4 H. hepaticus elicited Atm-dependent immune response is modulated by host diet. 
Specific IgG1 responses (absorbance at 405 nm) were measured by ELISA against HhepWCL 
(A) and HhepCdtB (B) in mice fed with high cholate diet over 10 weeks p.i. The plates were 
coated with 0.02 µg of antigen and incubated with 1:100 diluted sera for 2 h at 37 °C. Following 
wash, the plates were incubated with 1:2000 dilutes anti-mouse IgG1-HRP. Following wash, 
peroxidase substrate was added to the plates and color development up to 20 mins was detected 
by spectrophotometer after adding 5% SDS stop reagent. The data represent mean values of three 
technical replicates. Number of mice used in each group is listed in Table 5.2. For each time 
point, the mean values were compared by using two way ANOVA test with Bonferroni 
correction [(*, p < 0.05; NS, not significant), (R. N. J. and G. E. D)]. 
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Fig. 5. 4. 
(A) WCL 
 
  
(B) CdtB 
    
Quantitative assessment of bacterial load in cecal tissue at10 weeks p.i.  
In a representative preliminary experiment for quantitative assessment of bacterial load in cecal 
tissue at10 weeks p.i. in mice fed with conventional diet revealed a marginally high level of 
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colonization in Atm null mice. However, the mice fed with high cholate diet had a lower 
bacterial load compared to mice fed with conventional diet (Table 5.3). Even in the mice fed 
with high cholate diet, high level of colonization was detected in Atm null mice. 
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Table 5.3. Quantitative assessment of bacterial load in cecal tissue 10 weeks p.i. 
Genotype 
Diet 
Conventional  High cholate  
Cт Mean SD Cт Mean SD 
Atm
+/+ 
25.53 (n=2) 4.27 31.10(n=3) 0.53 
Atm
+/- 
25.73(n=3) 2.38 29.49(n=3) 0.53 
Atm
-/- 
19.84(n=2) 0.44 21.01(n=1) 0.08 
Preliminary data from a representative experiment depicting the mean threshold (Cт Mean) 
values and standard deviations for detecting H. hepaticus genomic DNA in total DNA extracts of 
ceca from mice infected with H. hepaticus 10 weeks p.i. Each sample was assayed in triplicate 
(R. N. J.). 
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Discussion 
As most of the previous studies on H. hepaticus infection in mice have been performed using 
laboratory strains of H. hepaticus, we used a field strain of H. hepaticus isolated from the liver of 
a mouse from the conventional mouse colony at TMCF in order to get a better understanding of 
the immune response during H. hepaticus infection.  In mice fed with either type of diet, a 
significant IgG1 response was observed against both HhepWCL and HhepCdtB in infected group 
compared to controls. This indicates the development of adaptive immune responses against H. 
hepaticus and HhepCdtB, suggesting the production of CDT during pathogenesis. Adoptive 
immune responses for HhepWCL has been reported before, however this is the first report 
characterizing the adoptive immune response against HhepCdtB (Ge et al., 2005; Pratt et al., 
2006; Young et al., 2004). As expected wild type and heterozygous mice had a significantly 
higher IgG1 response compared to Atm-null mice and this is the first demonstration of the 
inability of Atm null mice to mount an adaptive immune response against a bacterial pathogen. 
Interestingly, the heterozygous mice had a marginally lower IgG1 response as compared to wild 
type and Atm-null mice. This is an interesting preliminary finding given the fact that 1-2 % of 
human population is heterozygous for Atm, they might be in an increased risk for infection with 
CDT producing bacteria (Lu et al., 2006; Smilenov et al., 2001).  
 
The Atm
–/–
 mice used in this study were initially designed and characterized by Elson et al., 1996 
and has defective immune systems characterized by smaller thymi compared to wild type mice, 
reduced number of thymocyets,  reduced cortex and a large medulla (Elson et al., 1996). 
Additionally, Atm
–/–
 mice develop spontaneous thymic lymphomas between 3-4 months of age 
(Elson et al., 1996).  Further, spleen and peripheral blood from Atm
–/–
 mice had significant 
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reduction in T cells; however, no significant alterations were observed in the relative proportion 
of B cells (Elson et al., 1996). An independent Atm
–/–
 mice model developed by Barlow et al., 
1996 had similar observations regarding lymphocyte development and T cell maturation while  
no significant defects were observed in B cell development (Barlow et al., 1996). However, 
independent studies have demonstrated similar developmental defects in B cells (Xu et al., 
1996).  However, more recent evidence suggest that ATM deficiency also impairs IgG class-
switch recombination (Lumsden et al., 2004) and result in low antibody titer (Reina-San-Martin 
et al., 2004; Xu et al., 1996), even though ATM is not essential for somatic hyper mutation 
(Reina-San-Martin et al., 2004).  
 
Based on the observations that high concentrations of all three CjejCDT subunits are present in 
detergent extracts of purified outer membrane preparations of C. jejuni suggests that it is 
primarily membrane-associated (Hickey et al., 2000; Lindmark et al., 2009).  Incubation of C. 
jejuni in the presence of 25 mM or 0.1% bile acid sodium deoxycholate, a concentration 
physiologically relevant to the intestinal lumen, releases the membrane-associated CdtA, CdtB 
and CdtC subunits into the culture supernatant (Hickey et al., 2005). We hypothesized that the 
increased release of CDT in the high deoxycholate diet environment could have a negative 
impact on the adoptive immune response because increasing concentrations of CDT might 
inhibit the proliferation or cause increased apoptosis in rapidly proliferating lymphocytes. The 
high cholate diet had an overall effect of reducing IgG1 responses against HhepWCL and 
HhepCdtB. Further, the response did not increase over time as compared to mice fed with 
conventional diet. Similar to mice fed with conventional diet, wild type mice had a significantly 
higher IgG1 response compared to Atm-null mice and the heterozygous mice had an 
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intermediate IgG1 response as compared to wild type and Atm-null mice. The difference 
between IgG1 responses of wild type and heterozygous mice were more pronounce in high 
cholate diet fed mice compared to mice fed with conventional diet.  Even though our mouse 
model does not fully reproduce human AT phenotype, which is caused by several point and 
truncating mutations, there is some evidence to support that Atm heterozygous mice are more 
susceptible to cancer and IR (Barlow et al., 1999; Spring et al., 2002; Worgul et al., 2002) 
 
However, preliminary quantitative assessment of bacterial load in cecal tissue at10 weeks p.i. in 
mice fed with conventional diet reveals a marginally high level of colonization in Atm null mice. 
However, the mice fed with high cholate diet had lower bacterial load compared to mice fed with 
conventional diet. Even in the mice fed with high cholate diet, high level of colonization was 
detected in Atm null mice. In this context, even though we can assume Atm defective mice are 
more susceptible to H. hepaticus infection, we cannot rule out any additional effects by the high 
cholate diet that might cause reduction in colonization levels of H. hepaticus.  
 
Additionally, we did not observe any significant intestinal inflammation during histopathological 
examination of uninfected or infected mice of any genotype euthanized at 4 or 10 weeks post 
challenge. This could be in part due to the shorter duration of the experiment or strain 
differences. Almost all previous studies H. hepaticus infection mice were performed with 
ATTCC reference strains investigation chronic infection and usually lasted for at lasted at least 
16 weeks post infection (Ge et al., 2005; Pratt et al., 2006; Young et al., 2004). Overall here we 
report for the first time that Atm null mice have reduced adaptive immune response against the 
infection with mouse pathogen H. hepaticus suggesting that DDR mechanisms are essential for 
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bacterial and CDT-specific host adaptive immune responses. Additionally, we provide 
interesting preliminary data for the future characterization of immune responses in Atm 
heterozygous mice and the effect of host diet in modulation of immune responses against CDT-
producing bacteria.  
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CHAPTER 6 
Summary and Future Directions 
It is well-established that the bacterial genotoxin, cytolethal distending toxin causes DNA 
damage in a wide range of eukaryotic cells in vitro and this result in a robust DNA damage 
response (DDR) in which ataxia telangiectasia mutated (ATM) plays a central role. Moreover, on 
the basis of a higher sensitivity of hematopoietic cells to CDT, it has been suggested that CDT 
modulates the host immune response in vivo. In chapter one,  we proposed the models for CDT-
induced cell cycle arrest and apoptosis based on most current literature and highlight the 
importance of investigating the CDT-induced G2/M and intra S-phase checkpoint. In chapter two 
we described the methods for the generation of mouse thymic lymphoma cell lines. We were 
able to generate several cell lines using this protocol and had been successfully used for our 
investigations.  In chapter three, for the first time we demonstrated the activation of the ATM-
dependent intra-S checkpoint by H. hepaticus CDT in primary mouse thymic lymphocytes and 
thymic lymphoma cell lines by observing a transient reduction in DNA synthesis (classical 
marker for intra S-phase checkpoint).  Further in chapter three, we demonstrated an ATM-
dependent reduction in phosphorylated histone H3 (classical marker for mitotic cells) and 
thereby definitively demonstrating CDT-mediated G2/M cell cycle arrest. Taken together, we 
provide first evidence to suggest that broadly conserved genotoxin CDT is capable of inducing 
cell cycle arrest in all phases of the cell cycle. 
 
In chapter four, using CDT from C. jejuni, we conclude that p53 mutational status highly 
correlates with the variable CDT-susceptibility of human lymphoma and leukemia cell lines. We 
also conclude that variable CDT-susceptibility of human lymphoma and leukemia cell lines does 
 226 
 
not significantly depend on the degree of activation of Akt pathway, which suggest that the 
major molecular mechanism of CDT-induced apoptosis is the nuclease activity of CdtB. We also 
report for the first time, the activation of Chk1 in human leukemia cell lines by CDT, suggesting 
the involvement of ATR in the DDR process and together with the absence of chromosomal 
breaks; this provides a new perspective for CDT-induced DDR. Finally in chapter five we 
assessed the adaptive humoral immune response induced by H. hepaticus infection in laboratory 
mice with a defective DDR due to mutation in Atm and demonstrate that ATM is are essential for 
bacterial and CDT-specific host adaptive immune responses.   
 
Therefore further investigation of molecular mechanisms involved in a potential synergistic 
activity between ATM and ATR, including the immune responses in ATR defective mouse 
model is suggested. Additionally investigating the pathways involved in p53-independent 
apoptosis, particularly Chk1/Chk2-E2F1/p73 axis will elucidate the molecular mechanisms of 
p53-indepent late apoptosis observed in certain cell lines. Finally, based on our clear in vitro 
evidence showing that p53 status highly correlates with differential CDT susceptibility of cell 
lines, investigating a H. hepaticus infection model on a p53 defective background will further 
enhance the understanding of CDT-induced DDR. 
 
 
